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Cancer progression can be driven by signalling via growth factors such as hepatocyte 
growth factor (HGF) and by the surrounding microenvironment. During initial 
tumour expansion intratumoral hypoxia can develop due to inadequate vasculature 
supply. To resist the negative effect of hypoxia, cells increase expression of 
transcription factor hypoxia-inducible-factor-1 (HIF-1α). However, little is known 
about how HIF-1α might influence the invasive behaviour of the cancer cells. Cell 
invasion requires actin cytoskeletal reorganisation and cells are thought to utilise 
specialised membrane protrusions termed invadopodia. Rho family GTPases Rac and 
Cdc42 through interaction with effector proteins p21-activated kinases (PAKs) are 
known to regulate actin cytoskeletal dynamics. Indeed, PAK1/2 are over-expressed 
in breast cancer however the role of PAK1/2 in invadopodia formation has not been 
fully investigated.    
This project sought to investigate the relationship between growth factor signalling, 
induction of HIF-1α expression and PAK activity during invadopodia formation in 
MDA-MB-231 cells. Analysis revealed that increased invadopodia formation can be 
induced by HGF. Furthermore, increasing levels of HIF-1α using 
dimethyloxaloylglicine (DMOG) treatment or overexpression of GFP-HIF-1α 
correlated with increased invadopodia activity that was dependent upon the 
expression of HIF-1α. Subsequent studies revealed that PAK1 and 2 are required for 
both HGF and DMOG induced invadopodia formation. However, whilst PAK1/2 
were activated downstream of HGF, there was no change in PAK1/2 expression 
levels or activity following DMOG treatment. Interestingly both DMOG treatment 
and HIF-1α overexpression did lead to up-regulation of cytoskeletal protein 
expression including β-PIX. β-PIX interacts with PAK1 but has not been previously 
linked to invadopodia formation. It is shown here for the first time that a reduction in 
β-PIX expression significantly reduced invadopodia activity following DMOG 
treatment. Overall, these studies demonstrate the dynamic nature of invadopodia 
formation; identify novel regulators of invadopodia activity and highlight the direct 
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Chapter 1 - Introduction  
1.1 Breast cancer metastasis 
Breast cancer is the second most common cause of death in women in western 
countries (Dumitrescu and Cotarla, 2005; Siegel et al., 2012). One in eight women 
develop breast cancer at some stage during their life (Jemal et al., 2007) and 
treatment is particularly difficult when metastasis occurs (Giretti et al., 2008). 
Diagnosis of advanced breast cancer represents a severe decrease in 5-year survival 
~(23.3%) compared with localised forms of the disease ~(98.3%) (Hayat et al., 
2007). 
 
The term, metastatic, describes a cancer that has spread to distant organs from the 
original tumour site. Metastatic breast cancer is the most advanced stage of breast 
cancer (Hunter et al., 2008) where cancer cells have spread past the breast and 
axillary (underarm) lymph nodes to other areas of the body, where they continue to 
grow and proliferate. Breast cancer has the potential to spread to almost any region 
of the body. The most common region is the bone, followed by the lung and liver. 
Treatment of metastatic breast cancer generally focuses on relieving symptoms and 
extending a woman‟s lifetime. Breast cancer often begins in the breast ducts as 
ductal carcinoma in situ (DCIS) (Hunter et al., 2008).  
 
In some cases, cancer cells may spread into the bloodstream without being detected 
in the lymphatic system. In ~10% of breast cancer diagnoses, the cancer cells have 
already spread to distant organs in the body. A primary diagnosis of Stage IV breast 
cancer may indicate a rapid progression of the disease or that the cancer was present 
but not detected in the breast for some time. Despite the recent improvements in 
survival rates, many patients relapse, and the majority of these patients die because 
of disseminated metastatic disease, which supports the critical need for new 







1.2       Metastatic cascade 
Cancer metastasis involves a series of changes in cell behaviour, driven by 
oncogenic transformation, which leads to local invasion of the basement membrane 
and surrounding tissue, migration through tissue, entry or intravasation into the 
blood vessels (vascular) or lymphatic system and survival there, followed by 
extravasation/colonization and growth at different organ sites (figure 1.1) (Siegel et 
al., 2011; Sporn, 1996). To achieve these steps, precise coordination of cell 
movement and matrix remodelling are essential (Friedl and Wolf, 2003). Each of 
these steps requires a recognised molecular program in which the regulation of the 
adhesive, migratory and cytoskeletal properties of the spreading tumour cells play 
pivotal roles (Yilmaz and Christofori, 2009). At any given time, only a small 
proportion of tumour cells are invading and disseminating (Wang et al., 2004). 
Understanding the mechanisms that drive invasive migration of these tumour cells is 
crucial to better understand metastasis.  
 
The acquisition of an invasive phenotype is a hallmark of metastatic cancer and 
signifies a poorer prognosis (Hanahan and Weinberg, 2000). One of the key aspects 
of tumour metastasis is that tumour cells transform from local, non-invasive 
confined cells to migrating, metastatic cancer cells. This transition process is 
initiated when the cells obtain the ability to dissociate from intercellular adhesions 
and become motile (Friedl and Wolf, 2003), which is usually driven by complex 
regulatory signalling cascades that transiently and/or permanently alter the 
expression of multiple proteins that act to reorganize the cytoskeletal network 
(Kedrin et al., 2007; Yamazaki et al., 2005).  
 
Invasion into the surrounding stromal tissues requires the coordinated regulation of 
both actin cytoskeletal rearrangement and cell substratum adhesion turnover (Chaffer 
and Weinberg, 2011; Chambers et al., 2002) (figure 1.1). To successfully migrate 
through the stromal microenvironment, cells must be able to extend processes 
(lamellipodia, filopodia, invadopodia), anchor these nascent protrusions to the 
underlying matrix (cell adhesions), generate the forces required for forward 
movement and ultimately dissolve adhesions at the rear of the cell (Friedl and 





Figure 1.1 Progression of metastatic cancer. Schematic representation of epithelial 
carcinoma as a multistage process beginning with oncogenic transformation of cells, 
aberrant growth and proliferation to form a primary tumour. Tumour cells eventually acquire 
a migratory phenotype and invade their surrounding extracellular matrix (ECM) in a process 
possibly involving interplay with non-tumour cells such as fibroblasts. Cells metastasise, 
entering blood or lymphatic vessels by intravasation. At some point, metastatic cancer cells 
will attach and extravasate, establishing a secondary site. 
 
 
Invasion is a key ability of cells in a variety of both physiological and pathological 
scenarios, including migration of immune cells to sites of infection or dissemination 
of cancer cells during metastasis. In all cases, cells encounter barriers hindering their 
mobility such as blood vessel walls, tissue boundaries and more importantly, the 
meshwork of the extracellular matrix (ECM). This complex network of fibrillar 
proteins and polysaccharides bridges the intercellular space, where it functions as a 
surface for cell adhesion molecules and supports tissue connectivity and 
differentiation (Hynes, 2009). Cancer cell invasion involves rapid production of 





Depending on the meshwork size of the ECM, cells are either able to undergo 
amoeboid, non-lytic invasion through interfibrillar gaps or are forced to 
proteolytically degrade denser matrix material (Friedl and Wolf, 2003). Recent 
evidence indicates that, in vivo, covalent cross-links are typically present between 
ECM fibers, which would favour proteolytic mechanisms of invasion (Sabeh et al., 
2009). Therefore, the mechanisms of localised ECM degradation are likely of central 
importance for cell invasion in both health and disease. 
 
1.3       Promotion of cancer cell metastasis by environmental factors 
 
Migration and invasion of cells in tumour stroma result from co-operation among 
protrusive, adhesive, contractile, and proteolytic mechanisms. These occur as a result 
of the combined influence that both tumour and stromal cells have on the content and 
architecture of the ECM, as well as on the autocrine and paracrine production and 
activation of proteinases and growth factors (Hanahan and Weinberg, 2000). The 
aberrant proliferation of cells harbouring oncogenic lesions is challenged by multiple 
layers of mechanisms that affect tumour formation. Whilst several of these barriers 
are intrinsic to the cell, an entirely distinct class of pressures comes from sources that 
are extrinsic to the cancerous cells. Factors in the tumour microenvironment that 
influence tumour progression includes growth factors and the limited availability of 
nutrients and oxygen. How tumour cells respond to these external cues influences, 
sometimes in dramatic fashion, their metastatic potential (Fidler, 2003).  
 
1.3.1 Growth factors 
 
Extrinsic factors in the tumour microenvironment can promote the invasion of cancer 
cells. Indeed, micro-metastases are often genetically heterogeneous, suggesting that 
invasive behaviour might not be entirely intrinsically specified (Klein et al., 2002). 
Growth factor signalling can modulate invasive activity either directly or indirectly. 
The complex microenvironment surrounding tumour cells contains migration-
stimulating factors such as vascular endothelial growth factor (VEGF) and basic 
fibroblast growth factor (bFGF) produced by tumour cells themselves; matrix 
metalloproteinases (MMPs) and urokinase-type plasminogen activator (uPA) 
produced by fibroblasts and endothelial cells, transforming growth factor-β (TGF-β) 
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also produced by tumour cells or released from the ECM by proteinase activity and 
platelet-derived growth factor (PDGF) produced by tumour cells (Liotta and Kohn, 
2001). 
 
Tumour-associated macrophages express epidermal growth factor (EGF) and 
promote EGF receptor-dependent carcinoma cell invasion in vivo (Wyckoff et al., 
2004). Accumulating evidence suggests that EGF receptor ligands and the EGF 
receptor signalling pathway are critical for the invasiveness and metastasis of cancer 
cells. Furthermore, invasive carcinoma cells and tumour-associated macrophages 
have been shown to interact through the CSF-1/EGF paracrine loop, which enhance 
migration, invasion and intravasation of carcinoma cells (Goswami et al., 2005; 
Wyckoff et al., 2004).      
 
Myofibroblasts can promote „mesenchymal‟ cancer cell invasion by producing 
hepatocyte growth factor (HGF)/scatter factor (SF), which is the ligand for the c-Met 
receptor (De Wever et al., 2004). Whilst HGF/SF-induced cellular effects are 
required for many normal physiological processes, aberrant Met activation has been 
implicated in most types of solid tumours, often correlating with poor prognosis. In 
this case, activation of c-Met leads to an invasion process by which tumour cells 
weaken tissue constraints, migrate and colonise foreign districts resulting in 
metastasis (Birchmeier et al., 1997). More specifically, the exposure of Met-
expressing cells to HGF/SF can elicit a variety of cellular responses including 
proliferation, migration, invasion and branching morphogenesis (Birchmeier et al., 
2003; Gao and Woude, 2005). 
 
1.3.2 Hypoxia 
Breast epithelial cells, similar to other epithelia, are able to survive and differentiate 
because of the tissue architecture and the growth factor milieu present in the 
mammary gland (Hagios et al., 1998). This rich environment, however, is 
progressively lost during malignant transformation, especially as malignant cells 
become invasive and metastatic. Such cells must acquire mechanisms that maintain 
their survival and promote their invasion outside the confines of the mammary gland 
(Fearon, 1999; Hanahan and Weinberg, 2000). Alongside growth factors in the 
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tumour microenvironment, tumour cells must survive under environmental stresses 
not present in normal tissue. One of the most formidable barriers to their survival is 
hypoxia (Brown, 1999), which is emerging as a major factor that shapes the 
aggressiveness of breast tumours. The oxygen tension within many solid tumours is 
substantially less than that in the adjacent normal tissue usually with pO2 values less 
than 5-10mmHg (Brown, 1999; Brown and William, 2004; Travers, 2006).  
 
This phenomenon is due to poor vascularisation during tumour expansion (Brown, 
1999; Hockel and Vaupel, 2001). Although hypoxia can destroy most normal cells 
and some tumour cells, it also provides a strong selective pressure for the survival of 
the most aggressive and metastatic cells. In fact, clinical studies have clearly shown 
that the low pO2 tension within a neoplastic lesion is an independent prognostic 
indicator of poor outcome and correlates with an increased risk to develop distant 
metastasis irrespective of therapeutic treatment (Brown, 1999; Hockel and Vaupel, 
2001). Although a limiting factor for tumour growth, hypoxia alters important 
intracellular pathways and is recognised as a positive stimulus for invasion, 
angiogenesis and metastasis (Semenza, 2002). Tumour cells unlike normal cells, are 
able to survive adverse hypoxic conditions through a diversity of mechanisms 
(Reynolds et al., 1996; Semenza, 2003; Xie and Huang, 2003) including changes in 
gene expression, inactivation and/or activation of genes and enhanced genomic 
instability (Denko et al., 2003; Lal et al., 2001; Semenza, 2000; Semenza, 2006; 
Vaupel, 2004). Cells that are able to resist the negative effects of low oxygen 
conditions and then competitively flourish in hypoxic environments have been 
shown to be highly dependent on the expression of the transcription factor hypoxia-
inducible-factor-1 (HIF-1) (Semenza and Wang, 1992). HIF is activated in low 
oxygen (1% O2) and coordinates extensive changes in transcription, which leads to 
broadly adaptive changes, including increased erythropoiesis, glycolysis, and 
angiogenesis (Maxwell, 2005). HIF-1 was discovered in 1992 when the mechanisms 
of hypoxia that induce erythropoietin expression were dissected (Semenza and 
Wang, 1992). One of the best characterised HIF-dependent genes is the potent 
endothelial mitogen, VEGF, which regulates endothelial cell proliferation and blood 




Approximately 40% of breast carcinomas examined were found to contain hypoxic 
tissue areas (pO2 of <2.5mmHg) (Vaupel et al., 1991). Up-regulation of HIF-1α 
signalling pathways have been associated with the molecular expression signature of 
micro metastasis in human breast cancer (Woelfle et al., 2003). HIF-1α is over-
expressed in most common human cancers, including breast, brain, cervical, colon, 
lung, ovarian and prostate (Semenza, 2002) and has been associated with increased 
blood vessel density, tumour aggressiveness and poor prognosis (Vleugel et al., 
2005). In early stage cervical carcinoma, HIF-1α over-expression is correlated with 
patient mortality (Birner et al., 2000). Also, during early stages of esophageal cancer, 
HIF-1α over-expression is associated with failure to achieve a complete response to 
radiotherapy (Koukourakis et al., 2001). 
 
1.3.3 HIF-1 structure 
HIF-1 is a heterodimeric protein that is composed of an O2-dependent 120 kDa HIF-
1α subunit and a 91-94 kDa constitutively expressed aryl hydrocarbon (Ah) nuclear 
receptor translocator (ARNT), also known as HIF-1β (Wang, 1995). Both 
polypeptides belong to the basic helix-loop-helix (bHLH)-PAS family (PAS is an 
acronym for the three members first recognised: Per, ARNT, Sim). In HIF-1α and 
HIF-1β, the N-terminal bHLH domain precedes the PAS domains (figure 1.2). The 
basic domain is essential for DNA binding, whereas the HLH and the PAS domains 
are necessary for hetero-dimerization. Both polypeptides contain nuclear localization 
signals (NLS). Functionally important are two transcriptional activation domains 
(TAD) in HIF-1α, an N-terminal TAD (N-TAD) that partially overlaps with the 
oxygen-dependent degradation domain (ODDD) and a C-terminal TAD (C-
TAD)important for cofactor recruitment (figure 1.2). HIF-1α belongs to a family of 
related proteins including HIF-2α (Tian et al., 1997) and HIF-3α (Gu et al., 1998). 
While both HIF-2α and HIF-3α show similar biochemical properties such as hetero-
dimerization with HIF-1β, their biological functions remain unclear. HIF-2α has 
extensive sequence similarity to HIF-1α; it is also regulated by proline and 
asparagine hydroxylation, dimerizes with HIF-1β and activates transcription of a 
group of target genes that overlaps with, but is distinct from those regulated by HIF-
1α (Lau et al., 2007). In contrast, it has been proposed that HIF-3α is an inhibitor of 
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HIF-1 that may be involved in feedback regulation because its expression is 
transcriptionally regulated by HIF-1 (Makino et al., 2007) 
 
Figure 1.2 Schematic representation of HIF-1α and its four functional domains. The 
basic-helix-loop-helix (bHLH) and PER-ARNT-SIM (PAS) domains of hypoxia-inducible 
factor-1α (HIF-1α) are involved in dimerization and DNA binding; the oxygen-dependent 
degradation domain (ODDD) is required for degradation via the proteasome; and the 
transactivation domains (N-TAD and C-TAD) are involved in transactivation activity. 
Hydroxylation of proline residues 402 and 564 within the ODDD mediates its interaction 
with the von Hippel-Lindau tumour suppressor protein (pVHL). Hydroxylation of 
asparagine 803 in the C-TAD blocks its association with transcriptional co-activator 
p300/CBP. Adapted from (Poon et al., 2009) 
 
 
1.3.4 HIF-1 Regulation 
HIF-1 activity is primarily regulated by the abundance of the α-subunit. Although the 
HIF-1α gene is constitutively transcribed, HIF-1α is highly unstable and virtually 
undetectable at normal oxygen levels (normoxic condition 20% O2) due to its oxygen 
dependent degradation. In contrast, HIF-1β is constitutively found in the nucleus of 
all cells (Wang, 1995). HIF-1α is subjected to O2-dependent hydroxylation on 
proline residue 402 and 564 by prolyl hydroxylase domain protein 2 (PHD2).  Both 
residues are situated in the oxygen-dependent degradation domain (ODDD) of HIF-
1α (figure 1.3). Three different HIF prolyl-hydroxylases have been described, 
termed PHD1, PHD2, and PHD3 by way of their different prolyl hydroxylase 
domain (Bruick and McKnight, 2001; Epstein et al., 2001). Although all three PHDs 
have been shown to regulate HIF-1α, the key isoform responsible for HIF-1α 
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regulation in many cell types is PHD2 (Appelhoff et al., 2004; Berra et al., 2003). It 
has been shown that PHD1 and PHD3 also hydroxylate HIF-1α in vivo and in vitro. 
However, the exact relevance of these two isoforms in cells remains to be elucidated 
(Appelhoff et al., 2004; Epstein et al., 2001). PHD enzymes hydroxylate HIF-1α 
using oxygen and 2-oxoglutarate as substrates and iron and ascorbate as essential 
cofactors (figure 1.3). This modification creates an interface for interaction with the 
von Hippel-Lindau tumour suppressor protein (VHL), which recruits an E3 
ubiquitin-protein ligase that catalyzes polyubiquitination of HIF-1α, thereby 
targeting it for proteosomal degradation (Kaelin and Ratcliffe, 2008).  
 
Under hypoxic conditions (~1% O2), the major substrate dioxygen is unavailable and 
thus hydroxylation is inhibited and HIF-1α can escape degradation, instead it rapidly 
accumulates and translocates into the nucleus to dimerize with HIF-1β (figure 1.3). 
The heterodimeric HIF-1 complex binds to the conserved DNA binding sequence, 
5‟-RCGTG-3‟ (where R is either an A or G), in the hypoxia response element (HRE) 
on the promoter region of target genes. HIF activates the transcription of its target 
genes such as the proangiogenic growth factor, VEGF, heme oxygenase, glucose 
transporter-1 (GLUT1), and erythropoietin (EPO) (Semenza and Wang, 1992; Wang, 
1995) by recruiting additional coactivators/cofactors such as p300, CREB binding 
protein (CBP) and steroid receptor coactivator (SRC)-1.  
 
HIF-1α activity is also controlled by O2-dependent hydroxylation of asparagine-803 
in the C-TAD of HIF-1α. This is mediated by the asparagine hydroxylase factor 
inhibiting HIF-1 (FIH-1) which acts by blocking the interaction of HIF-1α with 
coactivators p300 and CBP under normoxic conditions (Lando et al., 2002). Both 
PHD2 and FIH-1 utilize O2 and α-ketoglutarate as substrates and generate CO2 and 
succinate as by-products of the hydroxylation reaction. Additionally, Siah-1 (a 
ubiquitin ligase) has been identified as facilitating proteosomal FIH degradation 





Figure 1.3 Regulation of HIF-α during normoxia and hypoxia. In the presence of 
oxygen, HIF-α is hydroxylated (OH) at two proline residues (P) and one asparaginyl residue 
(N). These lie within the oxygen dependent degradation domain (ODDD) and C-terminal 
transactivation domain (CTAD) respectively. The prolyl hydroxylation leads to capture by 
von Hippel-Lindau tumour suppressor (VHL). The asparaginyl hydroxylation blocks co-
activator recruitment. This results in HIF destruction. In the absence of hydroxylation under 
hypoxic conditions, HIF-α moves to the nucleus where it heterodimerises with HIF-
1β/ARNT and the CTAD recruits the co-activator CBP/P300 and activates expression of 
target genes. Adapted from (Kiriakidis et al., 2007). 
 
 
Members of the CITED (CBP/p300 interacting transactivator with ED-rich tail) 
family, such as CITED2 (Bhattacharya et al., 1999) and CITED4 (Fox et al., 2004), 
were found to bind to p300. This binding disrupts the interaction between p300 and 
HIF-1α, thus inhibiting HIF-1 transactivation and gene expression during hypoxia. 
An alternative splicing product of the HIF-3α locus named inhibitory PAS protein 
(IPAS) has been found to function as a dominant negative regulator of HIF function 
(Makino et al., 2001). IPAS complexes with HIF proteins and thereby impairs 
productive interaction between HIF and hypoxia response elements of target genes. 
This inhibitory protein lacks the transactivation domain and is expressed mainly in 




The levels of HIF-1α expression and activity are also controlled by major signal 
transduction pathways, including those involving phosphatidylinositol 3-kinase/Akt 
and mitogen-activated protein kinase (MAPK/ERK). Under normoxic conditions, 
growth factors and cytokines induce PI3K and its downstream effectors Akt, mTOR 
and p70S6K, leading to increased HIF-1α levels (Bardos and Athcroft, 2004). 
Activation of Src, which lies downstream of receptor tyrosine kinases and upstream 
of the PI3K pathway, also induces HIF-1α expression (Jiang et al., 1997). Yet, the 
mechanism by which the PI3K pathway potentiates HIF-1 activity under hypoxic 
conditions remains unclear and moreover, it is not known whether GSK3β, a 
downstream target of Akt, plays a role. However, under prolonged hypoxia it may be 
that GSK3β prevents the accumulation of HIF-1α (Schnitzer et al., 2005). ERK1/2 
MAP kinases have been shown to phosphorylate HIF-1α at specific sites and are 
mainly thought to be implicated in the nuclear accumulation and transcriptional 
activity of HIF-1α (Sang et al., 2003). 
 
1.3.5 HIF-1α in cancer cell invasion  
HIF-1α is involved in tumour angiogenesis and metastasis by regulating genes 
involved in the response to hypoxia. Clinical evidence showed that HIF-1α is 
associated with a worse prognosis in patients with invasive breast carcinoma (Dales 
et al., 2005). An important property of tumour cells that are able to survive under 
hypoxia is that they exhibit an enhanced propensity to invade (Le et al., 2004), a 
finding that underscores the hypothesis that hypoxia facilitates tumour progression. 
An understanding of the mechanism by which hypoxia stimulates invasion would 
provide insight into the nature of invasion itself. HIF-1 acts as a master regulator of 
oxygen-regulated gene expression. Four groups of direct HIF-1 target genes 
particularly relevant to cancer, encode angiogenic factors, proliferation/survival 
factors, glucose transporters/glycolytic enzymes and invasion factors (Semenza, 
2003). The products of the genes that HIF-1 regulates act at several steps in the 
invasive migration processes. Invasion of the basement membrane is the defining 
characteristic of epithelial cancers. Epithelial cells are normally constrained by cell-
cell contacts and by the basement membrane. Basement membrane disruption, 
through a proteolytic cascade (Krishnamachary et al., 2003) which digests the 
basement membrane/ECM, was shown to be promoted by HIF-1α-dependent up-
regulation of cathepsin D (CTSD), proteases including uPAR and matrix 
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metalloproteinase-2 (MMP2). Subsequently as a result of hypoxia, degraded ECM is 
replaced by the production of fibronectin-rich matrix and other ECM proteins that 
are recognised by integrins expressed on the cancer cell surface (Krishnamachary et 
al., 2003). Hypoxia-induced HIF-1α also up-regulates expression of lysyl oxidase 
(LOX), an extracellular enzyme that covalently modifies collagens to increase focal 
adhesion kinase (FAK) activity, cell migration and metastasis (Erler et al., 2006). 
Another mechanism inducing increased invasive migration is through the activation 
or over-expression of surface tyrosine kinase c-Met receptors by HIF-1α 
(Pennacchietti et al., 2003). Following c-Met over-expression, tumour cells can then 
respond to HGF, which is produced at an elevated level, under hypoxia (Ide et al., 
2006) . 
 
HIF-1α protein has been suggested to be a key factor in glioma cell migration and 
invasion under hypoxic conditions. It has also been reported that chondrosarcoma 
cell invasion is increased by hypoxia induced expression of CXCR4 and MMP1 and 
is mediated by HIF-1α  and ERK (Sun et al., 2010). Recently, Ras was shown to be 
activated in response to hypoxia, which then aids stabilization of HIF-1α, and in turn 
upregulates MMP-9 expression (Choi et al., 2011). MMP-9 is upregulated 
concurrently with HIF-1α in tumour tissues from patients with breast cancer 
suggesting that HIF-1α promotes cell invasion through an MMP-9-dependent 
mechanism (Choi et al., 2011). 
 
Rho GTPases have been implicated in oxygen sensing since Rac1 was identified as a 
component of the NADPH oxidase complex in phagocytes (Abo et al., 1992). 
Subsequent studies demonstrate that Cdc42 activity is required for hypoxia-induced 
activation of HIF-1α in renal carcinoma cells (Turcotte et al., 2003). Small GTPases 
are involved in the motility and invasion of a variety of carcinoma cell lines and 
have emerged as important control elements in the reorganization of the actin 
cytoskeleton and vesicular trafficking (Oxford and Theodorescu, 2003). Hypoxia 
was shown to induce activation of RhoA in breast carcinoma as early as 6 hours after 
hypoxia exposure (Munoz-Najar et al., 2006). Additionally, dominant-negative 
expression of RhoA specifically blocked hypoxia-induced invasion and plasma 
membrane localization of  MT1-MMP (Munoz-Najar et al., 2006) confirming a role 




Recently, over-expression of RhoE in normoxia or hypoxia-induced HIF-1α 
expression was shown to up-regulate the mesencymal marker Vimentin, down-
regulate the epithelial marker E-cadherin, and significantly increase cell invasion in 
vitro (Zhou et al., 2011). In gastric cancer cells, RhoE was identified as a direct 
target of HIF-1 and extopic expression of the Rho GTPase in these cells induced the 
up-regulation of MMP2/MMP-9. Therefore, RhoE up-regulation represents a pivotal 
cellular adaptive response to hypoxia with implications in gastric cancer cell 
invasion (Zhou et al., 2011).  
 
Rac1 has been demonstrated as an intermediate in the PI3K-mediated induction of 
HIF-1α (Xue et al., 2011). There was a significant down regulation of the tumour 
suppressor genes p53 and VHL in cells expressing a constitutively active form of 
Rac1. Rac1-mediated inhibition of p53 and VHL could therefore be causal in the up 
regulation of HIF-1α expression (Xue et al., 2011). Hypoxia was shown to stimulate 
cell invasion by stabilizing microtubules and promoting α6β4 integrin trafficking to 
the plasma membrane (Yoon et al., 2005).  
 
Since this study was initiated, one report has suggested that hypoxia promotes 
invadopodia formation in human fibrosarcoma cells (Lucien et al., 2011). Hypoxia 
increases the activity of NHE-1 (a pH-regulator in cancer cells) which occurs in a 
HIF-1 independent manner and NHE-1 was found to be required for hypoxia-
induced invadopodia formation and function in cancer cells (Lucien et al., 2011).  
However, so far, there is no evidence to show a direct effect of increased HIF-1α 
expression on invadopodia formation and matrix degradation in breast carcinoma 
cells.  
  
1.4       Invadopodia as a marker of invasive potential 
Invasion of cells through layers of extracellular matrix is a key step in tumour 
metastasis (Weaver, 2006). Stages of invasion include adhesion to the matrix, 
degradation of proximal matrix molecules, extension and traction of the cell on the 
newly revealed matrix, and movement of the cell body through the resulting gap in 
the matrix. To become invasive, the first barrier that tumour cells must overcome is 
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their epithelial basement-membrane. In order to cross the basement membrane, 
tumour cells are thought to require specialised membrane protrusions in the direction 
of cell movement. These structures are rich in actin filaments, integrins, tyrosine 
kinase signalling machinery, adhesion proteins, membrane-type and secreted 
proteases (MMPs) and signalling proteins that regulate the actin cytoskeleton and 
membrane remodelling. These protrusions are termed invadopodia. There is growing 
evidence that the formation of invadopodia is part of the invasion process (Eckert et 
al., 2011; Yilmaz and Christofori, 2009). It is currently unclear the degree to which 
carcinoma cells must proteolytically digest the epithelial basement membrane as they 
initially invade, and whether stromal cells are also involved in this process. 
However, recently there is evidence for the involvement of invadopodia-mediated 
proteolysis of vascular basement membrane during intravasation and metastasis 
(Gligorijevic et al., 2012). Localised proteolytic activity of invasive cells has been 
demonstrated when these cells are cultured on different substrates such as gelatin, 
fibronectin, collagen type I, collagen type IV or laminin (Chen, 1989; Kelly et al., 
1994; Mueller and Chen, 1991).  
 
1.4.1 Discovery 
Invadopodia were discovered in Rous sarcoma virus-transformed fibroblasts, driven 
by oncogenic vSrc tyrosine kinase (Chen, 1989). Src-transformed cells grown on 
fibronectin formed prominent ventral protrusions with adhesive (Tarone et al., 1985) 
and degradative properties (Chen et al., 1984). In addition, vSrc was found to 
localise at the sites of fibronectin degradation (Chen et al., 1985). Invadopodia were 
subsequently described in invasive tumour cells such as human malignant breast 
tumour cells MDA-MB-231 (Chen et al., 1994) and human malignant melanoma 
cells (Aoyama and Chen, 1990). Moreover, these specialised structures have been 
identified in cell lines or primary tumour cells from malignant melanoma 
(Baldassarre et al., 2003; Mueller et al., 1999; Seals et al., 2005; Tague et al., 2004), 
breast/mammary carcinoma (Artym et al., 2006; Hashimoto et al., 2004; Lorenz et 
al., 2004), glioma (Angers-Loustau et al., 2004; Chuang et al., 2004), head and neck 
squamous cell carcinoma (Clark et al., 2007) and prostate carcinoma cells (Desai et 
al., 2008). Invadopodia are distinct from other cell adherence sites such as focal 
contacts and focal adhesions. Indeed, these adhesions are not traditionally associated 
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with proteolytic activity (Chen, 1989). However, a recent study has shown that focal 
adhesions can also promote matrix degradation activity in highly invasive cells 
(Wang and McNiven, 2012).  
 
1.4.2 Molecular characteristics of invadopodia 
At the ultra-structural level, invadopodia are filament-like extensions protruding 
from the ventral surface of cells adherent to matrix (figure 1.4). The size of 
invadopodia ranges from 8-10 µm in diameter and reach up to 5 µm in depth 
(Linder, 2009). Time-lapse image analysis has shown that invadopodia are formed 
de novo and their lifetime varies from minutes to several hours. An in vitro matrix 
degradation assay is used to detect invadopodia activity (Artym et al., 2006; Chen et 
al., 1984; Yamaguchi et al., 2006). In this assay, cells are seeded on two-dimensional 
(2D) surfaces coated with matrix proteins, and form invadopodia at the ventral 
surface. Routinely, the matrix is fluorescently-labelled native ECM substrates for 
example fibronectin or with substitute proteins such as gelatin (denatured collagen) 
(figure 1.4). Digestion of matrices by invadopodia at discrete sites under the cells 
results in fluorescence-negative cavities with dot-like accumulations of F-actin 
which are detected by fluorescence microscopy (Artym et al., 2009). Recently, a 
study demonstrated that cells assemble invadopodia-like structures and invade into 
matrigel in a circular invasion assay (Yu and Machesky, 2012). This assay is 
proposed to be useful for comparison of cell migration parameters with cell invasion 
and for visualizing cells whilst they interact with a 3D matrix but still remain close 
to a glass surface.  
 
Invadopodia are often highly enriched with actin filaments (F-actin) and components 
required for actin assembly including the Arp2/3 actin-nucleating complex, neural 
Wiskott Aldrich Syndrome protein (N-WASP) and cortactin (Artym et al., 2006; 
Buccione et al., 2004; Clark et al., 2007; Linder, 2007; Lorenz et al., 2004; Mizutani 
et al., 2002). Tyrosine phosphorylation of cortactin causes its dissociation from 
cofilin enabling cofilin to generate barbed ends by severing actin filaments and thus 
initiating actin polymerization (Oser and Condeelis, 2009; Oser et al., 2009). After 
barbed end formation, cortactin is dephosphorylated, which blocks cofilin severing 
activity thereby stabilizing invadopodia and the maturation of invadopodia (Oser et 
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al., 2009; Yamaguchi et al., 2005). Live cell kinetic studies have identified four 
distinct phases of invadopodia maturation on the basis of i) localisation of cortactin 
to ventral actin puncta, ii) the recruitment of membrane type-1 matrix 
metalloproteinases (MT1-MMP) to these sites, iii) the appearance of degraded foci in 
the underlying matrix, and iv) the dissociation of cortactin from these sites (Artym et 







Figure 1.4 Confocal microscopy image of double immunofluorescence labelling of MDA-
MB-231 carcinoma cells plated on TRITC-conjugated gelatin: (A) invadopodia structures 
marked by phalloidin-488; (B) invadopodia structures marked by anti-cortactin antibody; 
(C) degradation areas on the underlying TRITC-conjugated gelatin. Arrows indicate the 
colocalization between actin, cortactin and puncta of degraded extracellular matrix (ECM). 
 
 
Other features that can be used to recognize invadopodia in some cell lines, include 
their localisation close to the nucleus and proximal to the Golgi complex, the central 
regulator for intracellular trafficking (Baldassarre et al., 2003), and their extended 
half-life of up to two hours or more (Baldassarre et al., 2006; Yamaguchi et al., 
2005) in comparison to other protrusive adhesions. Cell culture in 3D that mimics 
the in vivo environment has been used to reveal differences in the morphology, 
metabolism and survival of cancer cells (Murphy and Courtneidge, 2011). There is 
much circumstantial evidence to suggest that invadopodia are physiologically 
relevant structures. Recent studies have used 3D systems to address invadopodia 
formation and function, by which invading cells were thought to frequently extend 
long protrusions that degrade the matrix (Friedl and Gilmour, 2009; Schoumacher et 




(A) (B) (C) (D) 
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1.5     Induction of invadopodia formation 
Studies have shown that stimulation with growth factors, such as platelet-derived 
growth factor (PDGF) (Eckert et al., 2011) and transforming growth factor-β (TGFβ) 
(Rottiers et al., 2009) induces invadopodia in cancer cells and podosome formation 
in normal cells respectively. These stimuli elicit the phosphorylation and/or 
activation of the key invadopodia-associated proteins through canonical signalling 
pathways. 
 
1.5.1 Stimulation by EGF/HGF 
EGF is a well-known growth factor that induces dynamic cell protrusions associated 
with the actin cytoskeleton. EGF and CSF-1 stimulation enhances invadopodia 
formation and ECM degradation in metastatic rat MTLn3 mammary carcinoma cells 
and podosomes in macrophages, respectively (Yamaguchi et al., 2005; Yamaguchi et 
al., 2006). Recently, EGF has also been implicated in the induction of invadopodia 
formation in human breast carcinoma cells (Mader et al., 2011). However, this work 
is still preliminary and has not been validated across several human cell lines from 
other tissue types. 
 
In LOX melanoma cells, HGF stimulation of endogenous c-Met is implicated in 
enhancing matrix substrate degradation, possibly via induction of invadopodia 
activity (Tague et al., 2004). This effect of HGF was completely suppressed by a 
dominant negative mutant of small GTPase, ADP-ribosylation factor 6 (Arf6) 
(Tague et al., 2004). Recently, a report has suggested that HGF promotes 
invadopodia formation in breast carcinoma cells and that this formation is dependent 
on Met activity (Rajadurai et al., 2012). Furthermore, Met localizes to invadopodia 
along with cortactin and promotes phosphorylation of cortactin (Rajadurai et al., 
2012).   
 
1.5.2 Rho family GTPases 
Invadopodia formation requires reorganization of the actin cytoskeleton. The Rho 
family small G proteins, consisting of the Rho, Rac and Cdc42 subfamilies, are 
implicated in various cell functions, such as cell shape change, adhesion, motility, 
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and invasion through their ability to coordinate reorganization of the actin 
cytoskeleton (Hall, 1998; Takai et al., 1995). 
 
Rho, Rac and Cdc42 are the most studied Rho family GTPases, these proteins act as 
molecular switches existing in two conformational states, inactive-GDP and active-
GTP bound (Jaffe and Hall, 2005). Only in a GTP-bound state are these proteins able 
to bind effector proteins and transfer signals from a pool of membrane receptors such 
as cytokine and growth factor, adhesion and G-protein receptors (Buchsbaum, 2007; 
Juliano, 2002). The intrinsic exchange of GDP for GTP within the Rho family is 
relatively slow and is accelerated by their association with guanine nucleotide 
exchange factors (GEFs). Small Rho GTPases are known to regulate many 
cytoskeleton-dependent processes such as changes in cell shape, cell adhesion, cell 
spreading, cell migration and cell polarity (Hall, 2005). RhoA maintains the 
development of contractile actomyosin bundles (stress fibres) and focal adhesions, 
Rac1 organizes the creation of actin-rich protrusions (lamellipodia) as well as 
membrane ruffling, and Cdc42 regulates filopodia and the formation of peripheral 
actin microspikes (Hall, 2005).  
 
Rac and Cdc42 have been implicated in the formation of invadopodia in human 
melanoma cells by way of a dominant active mutant of Cdc42 which enhanced dot-
like degradation; whereas a dominant active mutant of Rac enhanced diffuse-type 
degradation (Nakahara et al., 2003). Furthermore, over-expression of frabin, a 
GDP/GTP exchange protein (GEF) for Cdc42 with F-actin-binding activity, 
enhanced both dot-like and diffuse-type degradation. However, a dominant active 
mutant of Rho did not affect the matrix degradation. Moreover, inhibition of 
phosphatidylinositol-3 kinase (PI3K) disrupted the Rac and Cdc42-dependent actin 
structures and blocked the matrix degradation (Nakahara et al., 2003). Additionally, 
the expression of activated versions of Cdc42 and Rac1 has been suggested to induce 
primary rat aorta vascular smooth muscle cells (VSMCs) to form extracellular 
matrix-degrading actin-rich protrusions that are morphologically similar to the 
invadopodia formed by highly invasive tumor cells (Furmaniak-Kazmierczak et al., 
2007). Generation of membrane curvature is also crucial for invadopodia assembly. 
Recently, the F-BAR-containing protein CIP4 has been implicated in invadopodia 
(Pichot et al., 2010). CIP4 also binds Cdc42 and N-WASP, therefore acting as a 
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membrane-curving scaffolding protein. RhoA has also been implicated in 
invadopodia formation, however its contribution remains poorly understood; apart 
from a possible role in regulating exocyst binding to IQGAP1, which can also be 
mediated by Cdc42 (Buccione et al., 2009).  
 
Over 70 effector proteins have been outlined to bind the Rho GTPases (Bishop and 
Hall, 2000; Bustelo et al., 2007). The best characterised effector proteins that bind to 
activated Rac and Cdc42 are the p21-activated kinases (PAKs), which were the first 
Rho family GTPase-regulated kinases to be identified (Manser et al., 1994). Herein, 
this study will focus on PAK1/2 family proteins in mediating cytoskeletal signalling 
events that contribute to cancer cell invasion particularly invadopodia formation. 
 
1.6 PAK family proteins – major effectors of Rho GTPases 
PAK kinases were first identified in a screen for Rac and Cdc42 effectors and 
independently as a proteinase-activated kinase (Manser et al., 1994; Tahara and 
Traugh, 1981). They are widely conserved and found in yeast as well as Drosophila 
(Bokoch, 2003). In mammalian cells, six isoforms of PAK kinases have been found 
(PAK1-6), and these are sub-divided into two groups based on biochemical and 
structural features (figure 1.5). p21-activated kinase 1 (PAK1) was the first PAK 
family member to be identified (Manser et al., 1994)  as a serine threonine protein 
kinase activated by the small GTPases Cdc42 and Rac, followed by the closely 
related protein kinases, PAK2 and PAK3 (Bagrodia et al., 1995). More recently three 
other family members were discovered (PAK4-6) and the six proteins are now sub-
divided into two groups (figure 1.5) based upon sequence and structural homology 
(Jaffer and Chernoff, 2002; Whale et al., 2011). PAKs are highly conserved in 
evolution and have many known substrates whose phosphorylation affects numerous 
cellular processes, including cytoskeletal organization, cell cycle progression, and 
cell survival (Bokoch, 2003; Dummler et al., 2009) as well as significant non-kinase 
related effects (Arias-Romero and Chernoff, 2008; Dummler et al., 2009).  
 
Deletion of the PAK1 gene in mice has no adverse effects on the viability of the 
foetuses but there are subtle defects in neuronal function, mast-cell degranulation 
and macrophage function. Genetic deletion of PAK2 results in embryonic lethality at 
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day E8 due to multiple developmental abnormalities (Arias-Romero and Chernoff, 
2008).  
 
1.6.1 PAK1 and PAK2 in cancer 
The PAK1 gene is localised within chromosome region 11q13 , and 11q13.5-14 
amplifications involving the PAK1 locus that have recently been reported in bladder, 
ovary and breast cancer (Bekri et al., 1997; Brown et al., 2008). PAK1 kinase 
activity is required for the Ras-induced transformation (Tang et al., 1997) and PAK1 
over-expression has been reported in colon, ovarian, bladder transitional carcinoma, 
T-cell lymphoma and glioblastomas (Kumar et al., 2006). Indeed, glioblastoma 
patient survival time is significantly correlated with the presence of phosphorylated 
(active) PAK1 in the cell cytoplasm (Aoki et al., 2007). Important to the study herein 
is that PAK1 expression is widely up-regulated in human breast tumours and 
correlates with breast cancer invasiveness as well as tumour cyclin D1 expression 
(Balasenthil et al., 2004). Furthermore, PAK1 activity has been linked to estrogen 
(tamoxifen) resistance in estrogen receptor-positive breast cancers (Holm et al., 
2006; Rayala and Kumar, 2007). These effects appear to involve the phosphorylation 
of the estrogen receptor on Ser305 by PAK1, and correlate with PAK1 nuclear 
translocation. Moreover, inducible expression of a constitutively active form of 
PAK1 rapidly induces breast cancer cell proliferation and aggressive cell 
phenotypes, which included anchorage-independent growth and mitotic defects 
(Vadlamudi et al., 2000). PAK1 has also been shown to have a central role in the 
Schwann-cell tumours of neurofibromatosis type 1 (NF1), which is caused by the 
loss of a Ras GAP protein, through a Ras-dependent pathway (Tang et al., 1998). 
Moreover, both PAK1 and PAK2 have been associated with neurofibromatosis type 
2 (NF2), as PAKs phosphorylate the NF2 tumour-suppressor gene product, Merlin, 
on serine 518 and block its activity (Kissil et al., 2002; Xiao et al., 2002). 
 
1.6.2 Expression and localization of PAK1 and PAK2 
Individual PAK isoforms show differences in tissue distribution and subcellular 
localization, which may in part account for individual substrate specificities. PAK1 
is highly expressed in brain, muscle, spleen and basal expression has been reported 
in several tissues, including the mammary gland (Manser et al., 1994). All three 
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group I PAKs are highly expressed in the brain, and PAK1 and PAK2 are both 
highly expressed in most cells of haematopoietic origin. PDGF, insulin and certain 
other cell stimuli cause relocalization of PAK1 from the cytosol into cortical actin 
structures, such as lamellae at the leading edge, circular and peripheral dorsal ruffles 
in fibroblasts (Dharmawardhane et al., 1997; Sells et al., 2000), whereas PAK2 
localizes to the endoplasmic reticulum (ER) in COS-7 and 293T cells (Huang et al., 
2003). PAK1 localizes to the leading edge of motile neutrophils (Dharmawardhane 
et al., 1999), to pinocytic/phagocytic vesicles (Dharmawardhane et al., 1999; 
Dharmawardhane et al., 1997) and to the mitotic spindle and centrosomes (Banerjee 
et al., 2002; Maroto et al., 2008), as well as to the nucleus and nuclear membrane 
(Rayala and Kumar, 2007). In addition, PAK1 localizes to cell:substratum focal 
adhesions and the expression of a constitutively active form of PAK1 induces the 
rapid formation of lamellipodia, filopodia and dorsal ruffles, as well as increasing 
focal adhesion yield, and disassembly of stress fibres (Manser et al., 1997). PAK2 is 
expressed ubiquitously and is uniquely cleaved by caspases. The catalytic fragment 
generated from such cleavage translocates to the nucleus or to the endoplasmic 
reticulum, where it is essential for the induction of growth arrest (Huang et al., 
2003).  
 
1.6.3 PAK domain structure and function 
The group I PAKs share a number of important structural features (figure 1.5). All 
PAKs are characterised by a distinctive N-terminal regulatory domain and a highly 
conserved C-terminal kinase domain. The kinase domains of group I PAKs are at 
least 93% homologous and about 54% homologous to members of the other group. 
The regulatory domains of all PAKs consist of a GTPase-binding domain (GBD) and 
several proline-rich regions that potentially serve as docking sites for SH3 domain 
containing proteins. Furthermore, group I PAKs possess an autoinhibitory domain 
(AID) overlapping with the GBD (Zhao et al., 1998). Group I PAKs appear to form 
homodimers in cells, adopting a trans-inhibited conformation where the N-terminal 
AID of one molecule binds and inhibits the catalytic domain of the other and is 
important in the regulation of basal kinase activity (Lei et al., 2000). PAK3 has two 
alternatively spliced exons in the GBD/AID region that yield four splice variants, 
three of which have constitutive kinase activity (Kreis et al., 2008). These splice 
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variants have not been identified in PAK1/2. Active Cdc42 and Rac bind to the GBD 
releasing autoinhibition and enhancing kinase activity (Arias-Romero and Chernoff, 
2008; Bokoch, 2003).  
 
Signals from several growth factor tyrosine kinases including insulin, heregulin, 
PDGF, EGF, VEGF, HGF and G protein-coupled receptors promote activation of 
PAKs (Adam et al., 1998; Bagheri-Yarmand et al., 2000; Dadke et al., 2003; He et 
al., 2001; Royal et al., 2000; Tsakiridis et al., 1996). These pathways normally 
activate PAKs through sequential activation of PI-3 kinase (PI3K) and a GEF from 
the Dbl family, which then activates the small GTPases Rac and Cdc42. Receptor 
recruitment can be mediated through binding to Grb2 (Puto et al., 2003) and 
localization of PAK1 at the membrane is a critical step during PAK activation. 
However regulation of PAK1 activity is a complex process involving protein-protein 
interactions, phosphorylation/dephosphorylation and sphingolipid binding (Bokoch 
et al., 1998; Chong et al., 2001). The binding of Rac/Cdc42 to the PAK1 regulatory 
domain induces the phosphorylation of important sites throughout the protein, both 
by PAK1 itself (Chong et al., 2001) and/or by exogenous kinases such as JAK2 
(Rider et al., 2007), PDK1 (King et al., 2000) and PKA (Howe and Juliano, 2000).  
 
Indeed, phosphorylation of PAK1 serine 144 in the kinase autoinhibitory domain 
contributes significantly to kinase domain activation (Chong et al., 2001). Binding of 
Rac/Cdc42 also activates PAK2 and it is likely that the same mechanism that 
regulates PAK1 also regulates PAK2 catalytic activity. Like PAK1, Rac/Cdc42 
interaction stimulates PAK2 autophosphorylation on Thr402 in the activation loop, a 
requirement for kinase activity (Gatti et al., 1999).  
 
The adapter protein Nck (Bokoch et al., 1996) and PAK-interacting exchange factor 
(PIX) (Bagrodia et al., 1998) are key regulators of the group I PAKs, binding 
directly to PAK1-3 near the N-terminal GBD domain. Initially it was thought that 
Nck recruitment alone was sufficient to induce PAK kinase activity (Lu et al., 1997), 
though it later emerged that activation of PAK by membrane clustered Nck is 




Figure 1.5 Domain structures of p21-activated kinases. All PAK family members share a 
common domain structure: an N-Terminal p21/GTPase binding domain (GBD) and a C-
Terminal serine/threonine kinase domain. The GBD of Group I PAKs consists of a 
Cdc42/Rac interactive binding region (CRIB) which overlaps with an autoinhibitory domain 
(AID). PAK5 is the only member of the Group II PAKs that appear to contain an AID. All 
PAK proteins harbour variable numbers of core PxxP motifs, putative ligands for SH3 
domains, although specific interacting partners are mostly unidentified. The N-Termini of 
the Group I PAKs bind directly to the SH3 domains of Nck1/2 via a consensus binding motif 
(PxxPxRxxS) indicated in orange. The Group I PAKs also harbour a PIX binding site 
indicated in red. Neither motif is present in any of the Group II PAKs. In addition PAK4 
contains a unique GEF-H1 and Gab-1 interaction domain (GID) adjacent to the kinase 
domain. This kinase domain also contains a β5 integrin binding region. 
 
 
PAK to areas of the cell where active Rac/Cdc42 are likely to be localised. Nck is 
also able to recruit a PAK1: PIX complex to sites of cell adhesion (Turner et al., 
1999). PIX is a GEF for Rac/Cdc42 (Rosenberger and Kutsche, 2006) which can 
complex with paxillin (a major component of cell:substratum adhesions) and the 
interaction between PIX and PAK1 is thought to mediate adhesion dynamics by 
localising both active Rac/Cdc42 and PAK1 at sites of cell adhesion (Brown et al., 
2002) (figure 1.6). Autophosphorylation of PAK1, an early event in PAK1 
activation, drives the dissociation of PIX and Nck (Zhao et al., 2000) suggesting that 
there is a complex feedback mechanism; moreover the interaction between Nck and 
PAK can also be disrupted by phosphorylation of PAK on serine 21 by kinases such 
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as Akt (Zhou et al., 2003). In neuronal cells, PAK2 interacts with β-PIX (Hoelz et 
al., 2006) leading to the formation of a PAK2-β-PIX-Erk1/2 complex, which is 
essential for neurite outgrowth (Shin et al., 2002). Intriguingly, in this instance 
PAK2 inhibition blocks Rac activation, suggesting that PAK2 may also function 
upstream of Rac by regulating β-PIX activity (Shin et al., 2004). PAK2 is unique 
among the PAK isoforms because it can also be activated through proteolytic 
cleavage by caspases or caspase-like proteases to release an amino (N)-terminal 
fragment (PAK2p27) and a pro-apoptotic catalytic fragment (PAK2p34). Activation 
of full length PAK2 stimulates cell survival, whereas proteolytic activation of 
PAK2p34 is involved in programmed cell death. PAK2p34 exerts its pro-apoptotic 
effects via the activation of Jun N-terminal kinase (JNK) (Chan et al., 2007; Huang 
et al., 2009). 
 
Figure 1.6 Models for activation of Group I PAKs. Group I PAKs, exemplified by PAK1, 
exist as autoinhibited homodimers, in which the kinase domain of one PAK molecule is 
inhibited by interactions from the GBD/AID domain of a second PAK molecule. (A) Upon 
binding to Nck bound to activated transmembrane receptor (C) spingolipids or Rho family 
GTPases Cdc42 or Rac (A and D) autoinhibitory interactions are relieved enabling the 
kinase domain to undergo conformational change and autophosphorylation to become active. 
PAK1, 2 and 3 are also activated by phosphorylation by additional kinases, for example 
PDK1 (B), which inhibit AID-kinase and PIX interaction. Note that, despite their depiction, 






1.6.4 PAK signalling to the cytoskeleton 
Although the substrate preferences among group I PAKs has never been directly or 
systematically compared, PAK1/2/3 share 92-95% identity within their kinase 
domains (figure 1.5), suggesting that they may phosphorylate common substrates 
(Arias-Romero and Chernoff, 2008). Indeed, PAK1 and PAK2 have been reported to 
have many identical substrate in vitro (Rennefahrt et al., 2007). It is therefore likely 
that isoform-specific functions of the group I PAKs are mediated by their 
participation in distinct molecular complexes and their localization to distinct 
subcellular structures. To date, more than 30 proteins have been identified as direct 
substrates for group I PAKs, reflecting the important roles played by the PAK family 
kinases play in a variety of biological activities (Table 1.1).  
 
1.6.5 PAKs and cancer cell invasion 
Group I PAKs have been implicated in cell migration through their ability to 
phosphorylate multiple cytoskeletal regulators. In fibroblasts, PAK1 regulates 
lamellipodial extension and directionality (Sells et al., 1999; Sells et al., 2000) and 
the formation and disassembly of focal adhesions (Manser et al., 1997; Nayal et al., 
2006). In contrast, in endothelial cells both kinase dead and constitutively active 
PAK1 inhibited migration (Kiosses et al., 1999), indicating that the role of PAKs in 
cell migration is likely to be cell-type specific. In prostate cancer cells, knockdown 
of PAK1 inhibits HGF-induced loss of cell:cell junctions and subsequent migration 
whilst knockdown of PAK2 increases lamellipodium extension but does not affect 
migration speed (Bright et al., 2009). However, expression of either kinase-dead or 
constitutively active PAK1 has been shown to increase migration towards HGF in 
Boyden chambers (Zegers et al., 2003). siRNA-mediated knockdown of PAK1 in 
breast epithelial cells leads to decreased myosin light chain phosphorylation and 
smaller focal adhesions whilst dominant-negative PAK1 blocks the invasiveness of 
breast tumour cells (Adam et al., 2000). In contrast, knockdown of PAK2 has the 
opposite effects (Coniglio et al., 2008) suggesting they could have antagonistic roles. 
Interestingly, PAK1 has also been shown to co-ordinate extracellular matrix 




Table 1.1. PAK kinase substrates implicated in invasive migration  
 
Substrate Cellular function PAK reference 
Caldesmon Inhibitor of  myosin ATPase 
activity  
PAK1 & 3 (Foster et al., 2000) 
CPI17 Inhibitor of myosin phosphatase PAK1 (Takizawa et al., 2002) 
Desmin Intermediate filament protein PAK1 (Ohtakara et al., 2000) 
Filamin A Actin cross linking and adhesion 
protein 
PAK1 (Vadlamudi et al., 2002) 
GIT1 GTPase regulation Arf GAP PAK1 (Zhao et al., 2005) 
GEF-H1 Rho GTPase regulation, RhoA 
GEF 
PAK1 (Zenke et al., 2004) 
LIMK1 Actin cytoskeleton dynamics; 
cofilin kinase 
PAK1 & 2 (Edwards et al., 1999) 
MLCK Regulation of myosin activity 
and actin cytoskeleton dynamics 
PAK1 & 2 (Goeckeler et al., 2000; 
Sanders et al., 1999) 
Merlin ERM binding protein PAK2 (Kissil et al., 2002) 
p41-ARC 
 
Subunit of Arp2/3 complex, 
actin nucleation 
PAK1 (Vadlamudi et al., 2004) 
Paxillin Focal adhesion scaffold PAK1 & 3 (Turner et al., 1999) 
α-PIX  Rho GTPase regulation, Rac 
GEF 
PAK1 & 2 (Chong et al., 2001) 
β-PIX  Rho GTPase regulation, Rac 
GEF 
PAK1 & 2 (Shin et al., 2002; ten 
Klooster et al., 2006) 
Raf-1 MEK kinase PAK1 & 3 (King et al., 1998; Zang et 
al., 2002) 
Rho-GDI Inhibitor of Rho GTPase activity PAK1 (DerMardirossian et al., 
2004) 
R-MLC Regulatory chain of myosin 
motor  
PAK2 (Chew et al., 1998) 
Vimentin 
Cortactin 
Intermediate filament protein 




(Goto et al., 2002) 
(Vidal et al., 2002) 
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reported that PAK1 and PAK2 are involved in promoting cell migration and invasion 
in ovarian cancer cells (Siu et al., 2009). Cancer cell dissemination may require a 
loss of cell: cell contact and PAK1 kinase mutants can induce a loss of cell: cell 
junctions (Zegers et al., 2003). Additionally, active Rac acts via PAK1 to induce 
disassembly of E-cadherin-based adhesions (Lozano et al., 2008), a process that may 
depend on an interaction between PAK1 and E-cadherin associated protein β-catenin 
(He et al., 2008). 
 
1.6.6 PAKs and invadopodia  
PAK1 acitivity was found to be required to sustain invadopodia formation and 
activity in invasive human melanoma cells (Ayala et al., 2008) . The autoinhibitory 
domain of PAK1 (PAK1-AID), known to inhibit the endogenous kinase (Zhao et al., 
1998) was found to induce a substantial decrease in ECM degradation in vitro, where 
cortactin has been shown to be a substrate for PAK1 (Vidal et al., 2002) and the 
main residue targeted by PAK1 is serine 113 (Webb et al., 2006). Co-expression of 
PAK-AID with pseudophosphorylated cortactin
S113D
 was not sufficient to bypass the 
block induced by PAK-AID (Ayala et al., 2008). This suggests that PAK1 activity 
supports invadopodia formation.  
 
Invadopodia formation in VSMCs could also be potently induced by kinase-dead 
PAK1 (Furmaniak-Kazmierczak et al., 2007). In these same cells, over-expression of 
PAK1 kinase mutants induces podosome formation, and interaction with β-PIX is 
implicated to be necessary for localization of PAK1 to the podosomal ring structure 
(Webb et al., 2005). Similarly, cellular PAK4 localizes to macrophage podosomes 
(Gringel et al., 2006). Src and ERK kinase activity were also necessary for kinase 
dead PAK1 to promote invadopodia formation. The requirement of ERK is 
interesting because PAK1 directly binds ERK and facilitates its activation in VSMCs 
(Sundberg-Smith et al., 2005). Constitutively active PAK1 only weakly promotes 
invadopodia formation suggesting that its ability to phosphorylate substrates such as 
MLCK, LIMK, paxillin and vimentin may actively repress invadopodia formation 
(Furmaniak-Kazmierczak et al., 2007). However, to date, there is no evidence to 
show a direct effect of altered PAK1/2 expression levels on invadopodia formation 
and matrix degradation in breast carcinoma.  
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1.7 Aims of the project 
1. To use carcinoma cell lines and a 2D in vitro matrix degradation assay to 
determine 
a) whether invadopodia formation can be induced by growth factor stimulation 
b) whether invadopodia formation can be induced by increasing intracellular levels 
of HIF-1α (hypoxia) 
c) whether Group I PAKs regulate invadopodia formation downstream of growth 
factor and/or hypoxia signalling 
 
2. To use a PCR array to investigate cytoskeletal gene changes following increased 














































2.0 MATERIALS AND METHODS 
2.1 Materials  
2.1.1 General reagents  
Reagent Company 
Agarose 
Alexa Fluor®488 phalloidin 
Alexa Fluor®633 phalloidin 
Ampicillin 
Bromophenol blue 
Calcium Phosphate Transfection Reagent 
Cell-dissociation solution (1x) non-enzymatic 
DH5α competent cells 
DMEM (Dulbecco‟s Modified Eagle‟s Medium) 
DMEM +Glutamax™-1 
DMEM F-12 (Medium Ham‟s F-12) 
DMOG  
DMSO 
DPBS (Dulbecco‟s Phosphate Buffered Saline 1x) 
DTT 
ECL Nitrocellulose membrane 
ECL Western Blotting Detection reagent 
EGF (Recombinant Human) 
Gateway™ LR and BP Clonase™ Enzyme Mix 
Gelatin- Type A from porcine skin 
Gentamycin 
Glass coverslips 13mm 






























HGF (Recombinant human) 
Hyperfilm™ ECL™ X-ray film 
Invitrogen Mini and Maxi-prep Kits 
Lipofectamine 2000 transfection reagent 
LB agar and LB broth 
Menzel-Glaser Glass Slides 
Parafilm  
Paraformaldehyde 
Phosphate buffered saline (PBS) (DPBS) 
Phosphate buffered saline (PBS) tablets  
QIAquick Gel Extraction Kit 
Quickchange Site-directed Mutagenesis kit 
Rhodamine B Isothiocyanate 
RPMI-1640 
S.O.C media 
Slide-A-Lyzer® Dialysis Cassette, 12-30ml  
Sodium borohydride  
Sodium Chloride 














Pechiney Plastic Packaging,UK 
Sigma-Aldrich,UK   
Invitrogen,UK 
Oxoid Limited,UK 





















2.1.2   Mammalian cell lines 
A375MM (metastatic melanoma cells) was obtained from Dr. Ester Martin, King‟s 
College London, MCF-7 and MDA-MB-231 (breast adenocarcinoma cells), HT29 
(colon carcinoma cells), PC3 and DU145 (prostate carcinoma cells) and HEK-293 
(human embryonic kidney cells) were obtained from ATCC. 
2.1.3 Plasmids 
 
Mouse-Myc-PAK1 was obtained from Prof. Anne Ridley 
Human-Myc-PAK1/PAK2 were obtained from Dr. Jonathan Chernoff 
GFP-PAK1, GFP-PAK2, GFP-HIF-1α expression plasmids and HA-PAK2r mutant 
were generated using Gateway™ Technology  
pDEST™GFP and HA 
pDONOR™207 














Antibody Company Source Application Dilution 
Anti-c-Met Santa Cruz Rabbit Western Blotting 1:500 
Anti-EGFR Cell Signaling Rabbit Western Blotting 1:500 
Anti-PAK1  Cell Signaling Rabbit Western Blotting 1:2000 
Anti-PAK2 Cell Signaling Rabbit Western Blotting 1:2000 
Anti-Cortactin Upstate Mouse Immunofluorescence 1:50 
Anti-ERK Cell Signaling Rabbit Western Blotting 1:2000 
Anti-Myc Santa Cruz Mouse Immunofluorescence 1:50 
Anti-HA Santa Cruz Mouse Immunofluorescence 1:50 
Anti-phospho-PAK1/2 Cell Signalling Rabbit Western Blotting 1:1000 
Anti-Gapdh Santa Cruz Mouse Western Blotting 1:10000 
Anti-HIF-1α Cell Signalling Rabbit Western Blotting 1:1000 
Anti-HIF-2α Santa Cruz Mouse Western Blotting 1:500 
Anti-Cool1/β-PIX Cell Signalling Rabbit Western Blotting 1:1000 
Anti-E-cadherin Gene Tax Mouse Immunofluorescence 1:50 
Anti-E-cadherin Gene Tax Mouse Western Blotting 1:2000 
Table 2.2 Primary antibodies 
 
Antibody Company Source Application Dilution 
HRP conjugated anti mouse Dako Goat Western Blotting 1:2000 
HRP conjugated anti rabbit Dako Goat Western Blotting 1:2000 
Alexa Fluor® 488 anti-rabbit IgG Invitrogen Goat Immunofluorescence 1:200 
Alexa Fluor® 488 anti-mouse IgG Invitrogen Goat Immunofluorescence 1:200 
Alexa Fluor® 568 anti-rabbit IgG Invitrogen Goat Immunofluorescence 1:200 
Alexa Fluor® 568 anti-mouse IgG Invitrogen Goat Immunofluorescence 1:200 





Blocking solution 5% w/v milk powder or 5% w/v bovine serum 
albumin in TBS-Tween 
DNA loading buffer 40% w/v sucrose, 0.25% bromophenol blue 
SDS-PAGE running buffer (10X) Tris Base, glycine, SDS 
Dilute to 1X with dH2O 
SDS-PAGE sample buffer 100mM Tris pH 6.8, 10% w/v SDS, 30% v/v 
glycerol, 0.2% w/v bromophenol blue, 2% v/v β-
mercaptoethanol 
SDS-PAGE transfer buffer (10X) 0.39M glycine, 0.48M Tris base, 12.8mM SDS 
Make up to 1X transfer fresh on the day by 
diluting to 1X and adding methanol to a final 
concentration of 20% v/v 
TAE buffer 40mM Tris acetate, 10mM EDTA 
NP-40 Lysis Buffer 1M Tris pH7.6, 5M NaCI, 0.5M EDTA, 10% NP-
40 and add protease inhibitor cocktail fresh each 
time before use 
Protease inhibitor cocktail 1mM sodium orthovanadate, 50mM sodium 
fluoride, 1mM PMSF, 1µg/ml Aprotinin, 20µg/ml 
leupeptin, 1mM DTT  
Stripping buffer 25mM glycine pH2.0, 1% SDS 
PBS-Tween PBS + 0.1% Tween-20 
TBS-Tween 50mM NaCI, 0.1% v/v Tween, 25mM TRIS 
pH7.6 









2.2.1 Mammalian Cell culture and maintenance 
DU145 and PC3 cells were cultured in 10% FBS, 90% RPMI-1640, penicillin-
streptomycin, L-Glutamine. MDA-MB-231, HT29, MCF-7 and HEK-293 cells were 
cultured in 10% FBS, 90% DMEM + Glutamax™-1 and penicillin-streptomycin. 
A375MM cells were cultured in 10% FBS, 90% DMEM F-12, 15mM Hepes, 
penicillin-streptomycin and L-glutamine. These cells were incubated at 37ºC in a 
tissue culture incubator with humidified air, supplemented with CO2 to 5% over 
atmospheric levels. Adherent cells were grown in a 75cm
2
 vented tissue culture 
flasks until 80% confluent. The complete growth media was removed and the cells 
were washed with 10ml sterile PBS before being incubated with 3 ml trypsin/EDTA 
at 37ºC for about 2 minutes until they detached and checked by microscopy. 10 ml of 
complete media was then added to the cells to inactivate the trypsin. Cells were 
pelleted by centrifugation at 1000rpm for 5 minutes, the media removed and the cell 
pellet resuspended in 5ml complete media. Dilutions of the suspended cells were 
placed in a fresh tissue culture flask and the volume made up to 20ml in complete 
media. All media were warmed to 37ºC before use. 
2.2.2 Freezing and thawing cells 
Cells were harvested and re-suspended in 45% FBS and 45% complete growth 
medium with 10% DMSO. Cells were frozen overnight at -80ºC in a cryo freezing 
container before they were placed in a liquid nitrogen tank. When taken out of the 
nitrogen tank, cells were thawed rapidly at 37ºC. Cells were added to pre-warmed 
medium, then were gently centrifuged at 1000 rpm for 4 minutes to remove the 
DMSO and finally re-suspended in fresh complete growth medium for culturing. 
2.2.3 Cell treatments 
For growth factor stimulations, MCF-7 and MDA-MB-231 cells were seeded onto 6-
well plates at a density of 3X10
4 
cell/ml in 2mls media and incubated overnight to 
adhere. Cells were then incubated for 24 hours in 0.5% FBS media prior to being re-
seeded on gelatin-coated coverslips with 3 hours EGF (100ng/ml) or HGF (10ng/ml) 
stimulation. For PAK activation downstream of EGF/HGF, cells were stimulated for 
up to 1 hour followed by cell lysis. For HIF-1α induction, dimethyloxaloylglycine 
50 
 
(DMOG), a prolyl-4-hydroxylase inhibitor shown to upregulate the HIF activity 
(Asikainen et al., 2005) was used. 500mM stock of DMOG was prepared in dH2O 
and stored in -20ºC. A working concentration of 0.5mM DMOG was used to treat 
the cells on plastic dishes for up to 6 hours. Following treatment, cells were either 
lysed or re-seeded on gelatin-coated coverslips. 
2.2.4 Cell Lysis 
Treated or non-treated cells were lysed in NP-40 lysis buffer on ice for 10 minutes 
and centrifuged at 13000 rpm for 10 minutes to remove cell debris. Cell lysates were 
mixed with 2X SDS sample buffer, boiled at 95ºC for 3 minutes and used either 
immediately or stored at -20ºC. Proteins were resolved by SDS-PAGE and 
immunoblotted for the desired protein. 
2.2.5 Immunoblotting 
Up to 30μl of whole cell lysates were loaded in each well on SDS-PAGE gels 
covered with 1x running buffer and migrated through the gel using 125V. After 
electrophoresis proteins were transferred from the gel onto a nitrocellulose 
membrane in 1X SDS-PAGE blotting buffer using a wet transfer system (Biorad). 
Proteins were transferred at 100V for 1hour in cold transfer buffer. For 
immunodetection, membranes were then blocked in 5% milk/TBS-Tween for one 
hour at room temperature with rocking to prevent non-specific antibody binding. 
Then the membrane was washed in TBS-T and incubated with primary antibodies 
overnight at 4ºC on the roller (for antibody dilutions see Table 2.2). Following three 
washes in TBS-Tween for 10 minutes, the blots were incubated with the appropriate 
horseradish peroxidise-conjugated (HRP) (Dako) secondary antibodies for one hour 
at room temperature (for antibody dilutions see Table 2.3). After three more washes 
with TBS-T for 10 minutes, immunoprobed proteins were visualized by Enhanced 
Chemiluminescent Reagents (ECL Pierce) and exposed to Fuji X-Ray films followed 
by developing using Imaging systems Xograph compact X4 developer. To re-probe 
the membrane with another primary antibody, membranes were incubated in 
stripping buffer twice for 15 minutes followed by 5 minutes with PBS-Tween at 
room temperature, then blocked again in 5% milk or BSA in TBS-T for one hour and 
incubated overnight with new primary antibodies at 4ºC.  
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2.2.6 Quantification of blots 
To quantify the changes in phosphorylation levels, protein bands exposed onto ECL 
films were scanned onto computers and save as TIF files. The intensity of each 
phospho-protein and total protein band was determined using Andor IQ software 
from which the phospho-protein: total protein ratio was calculated and normalised to 
that of the starved only cells. Mean and SEM values were calculated from the data of 
3 independent experiments.  
2.2.7 Treatment of glass coverslips for invadopodia assay 
13mm diameter coverslips were gently placed in 70% ethanol for 30 minutes with 
rocking, and both surfaces of the coverslips were fully covered with the ethanol 
preferably in a 10cm dish. The 70% ethanol was then poured off followed by adding 
96% ethanol onto the coverslips for 30 minutes. In tissue culture hood, the coverslips 
were left to dry on paper towel before being placed in a fresh 10cm dish. The 
coverslips were kept sterile in the dish at room temperature for long term storage. 
2.2.8 Preparation of fluorophore-conjugated gelatin 
Fluorophore-conjugated gelatin is used to coat coverslips prior to seeding cells onto 
them for the invadopodia assay. This preparation is performed according to (Mueller 
and Chen, 1991), with the following modifications. 100mg gelatin is dissolved in a 
total of 50ml buffer mix containing 61mM sodium chloride (NaCI) and 50mM 
sodium borohydride (Na2B4O7) (pH 9.3) and then incubated at 37ºC for one hour. 
After incubation time, 1.8mg/ml of rhodamine ITC (or FITC) is added and mixed for 
4 hours in complete darkness at room temperature on the roller. This mixture is then 
dialysed in PBS overnight at 4ºC in complete darkness. Dialysis is usually repeated 
for 2 days with 3 buffer changes per day. After a quick spin to remove insoluble 
material and addition of 2% w/v sucrose, small aliquots are stored in the dark at 4ºC. 
2.2.9 Preparation of fluorophore-conjugated gelatin coated coverslips 
Fluorophore–conjugated gelatin coated coverslips are prepared and the assay carried 
out as described (Baldassarre et al., 2003; Bowden et al., 2001; Mueller and Chen, 
1991). Fresh gelatin-coated coverslips were prepared each time before seeding cells 
onto them. Sterile ethanol-washed coverslips were placed in a 24-well plate. The 
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coverslips were coated with pre-warmed fluorophore-conjugated gelatin solution, 
using enough to cover the surface, spread to the edges and incubated at room 
temperature in the dark for 10 minutes. 0.5% glutaraldehyde in PBS was prepared 
from 25% stock. A drop of 200μl of glutaraldehyde for each coverslip was dotted 
onto parafilm. The gelatin-coated coverslips were inverted onto the dots and 
incubated in the dark to crosslink for 15 minutes. Each coverslips were then 
transferred to a new 24-well plate with the coated side up, and gently washed for 3 
times with sterile PBS. The coverslips were finally incubated with 5mg/ml sodium 
borohydride prepared in PBS for 3 minutes at room temperature in darkness 
followed by 3 times PBS washes. Washed coverslips were then sterilized again in 
70% ethanol for 5 minutes. The ethanol was aspirated off and the coverslips are 
dried for 10 minutes under a sterile hood before quenching in DMEM medium for 1 
hour at 37ºC. At this stage, coverslips are ready for seeding cells. 
2.2.10 Invadopodia Assay 
Media was removed from treated or un-treated cells in culture plates. Adherent cells 
were washed once with sterile PBS. Non-enzymatic cell dissociation buffer was 
added into each well and incubated at 37ºC for 10 minutes until the cells detached 
from the bottom of the plate. Dislodged cells were then re-suspended in culture 
medium. Cells were counted and the number of viable cells was noted. The media on 
the coverslips were aspirated off and 2x10
4 
cells/ml were seeded onto them (1ml on 
each coverslips). Cells were then incubated at 37ºC for 3 hours before fixing the 
coverslips with 4% paraformaldehyde for 20 minutes at room temperature. During 
this incubation, treatment with 10ng/ml HGF, 100ng/ml EGF or 0.5mM DMOG was 
performed accordingly. Coverslips from 3 independent experiments in all cell lines 
were prepared in this way before they were all identically stained for F-actin with 
Alexa Fluor® 488 or 633 Phalloidin. Cells were imaged on an Olympus 1X71 
fluorescence microscope and LSM 510 Zeiss Confocal microscope. For invadopodia 
quantification, invadopodia images on the F-actin and gelatin were taken using the 
same fluorescence microscope settings. Cells were scored for the presence of 










Figure 2.1: Invasive carcinoma cells formed invadopodia that extended into the 
matrix substratum.  
2.2.11 Immunofluorescence staining 
Fixed cells were gently washed 3 times with PBS. The coverslips were 
permeabilised in 0.2% triton X-100/PBS for 5 minutes followed by 3 more PBS 
washes. Alexa Fluor® 488/633 Phalloidin were diluted in PBS at (1:500). The 
coverslips were then incubated with diluted Phalloidin for 1 hour at room 
temperature in dark humidified environment. For double staining with primary and 
secondary antibodies, fixed, PBS washed and permeabilised coverslips were blocked 
with 3% BSA in PBS for 30 minutes to block for non-specific bindings followed by 
3 times washes with PBS. Primary antibody was diluted with 3% BSA in PBS. The 
coverslips were then incubated with diluted primary antibody for 2 hours at room 
temperature in dark humidified environment followed by 3 times washes with PBS. 
Secondary antibody was also diluted in the same manner plus conjugated-phalloidin 
if it‟s required. The coverslips were incubated with diluted secondary antibody for 1 
hour at room temperature in dark humidified environment. Coverslips were washed 
twice with PBS, then once with dH2O to prevent salt crystals and mounted onto glass 
slides with anti-fade mounting solution. The set coverslips were stored at 4ºC or -
20ºC for long term storage. 
2.2.12 Gelatin degradation analysis 
ImageJ software (gelatin degradation plug-in) was used to measure area of matrix 
degradation per invadopodia forming cells. Cells and gelatin images were converted 
to 8-bit copy prior to combining all cell and gelatin images in separate stacks (cell 
54 
 
images in one stack and gelatin images in another stack). These stacks were then 
opened in ImageJ software to measure total degradation area per cell. Data will then 
be multiplied by pixel area (µm
2
) to get real degradation area. 
2.2.13 Calcium phosphate transfection of adherent HEK-293 cells 
HEK-293 cells were seeded at a density of 1 x 10
5 
cells/ml in 10mls into any of the 
dishes shown in Table 2.5. The plate was incubated at 37ºC for 24 hours. On the 
following day, 3 to 4 hours prior to transfection, the media on the plate was changed 
with a fresh media. The transfection mixture was made following the recipe in Table 
2.5.  
Table 2.5: HEK-293 calcium phosphate transfection mixture recipe 
Using a pipette, A was added to B slowly drop-wise with aeration until A was 
depleted. The mix was incubated at room temperature for 30 minutes. The plate with 
cells was taken from the incubator and the transfection mix was added to the cells 
drop-wise and the plate was dispersed for even spreading of the transfection reagent. 
The transfected cells were incubated at 37ºC overnight. Media was removed and 
replaced with fresh media the following day and reincubated for another 24 hours. 
Cells were fixed with 4% paraformaldehyde followed by staining with specific 
antibodies.  
 
10cm dish (10mls) 6cm dish (5mls) 2cm dish (2mls)/ 6-well 
plate 
To a tube labelled A add 
36μl  2M CaCI2  
20μg DNA 
Make volume to 300μl 
with sterile water 
To a tube labelled B add 
300μl 2x Hepes buffered 
saline (HBS) 
 
To a tube labelled A add 
18μl 2M CaCI2 
10μg DNA 
Make volume to 150μl 
with sterile water 
To a tube labelled B add 
150μl 2x Hepes buffered 
saline (HBS) 
 
To a tube labelled A add 
7.2μl 2M CaCI2 
4μg DNA 
Make volume to 60μl with 
sterile water 
To a tube labelled B add 




2.2.14 RNAi transfection 
MDA-MB-231 cells were seeded at 4X10
4 
cell/ml in 2mls complete growth medium, 
allowed to adhere for 24 hours and transfected with siRNA oligos using HiPerfect 
according to the manufacturer‟s protocol. Cells were transfected with 75nM small 
interfering (si) RNA targeting HIF-1α (Ambion, Catalogue number 4392420) for 48 
hours and 75nM non-specific siRNA (Qiagen) as control. For β-PIX siRNA, 75nM 
of a pool of 4 siRNA duplexes each designed to target human β-PIX (siGENOME 
SMARTpool) (Dharmacon, Catalogue number 8874) was transfected for 24 hours. 
2.2.15 Transfection using Lipofectamine 2000 
Lipofectamine 2000 transfection reagent (Invitrogen) was used to transfect 
PAK1/PAK2 shRNA oligos, GFP-PAK1/PAK2, GFP-HIF-1α, mouse-myc-PAK1 
and HA-PAK2
r  
DNA constructs. Cells were plated the day before transfection to 
allow them to adhere overnight. Prior to transfection, complete growth media was 
replaced with antibiotics-free growth media. Between 6-8 hours after the transfection 
mix was added to cells, the medium was replaced with fresh complete growth 
medium. Depending on the assay, cells were either re-seeded on fluorophore-
conjugated gelatin coverslips or lysed between 24-48 hours after transfection. 
2.2.16 Hypoxic and normoxic conditions 
MDA-MB-231 cells grown in complete growth medium were initially maintained in 
normoxia, humidified air (20% O2, 5% CO2 and balanced N2 incubator) at 37
o
C. In 
the case of hypoxia stimulations, cells were transferred from normoxia to a Galaxy R 
(New Brunswick Scientific) CO2 incubator under an atmosphere mixture (1.5% O2, 
94% N2 and 5% CO2) at 37
o
C for the specified amount of time.  
2.2.17 Transformation of E.coli cells 
DH5α and DB3.1 strains of E.coli cells were transformed with DNA plasmids by the 
process called heat shock. Competent E.coli cells stored at -80ºC were thawed out 
slowly on ice prior to the addition of 1-10 μg of plasmid DNA. Bacteria with the 
added DNA were incubated on ice for 30 minutes, placed at 42ºC for 30 seconds and 
then quickly returned to the ice. S.O.C media was added to the transformed bacteria 
and incubated at 37ºC with shaking for 1 h. The bacteria were then plated onto L-
agar supplemented with the required antibiotic and incubated overnight at 37ºC.  
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Table 2.6 RNA interference and oligonucleotide sequences 
2.2.18 Purification of plasmid DNA 
Invitrogen mini- and maxi-prep kits were used to isolate and purify plasmid DNA 
from E.coli cells. Transformed bacteria single colony was inoculated into L-broth 
supplemented with the required antibiotic grown in either 5ml (for mini prep) or 
200ml (for maxi prep) of LB broth at 37ºC overnight with shaking. Mini-prep kits 
were typically used to isolate 20μg of plasmid DNA from 1.5ml of L-broth while 
maxi-prep kits were used to isolate up to 500μg from 250ml. Plasmid DNA was 
eluted in TE from Invitrogen columns and stored at -20ºC.  
2.2.19 PCR reaction 
HIF-1α human cDNA clone was purchased from Origene,UK and used as the cDNA 
template in the generation of HIF-1α cDNA flanked by attB sequences. PAK1/PAK2 
were cloned out from the CMV-Myc vectors in the generation of PAK1/PAK2 
cDNA flanked by attB sequences. attB sequences were added to enable cloning into 
Name Target 
gene 
Target sequence Company 
shPAK1 PAK1 GCCTAGACATTCAAGACAA Open 
Biosystems 




  Open 
Biosystems 













 AATTCTCCGAACGTGTCACGT Qiagen 
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Gateway™ vectors. cDNAs flanked by attB sequences were generated by PCR 
amplification using the following primers: 
Name Experiment Sequence 5’-3’ 
HIF-1α attB1 
forward 




































































The Polymerase chain reaction (PCR) was conducted using AccuPrime™ Taq DNA 
Polymerase (high fidelity mix containing 200mM Tris-HCI (pH 8.4), 500mM KCI, 
15mM MgCI2, 2mM dGTP, 2mM dATP, 2mM dTTP, 2mM dCTP, thermostable  
AccuPrime™ protein, 10% glycerol). 200ng template DNA and 200nM of forward 
and reverse primers were used. The specific conditions of the PCR reaction used are 
shown in Table 2.8.  
Cycle/s Process HIF1α 
1 Pre-incubation 
(Initial denaturation) 
95ºC, 5 minutes 
 
30 Denaturation 95ºC, 15 seconds 
Annealing 56ºC, 30 seconds 
Extension 68ºC, 2minutes 30 
seconds 
1 Final Extension 68ºC, 10 minutes 
Table 2.8: Conditions for PCR of HIF-1α 
2.2.20 Gel purification of DNA fragments 
DNA samples were diluted in 10X loading buffer containing glycerol and 
bromophenol blue. PCR products were resolved on 1% w/v agarose gel (w/v) boiled 
in 1x TAE (0.04M Tris acetate pH 8, 0.01M EDTA) buffer containing 0.5μg/ml 
ethidium bromide, to separate reaction products mixed with 3μl of 5x loading dye. 
Samples were then separated at 130V in 1X TAE running buffer. The DNA was 
visualised under low intensity UV light (trans-illuminator). The desired fragment 
was excised from the gel with a razor and the DNA isolated from the agarose using a 
QIAquick gel extraction kit according to the manufacturer‟s instructions.  
2.2.21 Construction of entry clone 
A Gateway™ BP Recombination Reaction was set up between pDONOR™207 
vector and the attB sequence flanked PCR product according to manufacturer‟s 
instructions to produce pENTRY-plasmid. The reaction was incubated at room 
temperature for 1 hour before being terminated by the addition of Proteinase K for 
10 minutes at 37ºC. The reaction mixture was transformed into DH5α E.Coli cells 
and the plasmid DNA from individual colonies was isolated and screened by PCR. 
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DNA from positive clones was sent for sequencing to Eurofins MWG Operon's 
sequencing service, Germany using sequencing primers to verify insertion of the 
correct cDNA.  
2.2.22 Construction of GFP- HIF-1α, PAK1/2 expression clones 
To construct the expression plasmids, a Gateway™ LR Recombination Reaction was 
set up between the pENTRY entry clones and the pDEST destination vector 
(Invitrogen) according to manufacturer‟s instructions. The LR reactions were 
incubated at room temperature for 1 hour and terminated by the addition of 
Proteinase K. The reaction mixture was transformed into DH5α E.Coli cells and the 
plasmid DNA isolated from individual colonies and screened by PCR. DNA from 
positive clones was subsequently sent for sequencing to Eurofins MWG Operon's 
sequencing service, Germany using sequencing primers. 
2.2.23 Site-directed mutagenesis 
 The pENTRY-PAK2 plasmid was generated using the Gateway Cloning system 
(Invitrogen). Point mutations were introduced into the plasmid using the site-directed 
mutagenesis kit from Stratagene following the manufacturer‟s instructions. Primers 
were designed including the desired mutations (listed in Table 2.7). A 50µl reaction 
was set up containing 25ng plasmid DNA, 125ng of each primer, 1µl dNTP mix, 5µl 
10X reaction buffer and 1µl PfuUltra DNA polymerase. A PCR program with the 
following parameters was used: 








95ºC,  30 seconds 
18 Denaturation 95ºC, 30 seconds 
Annealing 65ºC, 1 minute 
Extension 68ºC, 6minutes 
60 
 
2.2.24 RT-PCR expression analysis 
Total cellular RNA was isolated using an RNeasy Plus Mini Kit (Qiagen). Template 
cDNAs were synthesized with Superscript III (Invitrogen). Semi-quantitative 
reverse-transcriptase (RT-PCR) was performed with Red-Taq PCR Mix (Sigma). A 
25µl reaction was set up containing 2µg cDNA template, 125ng of each primer, 
12.5µl Red-Taq PCR Mix. A PCR program with the following parameters was used: 
Cycle/s Process HIF1α 
1 Pre-incubation 
(Initial denaturation) 
95ºC, 5 minutes 
 
35 Denaturation 95ºC, 1 minute 
Annealing 55ºC, 1 minute 
Extension 72ºC, 1 minute 30 seconds 
1 Final extension 72ºC, 10 minutes 
Table 2.10: Conditions for RT-PCR 
2.2.25 PCR array 
A Human Cell Motility RT
2
 Profiler™ PCR Array was purchased from 
SABiosciences (a Qiagen company). This array was used to screen cDNA from cells 
treated with DMOG for 6 hours. The array was performed according to 
manufacturer‟s protocol on an ABI 7700 HT sequence detector (Applied 
Biosystems, Foster City, CA) using SYBR green technology (TebuBio, 
Peterborough, UK), with the program as follows: 
 
Cycle/s Process  
1 Pre-incubation 50ºC,  2 minutes 
1 Initial denaturation 95ºC, 10 minutes 
40 Denaturation 95ºC, 15 seconds 
Annealing 60ºC, 1 minute 
Extension 72ºC, 30 seconds 
Table 2.11: Conditions for PCR Array  
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Statistical analyses were performed by comparing dCt values (housekeeping gene 
minus gene of interest) and analyzed using t-test. After combining the results from 
two independent experiments, the data were analyzed using the 2-∆∆Ct model 
normalized to the expression of housekeeping genes (B2M: Beta-2-microglobulin, 
HPRT1: Hypoxanthine phosphoribosyltransferase 1, RPL13A: Ribosomal protein 
L13a, ACTB: Actin, beta). 
 
2.2.26 Statistical Analysis 
Statistical significance was calculated using unpaired, two-tailed t-Test. Values were 
considered statistically significant if the P value was <0.05. For all figures, * 
indicates P value <0.05; ** indicates P value <0.005; and *** indicates P value 






















Chapter 3 - The characterization of invadopodia 













Chapter 3 - The characterization of invadopodia formation 
in response to HGF and EGF  
3.1  Introduction 
3.1.1  Cancer cell invasion and invadopodia  
A key feature of cancer is the ability of tumour cells to break through tissue barriers 
and invade into the underlying tumour stroma (Chambers et al., 2002). Highly 
invasive cancer cells cultured on physiological substrates form specialised 
membrane protrusions rich in actin filaments termed invadopodia. These structures 
have the capacity to degrade underlying matrix and are connected with high levels of 
proteolysis and cell signalling (Buccione et al., 2004). There is no specific marker 
for invadopodia, however, they are often highly enriched with actin filaments (F-
actin) and components needed for actin assembly including the Arp2/3 actin 
nucleation complex, neural Wiskott Aldrich Syndrome protein (N-WASP) and 
cortactin (Artym et al., 2006; Buccione et al., 2004; Clark et al., 2007; Linder, 2007; 
Lorenz et al., 2004; Mizutani et al., 2002). A stepwise model for invadopodia 
formation has been proposed; however, the precise molecular mechanisms that 
govern the regulation of formation and dynamics of invadopodia are not well 
understood (Artym et al., 2006). 
3.1.2  Epidermal and Hepatocyte Growth Factors (EGF)/ (HGF) in 
invadopodia formation 
 
A large body of experimental evidence has demonstrated that HGF, c-Met, EGF and 
EGFR play critical roles in the motility and invasive growth of tumour cells, a 
hallmark of metastatic cancers (Comoglio and Trusolino, 2002; Maulik et al., 2002). 
EGF stimulation was shown to enhance invadopodia formation and ECM 
degradation in metastatic MTLn3 rat mammary adenocarcinoma cells, whereas 
inhibition of EGF receptor (EGFR) catalytic activity with the specific inhibitor 
AG1478 suppressed this effect (Yamaguchi et al., 2005). In addition to involvement 
in cell motility, HGF stimulation of endogenous c-Met receptors has also shown to 
promote invasion by enhancing the ability of cells to degrade matrix substrates 
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(Tague et al., 2004). Recently, HGF was shown to promote invadopodia formation in 
breast cancer cells which is dependent on Met activity (Rajadurai et al., 2012). 
This chapter investigates the level of invadopodia formation in a panel of human 



















3.2  Results 
3.2.1  Screening of cancer cells for invadopodia formation 
To study invadopodia formation, different cell lines were screened for their ability to 
degrade gelatin matrix. The aim was to identify a matched tissue pair of invasive and 
non-invasive cell lines. A panel of seven human cell lines were screened; highly 
metastatic melanoma, A375 cells were used as positive control for their well-
established ability to form invadopodia (Ayala et al., 2008; Baldassarre et al., 2003); 
breast carcinoma, MDA-MB-231; and prostate carcinoma, PC3 cells and less 
invasive and non-metastatic colon carcinoma, HT29; breast carcinoma, MCF-7; and 
prostate carcinoma, DU145 cells. In order to determine the invadopodia forming 
potential of these cell lines, an in vitro fluorescent two-dimensional (2D) gelatin 
matrix degradation assay was employed (Artym et al., 2006).  
There are a number of ways to quantify invadopodia depending upon image analysis 
procedures. The method employed in this study was to quantify the percentage of the 
cell population with invadopodia where they were defined as F-actin-rich puncta that 
co-localise with dark holes on the fluorescent gelatin (figure 3.2 d). Under basal 
growth conditions, A375, MDA-MB-231 and PC3 cells form invadopodia (figure 
3.2 a to c), which is consistent with previous studies (Artym et al., 2006; Baldassarre 
et al., 2003; Desai et al., 2008). In contrast, no evidence of invadopodia formation 
was observed in the HT29, MCF-7 and DU145 non-invasive cells (figure 3.4 a to c). 
The invadopodia forming potential of MCF10A cells, a non-tumorigenic human 
mammary epithelial cell line was also examined. These cells did not form 
invadopodia (figure 3.4 d). This suggests a direct correlation between the ability to 
form invadopodia and metastatic potential of cancer cells. 
3.2.2  EGFR and c-Met are expressed in a panel of six human cancer cell lines 
Having identified those cells with basal invadopodia activity, the potential role of 
epidermal/hepatocyte growth factor (EGF)/ (HGF) stimulation was characterised. 
The endogenous expression levels of receptors for both ligands in these cell lines 
were initially established. Similar levels of EGFR were expressed in DU145, PC3 
and MDA-MB-231 cells (figure 3.1). HT29 cells express low levels of EGFR and 
66 
 
even less expression was observed in the A375 and MCF-7 cells (figure 3.1). 
Similar levels of endogenous c-Met receptor expression were observed in DU145 
and PC3, and also in MDA-MB-231 cells. HT29, A375 and MCF-7 cells express 
lower levels of c-Met (figure 3.1).  
3.2.3  EGF and HGF signalling can drive invadopodia formation 
Having established that all cell lines express EGFR and c-Met, the ability of EGF 
and HGF to induce invadopodia formation was investigated. Initially, cells were 
maintained in 0.5% serum for 24 hours prior to growth factor stimulation. As 
expected, the percentage of A375, PC3 and MDA-MB-231 cells forming 
invadopodia was markedly reduced from above 30% in the basal growth condition to 
below 10% upon serum starvation (figure 3.2d).  During the analysis, F-actin puncta 
were observed to be present in some serum-starved cells where no gelatin 
degradation could be detected suggesting pre-invadopodia formation that is non-
functional. Previous studies identified the actin-binding protein cortactin as 
indispensable for invadopodial actin core formation and cortactin has been proposed 
as an invadopodial molecular marker in addition to actin (Artym et al., 2006). 
Confocal microscopy analysis revealed that under basal growth conditions, F-actin 
puncta in the A375 melanoma and MDA-MB-231 carcinoma cells co-localized with 
cortactin and the degradation area on the gelatin matrix (figure 3.3 a and b; top 
panel) indicated by arrows. However, cortactin puncta was absent in cells grown 
under serum-deprived conditions where F-actin puncta were present and no gelatin 
degradation activity was observed (figure 3.3 a and b; bottom panel), thus ruling 
out invadopodia formation in serum-starved cells.  
Interestingly, following serum starvation, stimulation with EGF induced a significant 
increase in the percentage of PC3 and MDA-MB-231 forming invadopodia but not 
in A375 cells (figure 3.2d). Furthermore, stimulation with HGF also showed a 
significantly increased invadopodia induction in A375, PC3 and MDA-MB-231 to 
almost the level of growing cells (figure 3.2d). However, neither EGF nor HGF 
could promote invadopodia formation in the non-invasive cell lines (figure 3.4e). 












Figure 3.1 EGFR and c-Met are expressed in HT29, A375, DU145, PC3, MCF-7 and 
MDA-MB-231 cells. Whole cell lysates of growing cells were immunoblotted for EGFR 
and c-Met expressions. Gapdh, a house-keeping protein is used as a loading control. These 


























Figure 3.2 EGF stimulates invadopodia formation in PC3 and MDA-MB-231 cells but 
not in A375 cells. HGF stimulates invadopodia formation in A375, PC3 and MDA-MB-
231 cells. (a-c) Cells were seeded onto TRITC-gelatin coated coverslips at 2X10
4
/ml, 
starved overnight and stimulated with EGF (100ng/ml) or HGF (10ng/ml). Cells were 
allowed to adhere and incubated at 37°C for 3 hours followed by fixation with 4% 
paraformaldehyde and stained for F-actin. Cells were imaged using fluorescence microscopy 
at X40 magnification. Black dots indicate areas where TRITC-gelatin was degraded by 
invadopodia (arrow). Scale bar=10μm. (d) Cells were scored for the presence of actin dots 
that co-localize with degradation on the gelatin and the mean percentage of cells with 
invadopodia formation calculated. The results shown are mean ±SEM of 30 cells from each 
experimental condition over three separate experiments. Statistical significance compared 







Figure 3.3 (a) A375 and (b) MDA-MB-231. Actin co-localizes with cortactin under 
basal growth conditions but not under serum deprived conditions. Cells were seeded 
onto TRITC-conjugated gelatin-coated coverslips at 2X10
4
/ml, allowed to adhere and 
incubated at 37°C for 3 hours followed by fixation with 4% paraformaldehyde. Cells were 
double stained for F-actin and cortactin. Cells were imaged using LSM 510 confocal 







Figure 3.4 (a) HT29, (b) DU145, (c) MCF-7 and (d) MCF-10A cells are defective at 
forming invadopodia even under basal conditions. Cells were seeded onto TRITC-
conjugated gelatin-coated coverslips at 2X10
4
/ml, allowed to adhere and incubated at 37°C 
for 3 hours followed by fixation with 4% paraformaldehyde and stained for F-actin. Cells 








3.2.4 Cells that do and do not form invadopodia are different in morphology  
Often not all cells in a population will exhibit proteolytic behaviour, furthermore 
differences in cell morphology within the population seeded on gelatin could be 
observed.  To further investigate these observations cell shape analysis using ImageJ 
software was performed to measure the elongation ratio and relative spread area of 
the invasive versus non-invasive cells and to test whether invadopodia forming cells 
have signature morphology. Interestingly invadopodia positive MDA-MB-231 cells 
were significantly less elongated than the invadopodia negative cells, whilst there 
was no significant difference between invadopodia positive and negative A375 cells 
(figure 3.5b). In addition, both invadopodia positive A375 and MDA-MB-231 cells 
were significantly spread compared to the invadopodia negative cell populations 
(figure 3.5a). This suggests that cell shape differs depending on whether cells are or 
are not forming invadopodia. 
3.2.5  Gelatin degradation in EGF and HGF stimulated cells 
Initial observations (figure 3.2) suggested that HGF not only induced the highest 
percentage of cells forming invadopodia but also induced increased underlying 
matrix degradation. To further investigate this observation, the degradation per cell 
area was quantified. As expected, there were trace amount of degradation observed 
in the starved cells (figure 3.6 a and b; left panel) consistent with their low ability 
to form invadopodia (figure 3.2d). EGF stimulated cells showed more degradation 
than the starved cells (figure 3.6) and strikingly, both A375 and MDA-MB-231 cells 
stimulated with HGF significantly degraded more gelatin matrix compared to EGF 
(figure 3.6 a and b; right panel). This indicates that HGF not only promotes 



















Figure 3.5 A375 and MDA-MB-231 cells that form invadopodia differ in morphology 
compared to those without invadopodia. Cells grown under basal conditions were seeded 
onto TRITC-conjugated gelatin-coated coverslips at 2X10
4
/ml. Images taken from 
fluorescence microscope were analysed for (a) relative spread area and (b) elongation ratio 
and quantified using ImageJ software. The results shown are mean ±SEM of 30 cells from 
each experimental condition over three independent experiments. Statistical significance 
compared to cells not forming invadopodia was calculated using Student‟s t-test; *, P < 0.05. 






















Figure 3.6 Gelatin degradation in EGF and HGF stimulated invadopodia forming cells. 
(a-b) Gelatin degradation assay was performed in starve, EGF and HGF treated A375 and 
MDA-MB-231 cells. This assay was done using ImageJ software. (c) The results shown are 
mean ±SEM of 30 cells from each experimental condition over three independent 
experiments. Statistical significance compared to cells not forming invadopodia was 







Invasive cancer cells can form a type of protrusive structure called invadopodia. 
These are actin-based membrane protrusions associated with ECM degradation, a 
critical step during cancer cell invasion (Murphy and Courtneidge, 2011). 
Considering that most tumour cells are surrounded by ECM in vivo, invadopodia are 
thought to be the protrusive structure formed and utilised by cancer cells in a 
physiological environment (Yamaguchi et al., 2005). Investigation of the molecular 
mechanisms involved in invadopodia formation and regulation are important for 
understanding tumour invasion and metastasis. 
A strong connection between the invasive potential of cells and their ability to 
develop invadopodia and digest a fluorescently labelled gelatin matrix in vitro has 
previously been reported (Coopman et al., 1998). Recently, invasive carcinoma cells 
were shown to assemble invadopodia-like structures and invade into 3D matrix (Yu 
and Machesky, 2012). Additionally, mammary tumour cells have been suggested to 
form invadopodia in vivo (Gligorijevic et al., 2012).  
In addition to Src-transformed fibroblasts, invadopodia have been reported in cell 
lines or primary tumour cells from malignant melanoma (e.g. LOX, RPMI7951), 
(Baldassarre et al., 2003; Mueller et al., 1999; Seals et al., 2005; Tague et al., 2004), 
breast/mammary carcinoma (e.g. MTLn3) (Artym et al., 2006; Hashimoto et al., 
2004; Lorenz et al., 2004),  and glioma (e.g. SNB19, U251MG) (Angers-Loustau et 
al., 2004; Chuang et al., 2004). Indeed, invadopodia may also be found formed by 
other malignant tumour cells.  
 In this chapter, seven cell lines were screened for invadopodia formation. In 
agreement with previous reports, the highly invasive MDA-MB-231, PC3 and A375 
cells can form invadopodia (figure 3.2) (Artym et al., 2006; Baldassarre et al., 2003; 
Desai et al., 2008). However, the non-invasive MCF-7, DU145, and HT-29 cells did 
not form invadopodia, suggesting a direct correlation between the ability to form 
invadopodia and metastatic potential of cancer cells (Yamaguchi et al., 2005). 
Possibly, these non-invasive cells have a reduced ability to synthesize or secrete 
proteases, lack cell surface receptors required to localize the proteases, or are 
missing cytoskeletal components needed to stabilize protrusive invadopodia. 
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Additionally, these cells grow in colonies and form tight cell-cell junctions enriched 
in E-cadherin that can inhibit their invasive potential (Rajasekaran et al., 2001), 
whereas the invasive cells grow as single cells and can therefore respond 
independently to extracellular stimuli. 
It is shown here that the percentage of highly invasive cells forming invadopodia 
markedly reduced upon serum starvation (figure 3.2). This is perhaps due to cells 
entering quiescent state (G0 phase) causing reduced production of natural growth 
factors or other molecular machineries required to sustain the invasive ability. A 
closer examination of some serum-starved cells within the population revealed that 
F-actin puncta were present in the absence of neither cortactin nor gelatin matrix 
degradation (figure 3.3). It has been reported that dendritic and bundled actin 
networks are first assembled at the ventral surface of the cell providing a core for 
invadopodia formation at pre-invadopodia or stage 0 (Schoumacher et al., 2010). 
Invadopodia formation involves sequential stages of cortactin recruitment to 
membranes, matrix proteases accumulation, ECM degradation, and cortactin 
dissociation (Artym et al., 2006). Time-lapse imaging of invadopodia assembly 
revealed that cortactin induces formation of actin-rich invadopodia structures prior to 
recruitment of matrix proteases and subsequent matrix degradation (Artym et al., 
2006). It is not well understood how cortactin is recruited to and its activity is 
regulated at invadopodia. Since cortactin can bind to several key components of 
invadopodia such as N-WASP and Arp2/3 complex, cortactin may cooperate with 
these proteins to assemble actin structures at invadopodia (Mizutani et al., 2002; 
Uruno et al., 2001). Therefore this suggests that serum-deprivation may only 
contribute to the induction of initial step that drives recruitment of invadopodia 
components to form pre-invadopodia F-actin structures. However, accumulation of 
these structures alone without recruitment of cortactin-dependent membrane 
proteases is insufficient to degrade the gelatin matrix.  
During tumorigenesis, cellular growth, adhesion and motility become aberrantly 
activated leading to tissue invasion and metastasis. These can be driven by various 
signalling molecules such as growth factors. Studies have shown that stimulation 
with growth factors, such as platelet-derived growth factor (PDGF), and 
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transforming growth factor-β (TGFβ) induces invadopodia formation in cancer cells 
(Yamaguchi and Condeelis, 2007).  
EGF receptor (EGFR) signalling is also known to play important role in the 
regulation of invadopodia formation. The most characterised role of EGFR 
signalling in invadopodia is its function upstream of Src activation and cortactin 
phosphorylation (Mader et al., 2011). EGF stimulation was reported to enhance 
invadopodia formation and ECM degradation in metastatic rat MTLn3 mammary 
carcinoma cells (Yamaguchi et al., 2005). In the current study, EGF was also shown 
to induce invadopodia formation in human MDA-MB-231 breast carcinoma cells 
(figure 3.2). Following on from the studies presented here, others have now reported 
that EGF can stimulate invadopodia formation in MDA-MB-231 cells (Pichot et al., 
2010). Additionally, EGF can also increase the proteolytic activity of MDA-MB-231 
cells (Busco et al., 2010). These data suggest that EGF is a potent stimulator of 
increased cell invasion and invadopodia formation not only in murine but also in 
highly invasive human breast carcinoma cells.  
EGF was also able to induce invadopodia formation in PC3 prostate carcinoma cells 
(figure 3.2), an observation that has not been previously reported. Although, EGF 
has been shown to stimulate PC3 cell invasion in a micro invasion assay. This 
enhancement of invasion occurs in part by an overproduction of uPA, an 
extracellular protease important for matrix degradation (Jarrard et al., 1994). 
Conversely, EGF could not enhance invadopodia formation in human A375 
melanoma cells likely to be as a result of low level of EGF receptor expression 
(figure 3.1). In contrast, HGF stimulation enhanced invadopodia forming potential 
of human A375 melanoma cells. Similarly, HGF was shown to enhance the capacity 
of LOX human melanoma cells to degrade matrix substrates (Tague et al., 2004). 
HGF could also increase invadopodia formation in MDA-MB-231 and PC3 cells 
(figure 3.2).  
Taken together, this study provides evidence that both HGF and EGF could promote 
invadopodia formation; however HGF was a more potent stimulator of gelatin 
degradation activity in comparison to EGF-induced invadopodia-forming cells 
(figure 3.6). This effect is interesting and presumably due to the contribution of 
HGF-induced signalling towards the increased production of matrix-
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metalloproteinases (MMPs), key proteolytic proteins involved in the formation of 
invadopodia (Poincloux et al., 2009). HGF has been shown to actively promote 
production of MT1-MMP in MDA-MB-231cells, which further activated MMP2 and 
enhanced the invasiveness of breast cancer cells (Jiang et al., 2006). These proteins 
act as bridging molecules between matrix proteins, such as collagen and integrins 
facilitating matrix degradation (Poincloux et al., 2009). The underlying mechanism 
modulating this pathway remains elusive. Recently, c-Met was shown to localise at 
invadopodia in breast cancer cells and that formation of invadopodia relies on its 
activity (Rajadurai et al., 2012). However, it is not known if EGF receptors localize 
to invadopodia. Additionally, HGF and EGF have been demonstrated to stimulate 
divergent as well as redundant signal transduction pathways (Stolz and 
Michalopoulos, 1994), thus partly supports the data showing different effects of 
HGF and EGF on inducing invadopodia and gelatin matrix degradation. 
EGF and HGF stimulation could not induce invadopodia in the non-invasive cell 
lines. HGF has a well-recognised role in promoting EMT by inducing cell scattering 
in MDCK (Balkovetz, 1998; Stoker and Perryman, 1985) and in DU145 colony 
forming cells (Bright et al., 2009; Wells et al., 2005). Data presented here would 
suggest that growth factor stimulation alone may be insufficient to facilitate the 
complete transition from a non-invasive to invasive phenotype with matrix degrading 
capacity. Perhaps for non-invasive cells to be able to form invadopodia and degrade 
matrix, they require neoplastic transformation by over-expression of oncogenic 
proteins such as Src to acquire invasive capacity (Chen, 1989).Cell shape analysis to 
test whether invadopodia forming cells have signature morphology revealed that 
invadopodia forming cells were more spread in both cell lines (figure 3.5). This 
could indicate the activation of integrin-mediated adhesion events at cell-matrix sites 
that triggers the assembly of invadopodia to facilitate movement and penetration of 
cell body to degrade matrix (Poincloux et al., 2009). One interesting possibility is 
that EGFR and c-Met may induce invadopodia via cross-talk with cell surface 
integrins (Ivankovic-Dikic et al., 2000).  
This chapter describes the effect of extracellular stimulation by EGF or HGF on 
invadopodia formation across a panel of cell lines. Following detailed analysis of 
invadopodia forming potential, two cell lines were selected for further study. MDA-
MB-231 cells exhibited significant invadopodia formation that could also be 
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substantially reduced by serum starvation and elevated by stimulation with both 
growth factors. MCF-7 cells were chosen as a complimentary tissue matched cell 
line as these cells had no significant invadopodia forming activity regardless of 
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Chapter 4 - The characterization of invadopodia formation 
in response to hypoxia 
 
4.1 Introduction 
Chapter 3 demonstrated that invadopodia formation could be induced by growth 
factor stimulation. However, during tumour progression, other environmental cues 
are also received by a cancer cell. One such cue is a change in the oxygen levels 
surrounding the tumour mass. Typically the local vasculature is unable to supply a 
sufficient amount of oxygen and nutrients to the rapidly growing tumour. This 
results in intratumoral hypoxia (Semenza, 2002; Vaupel, 2004). To resist the 
negative effects of hypoxia, tumour cells increase the expression of the α-subunit of 
HIF-1 which is largely known to promote angiogenesis (Harris, 2002; Semenza, 
2003; Vaupel, 2004). In some breast carcinomas, HIF-1α is over-expressed and has 
been associated with increased blood vessel density, tumour aggressiveness and poor 
prognosis (Bos et al., 2003; Kimbro and Simons, 2006; Vleugel et al., 2005). 
However, more recent studies also suggest that hypoxia can promote cancer cell 
invasion (Kimbro and Simons, 2006; Lu and Kang, 2010). 
Matrigel invasion assays using Boyden chambers demonstrated that hypoxia 
promotes invasion in breast carcinoma cells via HIF-1α over-expression (Choi et al., 
2011). Recently, hypoxia has been shown to influence invadopodia formation in 
human fibrosarcoma cells (Lucien et al., 2011). However a direct effect of HIF-1α 
over-expression in the formation of invadopodia has not been investigated.  
This chapter investigates the invadopodia forming potential of the chosen tissue-
matched cell lines MDA-MB-231 and MCF-7 in response to hypoxia by inducing 
increased expression of HIF-1α protein. Furthermore, to compliment chapter 3 
studies, the synergistic effect of hypoxia in combination with HGF stimulation was 






4.2.1 HIF-1α expression is maintained for up to 6 hours with DMOG 
In order to investigate the effects of hypoxia on the invasive behaviour of the two 
chosen breast cancer cell lines, the initial approach was to chemically induce HIF-1α 
expression with dimethyloxaloylglycine (DMOG) at a concentration of 0.5mM. 
DMOG, routinely used as a hypoxia mimetic, stabilizes HIF-1α protein by inhibiting 
prolyl and asparaginyl hydroxylases under normal oxygen tension (Marchbank et al., 
2011). The expression level of HIF-1α upon DMOG treatment over a period of 6 
hours was compared to the basal level in both cell lines. Endogenous HIF-1α 
expression level was significantly increased (figure 4.1a and b) and can be observed 
as early as 2 hours following DMOG treatment in MDA-MB-231 and MCF-7 cells. 
As expected, a weak basal level of HIF-1α expression was observed in the MDA-
MB-231 cells (figure 4.1a) whilst the MCF-7 cells do not detectably express HIF-1α 
under basal growth conditions (figure 4.1b). The expression level of a closely 
related family member HIF-2α was also determined. Whilst both MDA-MB-231 and 
MCF-7 cells express HIF-2α under basal conditions (figure 4.1c), there was no 
significant increase in the levels of HIF-2α observed in the MDA-MB-231 cells upon 
6 hours DMOG treatment (figure 4.1c).  
4.2.2 DMOG increases invadopodia formation and gelatin degradation  
Having successfully induced HIF-1α over-expression in the two cell lines, the effect 
on invadopodia forming potential was examined. In the non-treated cell population, 
37% of the MDA-MB-231 cells form invadopodia (figure 4.2 a left panel and b). 
When the cells were treated with DMOG, the percentage of cells forming 
invadopodia significantly increased to 50% (figure 4.2 a middle panel and b). The 
effect of maintaining DMOG presence during the gelatin degradation assay was next 
tested. Interestingly, when more DMOG was added to cells, a further increase in the 
percentage of invadopodia to 67% was observed (figure 4.2 a right panel and b). 
These results indicate that increased HIF-1α expression correlates with increased 















Figure 4.1 Increased HIF-1α expression is maintained for up to 6 hours upon DMOG 
stimulation.  (a) MDA-MB-231 and (b) MCF-7 cells were seeded at 3X10
4 
cells/ml and 
allowed to adhere for 24 hours. Cells were stimulated with (0.5mM) dimethyloxaloylglycine 
(DMOG) for up to 6 hours. Cells were lysed for 10 minutes in lysis buffer (see materials and 
methods). Equal amounts of protein lysates were electrophoresed on 7.5% SDS 
polyacrylamide gels. Western blot of the lysates was probed for levels of HIF-1α (Cell 
Signalling Technology) and (c) HIF-2α (Santa Cruz) antibodies. ERK was used as a loading 









Given that HGF also promoted invadopodia formation in these cells, HGF was also 
added to the DMOG treated cells seeded on TRITC-gelatin for 3 hours to determine 
whether there was a synergistic effect on invadopodia formation. However, no 
significant increase in the percentage of invadopodia was observed when the cells 
were stimulated with HGF compared to the cells stimulated with DMOG alone 
(figure 4.2b). In addition to its effect on increasing invadopodia forming potential, 
cells pre-treated with DMOG for 6 hours exhibited an increase in degradation 
activity in comparison to the untreated cells (figure 4.2 a bottom panel and c). 
Furthermore, cells with 6 hours pre-treatment followed by further addition of 3 hours 
DMOG enhanced  gelatin degradation in comparison to the other two conditions 
(figure 4.2 a bottom right panel and c). These results indicate that increased HIF-
1α expression does not only influence invadopodia forming potential but also 
increased gelatin matrix degradation activity of the MDA-MB-231 cells. 
4.2.3 DMOG does not induce invadopodia formation in MCF-7 cells 
MCF-7 cells do not form invadopodia even under basal growth conditions (figure 
3.4c). Furthermore, HGF could not induce invadopodia formation in these cells 
(figure 3.4e). No evidence of invadopodia formation in MCF-7 cells was observed 
(figure 4.3 f) following DMOG treatment for 6 hours. In parallel with DMOG-only 
treatment, maintaining the presence of DMOG for 3 hours and overnight was 
performed. This still resulted in no induction of invadopodia formation in these cells 
(figure 4.3 f). Additionally, stimulation with HGF for 3 hours could not induce 
invadopodia in the DMOG-treated cells (figure 4.3 f).  
Under basal/non-treated conditions, the MCF-7 cells grow in colonies (figure 4.3 a 
left panel), however following 6 hours DMOG treatment, some of these cells 
appeared to start dissociating from their colonies (figure 4.3 b middle panel). This 
cell:cell dissociation observation was quantified using an established protocol (Fram 
et al., 2011). The percentage of cells attempting to scatter from colonies significantly 
increased in response to DMOG treatment compared to untreated cells (figure 4.3 g). 
Moreover, maintaining DMOG for 3 hours and overnight further enhanced this effect 
(figure 4.3 g). A combined HGF stimulation in DMOG-treated cells also increased 
the percentage of cells attempting to scatter compared to DMOG stimulation alone 




Figure 4.2 DMOG increases invadopodia formation and gelatin degradation in MDA-
MB-231 cells. (a) Cells were seeded at 3X10
4 
cells/ml in a 6-well plate and then stimulated 
with (0.5mM) DMOG for 6 hours. Cells were dissociated using non-enzymatic cell 
dissociation buffer and re-seeded on gelatin-coated coverslips at 2X10
4 
cells/ml before being 
allowed to adhere for 3 hours at 37°C. Cells were then fixed with 4% PFA, stained for F-
actin using Phalloidin 488 (Invitrogen) and imaged using fluorescence microscopy. (b) Cells 
were scored for the presence of actin puncta that colocalize with an area of degradation on 
the gelatin (arrow) and the mean percentage of cells with invadopodia formation calculated. 
Scale bar=10µm.  (c) Gelatin degradation assay was performed with all three conditions. 
This assay was done using ImageJ software. The results shown are mean ±SEM of 30 cells 
from each experimental condition over three separate experiments. Statistical significance 
compared with grow was calculated using Student‟s t-test; *, P<0.05. **, P<0.005. ***, 
P<0.0005, ns= non-significant. 
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The cells that were attempting to scatter exhibited altered morphology in response to 
6 hours DMOG treatment, maintaining DMOG presence for 3 hours and overnight, 
and also stimulation with HGF (figure 4.3b-e). This phenotype was quantified using 
ImageJ cell shape analysis. DMOG-treatment significantly reduced cell spread area 
and cells became markedly elongated (figure 4.3 h and i). These results indicate that 
although DMOG could not induce invadopodia formation, it could promote cell:cell 
dissociation and affect cell morphology. 
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Figure 4.3 DMOG does not induce invadopodia formation in MCF-7 cells but reduced 
cell-cell contact between cells in colonies. (a) MCF-7 cells were seeded at 3X10
4 
cells/ml 
in a 6-well plate. Cells were then stimulated with DMOG for 6 hours (b). Cells were 
dissociated using non-enzymatic cell dissociation buffer. Cells were then counted and re-
seeded on gelatin-coated coverslips at 2X10
4 
cells/ml with (c) additional DMOG for 3 hours, 
(d) additional DMOG overnight and (e) stimulation with HGF and allowed to adhere for 3 
hours at 37°C. Cells were then fixed with 4% PFA, stained for F-actin using Phalloidin 488 
(Invitrogen) and imaged using fluorescence microscopy. (f) Mean percentage of 
invadopodia. (g) Mean percentage of cells attempting to scatter was calculated. (h-i) ImageJ 
software was used to analyse cell area and elongation ratio of cells. The results shown are 
mean ±SEM of 30 cells from each experimental condition over three separate experiments. 
Statistical significance compared with grow was calculated using Student‟s t-test; *, P<0.05. 
**, P<0.005, ns=non-significant. 
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4.2.4 Loss of HIF-1α expression attenuated DMOG response  
Results presented here (figure 4.2) suggest that increased HIF-1α expression leads to 
increased invadopodia forming potential (figure 4.2a-c). To rule out any off target 
effects of the compound, and to establish whether the DMOG-induced phenotype 
was a direct result of specific stabilization of HIF-1α expression, a HIF-1α depletion 
experiment was performed in the background of DMOG treatment. As shown in 
(figure 4.4a and b), 80% of HIF-1α protein expression was successfully depleted, 
with no detectable change in the expression of HIF-2α (figure 4.4a). Having 
successfully knocked-down HIF-1α expression, cells were treated with DMOG for 6 
hours then seeded on TRITC-gelatin coverslips for 3 hours (figure 4.4c). Cells 
transfected with control siRNA form invadopodia (figure 4.4c and d), consistent 
with previous results (figure 4.2) whilst DMOG treated cells with reduced HIF-1α 
expression had a significantly reduced response (figure 4.4c and d). 
 
4.2.5 GFP- HIF-1α is localised in the nucleus and functional 
To complement the DMOG studies and further investigate the specific role of HIF-
1α, an over-expression system was employed. Using Gateway Cloning Technology, 
a GFP-tagged version of HIF-1α was generated. Under normal oxygen conditions, 
HIF-1α is rapidly degraded. Thus the stability of GFP-HIF-1α was tested in HEK-
293 cells; as these cells have high transfection efficiency. A 72-hour time course 
experiment was performed to examine GFP-HIF-1α expression, stability and 
localisation. HIF-1α was successfully over-expressed in HEK-293 cells (figure 4.5a) 
and expression was maintained for up to 72 hours (figure 4.5b). Additionally HIF-




Figure 4.4 Loss of HIF-1α expression attenuated DMOG response. (a) MDA-MB-231 
cells were seeded at 3X10
4 
cells/ml and allowed to adhere for 24 hours. Cells were 
transfected with mock, control and HIF-1α siRNAs for 48 hours, followed by stimulation 
with DMOG for 6 hours. Cells were lysed for 10 minutes in lysis buffer (see materials and 
methods). Equal amounts of protein lysates were electrophoresed on 7.5% SDS 
polyacrylamide gels. Western blot of the lysates was probed for levels of HIF-1α (Cell 
Signalling Technology). Membrane was stripped and re-probed for levels of HIF-2α (Santa 
Cruz). ERK, a house-keeping protein was used as a loading control. (b) Relative expression 
of HIF-1α was measured using densitometric analysis. (c) HIF-1α KD cells were seeded on 
gelatin-coated coverslips. (d) Cells were scored for the presence of actin puncta that 
colocalize with area of degradation on the gelatin (arrow) and the mean percentage of cells 
with invadopodia formation calculated. Scale bar=10µm. The results shown are mean ±SEM 
of 30 cells from each experimental condition over three separate experiments. Statistical 
significance compared with grow was calculated using Student‟s t-test; *, P<0.05. **, 




















Figure 4.5 GFP-HIF-1α is localised in the nucleus and functional.  (a) HEK-293T cells 
were seeded at 1X10
5 
cells/ml on coverslips in a 6-well plate and transfected with GFP-HIF-
1α. Cells were fixed at 24, 48 and 72 hours following transfections with 4% PFA, stained for 
F-actin using TRITC-Phalloidin (Invitrogen) and imaged using fluorescence microscopy. (b) 
Cells were scored for the presence of GFP-HIF-1α expression in the nucleus at indicated 
time points (arrow). (c) MDA-MB-231 cells were seeded at 1X10
5 
cells/ml in a 6-well plate 
and transfected with GFP-HIF-1α using Lipofectamine 2000. Cells were lysed at 24 hours 
following transfections. Western blot of the lysates was probed for levels of HIF-1α (Cell 
Signaling Technology) and (d) HIF-2α (Santa Cruz). ERK and gapdh, are used as loading 
controls. (e) RT-PCR of MDA-MB-231 cells transfected with GFP-control and GFP-HIF-1α 
using VEGF specific primers. (f) Relative expression of VEGF was measured using 
densitometric analysis.  Scale bar=10µm. The results shown are mean ±SEM of 30 cells 
from each experimental condition over three separate experiments. Statistical significance 




Subsequently, GFP-HIF-1α over-expression was tested in the breast cancer cell lines. 
HIF-1α over-expression was stable under normal oxygen tension (figure 4.5) and 
western blot analysis confirmed the size and stability of over-expressed HIF-1α in 
both cell lines at 150kDa (figure 4.6a and 4.7a). The expression level of a closely 
related family member HIF-2α was also determined. There was no change in the 
expression of HIF-2α in the presence of over-expressed GFP-HIF-1α   (figure 4.6b).  
The ability of GFP-HIF-1α to function normally in cells was also tested by 
monitoring the level of VEGF mRNA expression in control and transfected cells. 
HIF-1α is known to induce a large increase in VEGF expression and this increase 
was detected in MDA-MB-231 cells expressing GFP-HIF-1α compared to control 
cells expressing GFP-alone (figure 4.6 c and d).  
4.2.6 GFP-HIF-1α over-expression increases invadopodia formation and 
gelatin degradation 
 
Having established that GFP-HIF-1α is stable and functional when overexpressed in 
breast cancer cells, overexpressing cells were tested for invadopodia forming 
activity. GFP-HIF-1α or control GFP alone transfected cells were seeded on TRITC-
gelatin coverslips for 3 hours and assayed for invadopodia formation (figure 4.6e 
and 4.7b). Over-expression of GFP-HIF-1α significantly increased the percentage of 
cells with invadopodia in the MDA-MB-231 cells compared to GFP-alone (figure 
4.6e). Additionally, GFP-HIF-1α over-expressing cells also had an increased ability 
to degrade gelatin matrix (figure 4.6e right panel). The level of elevation was 
consistent with the level of DMOG-induced invadopodia formation and gelatin 
degradation (figure 4.2). In contrast, MCF-7 cells exhibited no induction of 




Figure 4.6 GFP-HIF-1α over-expression induces invadopodia formation and gelatin 
degradation in MDA-MB-231 cells.  (a) GFP-control and GFP-HIF-1α cells were seeded 
on gelatin coverslips for 3 hours. (b) Cells were scored for the presence of GFP-HIF-1α 
expression in the nucleus and corresponding actin puncta that colocalize with area of 
degradation on the gelatin. Scale bar=10µm. (c) ImageJ software was used to quantify the 
area of degradation per cell area. The results shown are mean ±SEM of 30 cells from each 
experimental condition over three separate experiments. Statistical significance compared 









Figure 4.7 GFP-HIF-1α over-expression does not induce invadopodia formation in 
MCF-7 cells. (a) MCF-7 cells were seeded at 1X10
5 
cells/ml in a 6-well plate and 
transfected with GFP-HIF-1α using Lipofectamine 2000. Cells were lysed at 24 hours 
following transfections. Western blot of the lysates was probed for levels of HIF-1α (Cell 
Signalling Technology). ERK, a house-keeping protein was used as a loading control (b) 
Cells were dissociated using non-enzymatic cell dissociation buffer. Cells were then counted 
and re-seeded on gelatin-coated coverslips at 2X10
4 
cells/ml. (c) Cells were scored for the 
presence of GFP-HIF-1α expression in the nucleus and corresponding actin puncta that 
colocalize with area of degradation on the gelatin. Scale bar=10µm. The results shown are 
mean ±SEM of 30 cells from each experimental condition over three separate experiments. 






4.2.7 GFP-HIF-1α over-expression increases cell: cell dissociation  
DMOG treatment has revealed a significant induction of cell: cell detachment from 
tight colonies in MCF-7 cells (figure 4.3). Interestingly, GFP-HIF-1α over-
expression in MCF-7 cells also exhibited a similar phenotype (figure 4.8d). To 
verify this effect, E-cadherin, a well-established epithelial marker was used to label 
cell: cell junctions in GFP-HIF-1α over-expressing cells. E-cadherin staining was 
specifically reduced in cells over-expressing GFP-HIF-1α particularly at junctions 
(figure 4.8c). In parallel, western blot analysis revealed an approximately 3-fold 
reduction in E-cadherin protein expression levels (figure 4.8a and b).  
4.2.8 Hypoxic environment increases gelatin degradation  
Increased HIF-1α expression by either DMOG or GFP-HIF-1α promotes 
invadopodia formation in MDA-MB-231 cells (figure 4.2 and 4.6). However, it is 
important to be able to demonstrate the effects of increased HIF-1α expression on 
invadopodia formation under more physiological conditions of oxygen deprivation. 
To do this, a hypoxia modulator incubator was utilised. Cells were incubated either 
under normoxic or hypoxic environment with either 20% or 1-1.5% oxygen supply 
respectively. This method is a physiological approach used in numerous hypoxia 
studies to observe different effects on cells (Fujiwara et al., 2007; Lee et al., 2010; 
Lu et al., 2010). HIF-1α levels drop rapidly when cells were removed from the 
incubator, thus the gelatin degradation assay was slightly modified to accommodate 
this effect. MDA-MB-231 cells were seeded onto TRITC-gelatin coverslips followed 
by incubation in a normoxia or hypoxia incubator for 6 hours. An additional time 
point of 16 hours was also chosen. In parallel, cells were seeded on plastic for 6 or 
16 hours in normoxic or hypoxic condition for extraction of protein lysates to assay  
for levels of HIF-1α expression. Endogenous HIF-1α expression level was 
significantly increased when cells were incubated in hypoxic conditions (figure 
4.9a) but HIF-2α expression remained unchanged (figure 4.9a).  Interestingly, cells 
incubated for 6 and 16 hours under hypoxic conditions significantly degraded more 
gelatin than normoxic conditions (figure 4.9b and c). These results indicate that 
hypoxia has a significant effect on tumour cell behaviour, in part by increasing 
















Figure 4.8 GFP-HIF-1α over-expression reduces E-cadherin expression and promotes 
cell: cell dissociation of MCF-7 cells. (a) MCF-7 cells were seeded at 1X10
5 
cells/ml in a 6-
well plate and transfected with GFP-HIF-1α using Lipofectamine 2000. Cells were lysed at 
24 hours following transfections. Western blot of the lysates was probed for levels of E-
cadherin (Cell Signaling Technology). Gapdh, a house-keeping protein was used as a 
loading control (b) Densitometric analysis of E-cadherin protein expression. (c) Cells were 
dissociated using non-enzymatic cell dissociation buffer. Cells were then counted and re-
seeded on glass coverslips at 2X10
4 
cells/ml. Cells were then fixed with 4% PFA, stained for 
F-actin using Phalloidin 488 (Invitrogen) and E-cadherin and imaged using confocal 
microscopy. (d) Mean percentage of GFP-HIF-1α over-expressing cells attempting to scatter 
was calculated. The results shown are mean value ±SEM of 30 cells from each experimental 
condition over two separate experiments. Scale bar=10µm. Statistical significance compared 




















Figure 4.9 MDA-MB-231 cells incubated under hypoxic conditions increase gelatin 
degradation.  (a) MDA-MB-231 cells were seeded at 3X10
4 
cells/ml in a 6-well plate, 
allowed to adhere and incubated in normoxia and hypoxia for 6 and 16 hours. Cells were 
then lysed for 10 minutes in lysis buffer (see materials and methods). Equal amounts of 
protein lysates were electrophoresed on 7.5% SDS polyacrylamide gels. Western blot of the 
lysates was probed for levels of HIF-1α (Cell Signaling Technology). Membrane was 
stripped and re-probed for levels of HIF-2α (Santa Cruz).  Gapdh, a house-keeping protein 
was used as a loading control.  (b) Cells were seeded on gelatin-coated coverslips and 
incubated in normoxia and hypoxia for 6 and 16 hours. (c) The results shown are mean grey 
value ±SEM of 30 fields of view from each experimental condition over three separate 
experiments. Statistical significance compared with normoxia was calculated using 




During tumour progression, oxygen tension in the microenvironment surrounding 
the tumour cells is reduced due to insufficient delivery of oxygen to the demand of 
the tissues, resulting in hypoxia (Brown and William, 2004; Fyles et al., 2006; 
Kimbro and Simons, 2006; Travers, 2006). Cancer cells resist the negative effects of 
hypoxia predominantly via the activity of transcription factor hypoxia-inducible-
factor-1 (HIF-1) (Semenza and Wang, 1992). It is well established that HIF-1α can 
promote angiogenesis by up-regulating the secretion of VEGF into the tumour 
stroma, hence maintaining oxygen supply and supporting tumour growth (Sullivan 
and Graham, 2007). However, tumour hypoxia is linked to increased metastatic 
potential (Goonewardene et al., 2002; Harris, 2002; Schindl et al., 2002), although 
the molecular mechanisms involved remain unclear.  
In this chapter, the effect of increased HIF-1α expression was tested on the chosen 
breast carcinoma cell lines MDA-MB-231 and MCF-7. HIF-1α stabilization was 
successfully induced by using an established protocol to mimic hypoxia with 
DMOG, which is a cell-permeable, non-toxic prolyl-4-hydroxylase inhibitor which 
allows HIF-1α to accumulate in cells (Milkiewicz et al., 2004). It is demonstrated 
here that DMOG treatment significantly increased invadopodia formation in MDA-
MB-231 cells (figure 4.2).  It is surprising to detect an increase of invadopodia 
formation as early as 6 hours in the presence of DMOG, indeed the increased 
formation of invadopodia was lost by 16 hours (data not shown). This suggests that 
HIF-1α is rapidly translocated into the nucleus and that transcriptional modulation of 
gene expression associated with invasive capacity occurs very quickly. Indeed, 
others have reported changes in protein levels following as little as 3 hours DMOG 
treatment (Hudecova et al., 2011). Interestingly, sustaining the presence of DMOG 
in cells throughout the assay exhibited a further elevated response (figure 4.2), thus 
indicating the higher the level of HIF-1α that is maintained the more invasive the cell 
population becomes. Not only was increased invadopodia activity detected but also a 




These results suggested that HIF-1α was directly influencing the behaviour of the 
cancer cells. DMOG inhibits the activity of prolyl and asparaginyl hydroxylases at 
two proline and one asparaginyl residues (Milkiewicz et al., 2004) but whilst the 
current data and others have reported that DMOG activity leads to stabilization of 
HIF-1α  expression, there is the possibility of off target effects. Indeed, DMOG 
activity has been associated with non-HIF-1α-related events (Elvidge et al., 2006). 
However, specific reduction of HIF-1α expression was able to attenuate the ability of 
DMOG to enhance increased invadopodia forming potential in the MDA-MB-231 
cells, thus providing further support for a specific role for HIF-1α on invadopodia 
formation. Since the work presented here was initiated it has been reported that 
hypoxia can influence invadopodia formation in fibrosarcoma cells (Lucien et al., 
2011), however this study only evaluated the effects of hypoxia and did not 
specifically address the role of HIF-1α.  
To further explore the role of HIF-1α in invadopodia formation, an overexpression 
strategy was utilised. This particular expression system was sufficient to overcome 
endogenous HIF-1α degradation pathways for up to 72 hours and deliver a 
significant increase in HIF-1α expression. Other studies using WT-HIF-1α constructs 
incorporated the treatment of MG132, a proteasome degradation inhibitor to stabilize 
HIF-1α expression (Choi et al., 2011). Hypoxia can also trigger HIF-2α expression 
and it can interact with HREs to up regulate gene expression (WENGER, 2002). 
Importantly, over-expression of HIF-1α did not alter the levels of HIF-2α. Consistent 
with DMOG studies, GFP-HIF-1α overexpressing cells exhibited a substantial 
increase in both invadopodia and matrix-degrading ability (figure 4.6). 
 To compliment the HIF-1α induction/over-expression studies, a hypoxia incubator 
was used to test the invasive potential of MDA-MB-231 cells under hypoxic 
conditions. Normoxic and hypoxic cells were subjected to an invadopodia assay and 
hypoxic cells demonstrated a significant increase in gelatin-matrix degradation 
which is consistent with previous experiments (figure 4.9). Collectively, these data 
strongly support a role for hypoxia, via HIF-1α activity in driving invasive potential 
of breast cancer cells. 
It is well established that invadopodia extension into the matrix relies on force driven 
by actin polymerization (Schoumacher et al., 2010; Wolf and Friedl, 2009) and 
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matrix-degrading proteases particularly MT1-MMP (Poincloux et al., 2009). The 
enhancement of invadopodia formation and degradation activity in response to 
increased expression of HIF-1α may be via regulation of MT1-MMP. HIF-1 is 
involved in desferoxamine-induced invasion in glioblastoma cells by activating 
proteolytic enzymes responsible for ECM degradation, such as MMP-2, MMP-9, 
MT1-MMP and urokinase plasminogen activator receptor (uPAR) (Elstner et al., 
2007). Additionally, HIF-1α has been demonstrated to promote invasion of breast 
cancer cells through a MMP-9 and Ras dependent mechanism (Choi et al., 2011). 
Moreover, hypoxia has been shown to promote RhoA-dependent trafficking of MT1-
MMP to the plasma membrane (Munoz-Najar et al., 2006) hence facilitating ECM 
degradation.  
In parallel with MDA-MB-231 cells, the effects of DMOG treatment and GFP-HIF-
1α were tested in MCF-7 cells. Increased HIF-1α expression using both methods 
resulted in dissociation of cells from their colonies (figure 4.3). This observation 
was quantified and a significant increase in the percentage of cells attempting to 
escape from colonies was observed (figure 4.3 and 4.8). Cell shape analyses also 
revealed that DMOG treatment reduced cell spread area and increased cell 
elongation (figure 4.3). This behaviour is likely to be a pre-requisite of 
invasion/invadopodia formation, by which once the cells escaped from colonies and 
become single cells, they could increase spread area and begin to invade as observed 
in chapter 3 (figure 3.5). Others have shown that hypoxia affects cytoskeletal re-
organization by increasing stress fibres and membrane ruffling (Huot et al., 1998) 
but a specific effect of HIF-1α overexpression on MCF-7 has not been reported. It 
was surprising to detect a reduction of E-cadherin positive cell junctions which was 
correlated with a significant reduction in expression at a protein level during HIF-1α 
over-expression (figure 4.8 a and b). Indeed, others have reported changes in E-
cadherin expression that was associated with increased HIF-1α expression in ovarian 
carcinomas (Imai et al., 2003). 
E-cadherin expression can be transcriptionally suppressed by other transcription 
factors such as Snail (Blechschmidt et al., 2008) and HIF-1α has been shown to up-
regulate Snail expression (Imai et al., 2003; Luo et al., 2011). Indeed, in renal cell 
carcinoma dysregulation of HIF-1 activity contributes to the down-regulation of E-
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cadherin expression, loss of cell-cell adhesion, and the  epithelial-to-mesenchymal 
transition (EMT) (Krishnamachary et al., 2006).  
Similar finding were also reported in gastric cancer cells where HIF-1 up-regulation 
contributed to the EMT phenotype and increased invasiveness (Zhou et al., 2011). 
Furthermore, DMOG has also been reported to inhibit LPS-induced TNF-alpha 
upregulation in macrophages (Takeda et al., 2009).  
Data presented here also implies that there is a synergistic relationship between 
hypoxia and growth factor stimulation where combined addition of DMOG and HGF 
leads to a significant increase in cell:cell dissociation above DMOG stimulated 
levels. HGF is known to be a potent inducer of cell: cell dissociation and scattering 
(Bright et al., 2009; Royal and Park, 1995; Wells et al., 2005), and hypoxia has been 
shown to increase both the level of c-met and HGF expression (Eckerich et al., 2007; 
Ide et al., 2006). Moreover, c-met signalling can also lead to increased HIF-1α 
expression (Tacchini et al., 2001). Thus, it is plausible to speculate that this 
symbiotic expression relationship contributed to the increase in cell: cell dissociation 
detected here.  
Although increased expression of HIF-1α in MCF-7 cells induced significant effect 
on cell-cell dissociation, no induction of invadopodia formation was detected. This is 
in contrast to the robust effect of DMOG/ HIF-1α over-expression on the highly 
invasive MDA-MB-231 cells. It would appear that in MCF-7 cells, HIF-1α over-
expression alone is insufficient to induce invadopodia formation. Indeed, MCF-7 
cells also did not respond to EGF or HGF stimulation suggesting that these cells lack 
intrinsic components of the invasive machinery. It would be interesting to make a 
comparison of the cytoskeletal and matrix degrading protein expression patterns 
between these two cell lines. 
Work presented in this chapter clearly shows that increased HIF-1α expression by 
chemical or over-expression strategies can enhance invadopodia formation in 
invasive breast cancer cells. Moreover, exposure of cells to a hypoxic environment 
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Chapter 5 – PAK1 and PAK2 are required for invadopodia 
formation in breast cancer cells 
5.1 Introduction 
Chapter 3 and 4 demonstrated that invadopodia formation could be induced by either 
growth factor stimulation or increased HIF-1α expression. An invasion process 
requires the production of signalling proteins that control the actin cytoskeleton. 
Among the proteins known to play a major role in the re-organization of the actin 
cytoskeleton are p21-activated kinases (PAKs). 
5.1.1 PAK1 and PAK2 in breast cancer invasion 
Over-expression and/or hyperactivation of PAK1 and PAK2 isoforms have been 
frequently observed in several human cancers (Kumar et al., 2006). PAK1 is 
localised to genomic regions, which are frequently amplified in a number of cancer 
cells including breast cancers. PAK expression is deregulated in breast cancers, and 
increased PAK1 activity correlates well with the invasiveness of human breast 
cancer cells and tumours via a correlation between high grades, protein level and 
kinase activity of PAK1 (Shrestha et al., 2011). PAK2 has also been found to be 
highly expressed in breast cancer cell lines and highly invasive breast carcinoma 
tissues (Li et al., 2011). However, little is known about the role of PAK1 and PAK2 
in the formation of invadopodia of human breast carcinoma cells with and/or without 
extracellular stimulations. Previous work using PAK1-AID has suggested that PAK 
activity is required to sustain invadopodia formation and activity in invasive 
metastatic human melanoma cell line A375MM (Ayala et al., 2008). This chapter 
describes the involvement of PAK1 and closely related family member PAK2 in the 









5.2.1 PAK1 and PAK2 are expressed in different breast cancer cells 
Initially, the expression level of PAK1 and PAK2 was assayed in breast cancer cell 
lines known to have different degrees of invasive ability. The non-tumorigenic MCF-
10A cells express low level of PAK1 and PAK2, whereas the highly invasive MDA-
MB-231 cells express consistently higher level of PAK1 and PAK2 (figure 5.1). 
This indicates that expression level of PAK1 and PAK2 correlated with the level of 
invasive ability of these cells. The PAK1 and PAK2 antibodies are isoform specific 
and do not cross-react with any other PAK family members (Bright et al., 2009).  
5.2.2 PAK1 is phosphorylated downstream of HGF in MDA-MB-231 and 
MCF-7 cells  
Work presented here (chapter 3) demonstrated that HGF can stimulate invadopodia 
forming activity. HGF interaction with the c-Met receptor initiates a number of 
signalling cascades and it has been shown to specifically activate PAK1 (Bright et 
al., 2009; Hunter and Zegers, 2010; Royal et al., 2000), but this has not been 
reported in breast cancer cells. Thus, the activation of PAK1 and closely related 
family member PAK2 was monitored downstream of HGF in breast cancer cells 
using an antibody that recognises an autophosphorylation site in both proteins. 
Several autophosphorylation sites have been identified, including serines 199 and 
204 of PAK1 and serines 192 and 197 for PAK2 (Manser et al., 1997). In this study, 
phospho-PAK1/PAK2 antibody detects endogenous PAK1 and PAK2 when 
phosphorylated at Thr423 and Thr402 respectively. A 60-minute time-course 
experiment was performed on cells seeded on either plastic or gelatin matrix, 
followed by Western blot analysis. For cells seeded on plastic, PAK1 became 
phosphorylated on Thr423 within 5 minutes of HGF stimulation in MCF-7 (figure 
5.2) and after 15 minutes in MDA-MB-231 cells (figure 5.2). The phosphorylation 
in MDA-MB-231 cells was maintained for up to 60 minutes (figure 5.2), whereas in 
MCF-7 PAK1 phosphorylation peaked at 15 minutes (figure 5.2). Cells seeded on 
gelatin demonstrated a slightly different trend in which consistently higher PAK1 
phosphorylation downstream of HGF was observed. In MDA-MB-231 cells, PAK1 
phosphorylation also increased (figure 5.3c and d) but not as robustly as in MCF-7 









Figure 5.1 PAK1 and PAK2 are expressed in MCF-10A, MCF-7 and MDA-MB-231 
cells. Whole cell lysates of growing cells were immunoblotted for PAK1 and PAK2 
expression. Gapdh, a house-keeping protein is used as loading control. These results are 



























Figure 5.2 PAK1 and PAK2 are phosphorylated by HGF in MCF-7 and MDA-MB-231 
cells seeded on plastic. (a and b) Cells were seeded at 3X10
4
/ml and allowed to adhere for 
24 hours. Cells were serum-starved for 24 hours and stimulated with HGF for up to 60 
minutes. Cells were lysed for 10 minutes in lysis buffer (see materials and methods). Equal 
amounts of protein lysates were electrophoresed on 7.5% SDS polyacrylamide gels. Western 
blot of the lysates was probed for levels of phospho-PAK1 and PAK2 (Thr423/Thr402) (Cell 
Signaling Technology). (c and d) Densitometric analysis was performed to measure the 
phospho-PAK1 and PAK2 signals that were normalised to total level of PAK1 and PAK2 
respectively. These results are representative of three independent experiments. Statistical 





5.2.3  PAK2 is phosphorylated downstream of HGF in MDA-MB-231 and 
MCF-7 cells 
For cells seeded on plastic, PAK2 became phosphorylated on Thr402 within 5 
minutes of HGF stimulation in MCF-7 (figure 5.2a) but inconsistent 
phosphorylation was observed in MDA-MB-231 cells in which PAK2 
phosphorylation was difficult to detect (figure 5.2b). In contrast, cells seeded on 
gelatin revealed a more pronounced effect; that PAK2 phosphorylation in MCF-7 
was seen as early as 5 minutes post-HGF stimulation (figure 5.3a). Whereas in 
MDA-MB-231 cells, PAK2 phosphorylation was increased even in starved cells, 
followed by a further increase at 5 minutes HGF stimulation and maintained for up 
to 60 minutes (figure 5.3b).  
5.2.4  Efficient knockdown of PAK1 and PAK2 protein expressions  
PAK1 and PAK2 are both responsive to HGF when seeded on gelatin matrix (Figure 
5.3) and HGF can stimulate invadopodia formation (chapter 3). Thus the 
requirement for PAK1/PAK2 during invadopodia formation was determined. shRNA 
and siRNA smartpool oligos were tested for specific knockdown of PAK1 and 
PAK2. Both strategies effectively knocked down expression of PAK1/2 in MDA-
MB-231 cells. Knockdown of one PAK isoform did not affect the expression level of 



















Figure 5.3 PAK1 and PAK2 are phosphorylated by HGF in MCF-7 and MDA-MB-231 
cells seeded on gelatin matrix. (a and b) 6-well plates were coated with gelatin prior to 
seeding cells. Cells were seeded at 3X10
4
/ml and allowed to adhere for 24 hours. Cells were 
serum-starved for 24 hours and stimulated with HGF for up to 60 minutes. Cells were lysed 
for 10 minutes in lysis buffer (see materials and methods). Equal amounts of protein lysates 
were electrophoresed on 7.5% SDS polyacrylamide gels. Western blot of the lysates was 
probed for levels of phospho-PAK1 and PAK2 (Thr423/Thr402) (Cell Signaling 
Technology). (c and d) Densitometric analysis was performed to measure the phospho –
PAK1 and PAK2 signals that were normalised to total level of PAK1 and PAK2 
respectively. These results are representative of three independent experiments. Statistical 






Figure 5.4 PAK1 and PAK2 expression are successfully reduced in MDA-MB-231 cells. 
(a and b) MDA-MB-231 cells were seeded at 1X10
5 
cells/ml and allowed to adhere for 24 
hours. Cells were transfected with mock, control shRNA, PAK1 shRNA and PAK2 shRNA 
oligos for 24 hours. Puromycin was added to the transfected cells for 48 hours post-
transfection. PAK1 siRNA smartpool was transfected in cells every 24 hours for 48 hours. 
Cells were lysed for 10 minutes in lysis buffer (see materials and methods). Equal amounts 
of protein lysates were electrophoresed on 7.5% SDS polyacrylamide gels. Western blot of 
the lysates was probed for levels of PAK1 and PAK2 (Cell Signaling Technology). Gapdh, a 
house-keeping protein was used as a loading control. Relative expression of PAK1 and 
PAK2 was measured using densitometric analysis. The results shown are representative of 
three separate experiments. Statistical significance compared with control shRNA was 









5.2.5 PAK1 is required for invadopodia formation 
The shRNA vector is bi-cistronic whereby shRNA expressing cells also express GFP 
to aid visualisation and quantification processes. Invadopodia formation in control 
shRNA-transfected cells is consistent with the percentage observed under basal 
condition as shown in Chapter 3 (figure 5.5b). However, PAK1 shRNA markedly 
reduced invadopodia formation in MDA-MB-231 cells (figure 5.5a and b). To 
determine that this effect was specifically due to the loss of PAK1 expression, a 
rescue experiment was performed. Technical difficulties prevented the generation of 
an RNAi-resistant PAK1 mutant, thus wild-type mouse PAK1 was used. Wild-type 
mouse PAK1 successfully rescued the phenotype observed in PAK1 knockdown 
cells whereby the percentage of cells forming invadopodia increased to almost 
control level (figure 5.5a and b). In parallel, wild type human PAK2 was also used 
in the rescue experiment. However, PAK2 over-expression was not able to rescue the 
PAK1 knockdown phenotype.  
5.2.6 PAK2 is required for invadopodia formation 
A reduction in PAK1 expression significantly reduced invadopodia formation and 
this phenotype could not be rescued by the presence of endogenous or overexpressed 
PAK2. Thus it might be expected that PAK2 is not involved in invadopodia 
formation. However, PAK2 shRNA also markedly reduced invadopodia formation in 
MDA-MB-231 cells compared to control (figure 5.6a and b). To determine whether 
this effect is specifically due to the loss of PAK2 expression a rescue experiment was 
performed. A wild type PAK2-resistant mutant was generated and used in the rescue 
experiment. WT-PAK2
r
 successfully rescued the phenotype observed in PAK2 
knockdown cells in which the percentage of cells forming invadopodia increased to 
almost control level (figure 5.6a and b). In parallel, wild type mouse PAK1 was 
tested and exhibited no rescue phenotype (figure 5.6a and b).   
5.2.7 HGF and DMOG could not induce invadopodia in PAK1/2 depleted cells 
PAK1 and PAK2 knockdown significantly decrease invadopodia formation 
suggesting an essential requirement for these proteins. It might be speculated 
therefore that PAK1 and/or PAK2 would be required for the increased invadopodia 
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activity demonstrated in the presence of DMOG. Thus, the effect of DMOG 
treatment in the background of PAK1/2 depletion was examined. As anticipated, in a 
background of PAK1/2 knockdown, DMOG treatment was unable to induce 
invadopodia formation in cells to control levels. However, there was still an 
induction of invadopodia formation in the PAK1/2 knockdown background (figure 
5.7a and b), suggesting that DMOG works through multiple signalling pathways to 
induce invadopodia formation.  
In parallel with DMOG, the effect of adding HGF to the PAK1/PAK2 depleted cells 
was also examined. Similar to DMOG, HGF stimulation was unable to induce 
invadopodia formation in PAK1/PAK2 knockdown cells to control levels (figure 
5.8). Indeed, induction of invadopodia formation in PAK1/PAK2 depleted cells was 
significantly reduced, suggesting these proteins are required during HGF-stimulated 



















Figure 5.5 The loss of PAK1 expression reduces invadopodia formation in MDA-MB-
231 cells. (a) MDA-MB-231cells were seeded at 1X10
5 
cells/ml and allowed to adhere for 
24 hours. Cells were transfected with mock, control shRNA and PAK1 shRNA for 48 hours. 
Puromycin was added to the transfected cells for 48 hours post-transfection for transient 






transfected into the knockdown cells for 24 hours. Cells were seeded on gelatin-coated 
coverslips for 3 hours followed by fixation with 4% PFA. Control and PAK1 shRNA cells 
were stained for F-actin using Phalloidin 633. (b) Cells were scored for the presence of actin 
puncta that colocalize with area of degradation on the gelatin and F-actin (in control and 
PAK1 shRNA) and for the co-expression of PAK1 shRNA and rescue-mutant (for rescue 
experiments). The mean percentage of cells with invadopodia formation was calculated.  
Scale bar=10µm. The results shown are mean ±SEM of 30 cells from each experimental 
condition over three separate experiments. Statistical significance compared with control 

















Figure 5.6 The loss of PAK2 expression reduces invadopodia formation in MDA-MB-
231 cells (a) MDA-MB-231cells were seeded at 1X10
5 
cells/ml and allowed to adhere for 24 
hours. Cells were transfected with mock, control shRNA, and PAK2 shRNA oligos for 48 
hours. Puromycin was added to the transfected cells for 48 hours post-transfection for 






transfected into the knockdown cells for 24 hours. Cells were seeded on gelatin-coated 
coverslips for 3 hours followed by fixation with 4% PFA. Control and PAK1 shRNA cells 
were stained for F-actin using Phalloidin 633. (b) Cells were scored for the presence of actin 
puncta that colocalize with area of degradation on the gelatin and F-actin (in control and 
PAK2 shRNA) and for the co-expression of PAK2shRNA and rescue-mutant (for rescue 
experiments). The mean percentage of cells with invadopodia formation was calculated. 
Scale bar=10µm. The results shown are mean ±SEM of 30 cells from each experimental 
condition over three separate experiments. Statistical significance compared with control 

















Figure 5.7 DMOG cannot fully rescue invadopodia defect in PAK1/PAK2 depleted 
MDA-MB-231 cells. Cells were seeded at 1X10
5 
cells/ml and allowed to adhere for 24 
hours. Cells were transfected with control shRNA and PAK1 shRNA for 48 hours. 
Puromycin was added to the transfected cells for 48 hours post-transfection for transient 
selection. At 48 hours after transfection, cells were re-seeded on gelatin-coated coverslips 
for 3 hours in the presence or absence of DMOG followed by fixation with 4% PFA. Cells 
were stained for F-actin using Phalloidin-633. (b) Cells were scored for the presence of F-
actin puncta that colocalize with area of degradation on the gelatin. The mean percentage of 
cells with invadopodia formation was calculated. Scale bar=10µm. The results shown are 
mean ±SEM of 30 cells from each experimental condition over three separate experiments. 
Statistical significance compared with control shRNA or control shRNA +DMOG was 




Figure 5.8 HGF could not induce invadopodia formation in the PAK1/2 knockdown 
MDA-MB-231 cells. Cells were seeded at 1X10
5 
cells/ml and allowed to adhere for 24 
hours. Cells were transfected with control shRNA and PAK1 shRNA for 48 hours. 
Puromycin was added to the transfected cells for 48 hours post-transfection for transient 
selection. At 48 hours after transfection, cells were starved for at least 16 hours before being 
re-seeded on gelatin-coated coverslips for 3 hours in the presence or absence of HGF 
followed by fixation with 4% PFA. Cells were stained for F-actin using Phalloidin-633. (b) 
Cells were scored for the presence of F-actin puncta that colocalize with area of degradation 
on the gelatin. The mean percentage of cells with invadopodia formation was calculated.  
Scale bar=10µm. The results shown are mean ±SEM of 30 cells from each experimental 
condition over three separate experiments. Statistical significance compared with control 






5.2.8 PAK1 and PAK2 are localised at invadopodia 
PAK1 and PAK2 are both required for invadopodia formation (figure 5.5 and 5.6) 
but cannot functionally compensate for each other. To further explore the specific 
role of these two proteins, their subcellular localisation was examined. Wild type 
PAK1 and PAK2 were cloned into a GFP-tagged expression vector using Gateway 
Cloning Technology to generate GFP-PAK1 and GFP-PAK2. PAK1 and PAK2 
over-expressing cells or control cells expressing GFP alone were seeded on gelatin-
coated coverslips and stained for F-actin. As expected, there was no co-localisation 
between GFP and F-actin puncta (figure 5.9a). Interestingly, F-actin puncta 
colocalized with both GFP-PAK1 and GFP-PAK2 at sites of gelatin degradation, 
thus suggesting that PAK1 and PAK2 are localised at invadopodia (figure 5.9b and 
c). 
5.2.9 PAK1 and PAK2 over-expression does not increase invadopodia 
formation 
 
Both HGF stimulation and DMOG treatment can induce increased invadopodia 
activity in MDA-MB-231 cells (Chapter 3). Given that PAK1 and PAK2 are 
localised to invadopodia and required for invadopodia formation, the effect of 
overexpressing PAK1 and PAK2 on invadopodia formation was examined. 
Surprisingly, over-expression alone does not affect invadopodia formation in which 
the percentage of invadopodia remained at approximately 35%, the same level 







Figure 5.9 PAK1 and PAK2 are localised at invadopodia in MDA-MB-231 cells.  Cells 
were seeded at 1X10
5 
cells/ml and allowed to adhere for 24 hours. Cells were transfected 
with (a) GFP-control, (b) WT-GFP-PAK1 and (c) WT-GFP-PAK2 for 24 hours. At 24 hours 
after transfection cells were seeded on gelatin-coated coverslips for 3 hours followed by 
fixation with 4% PFA. Cells were stained for F-actin using Phalloidin 633. Localisation was 
observed using confocal microscopy for the presence of F-actin puncta that colocalize with 
area of degradation on the gelatin and PAK1 and PAK2 over-expression on the GFP 









5.2.10 PAK1 and PAK2 over-expression does not induce invadopodia 
formation in MCF-7 cells 
Whilst neither PAK1 nor PAK2 overexpression increased the invadopodia forming 
activity of MDA-MB-231 cells, over-expression might be able to induce MCF-7 
cells to form invadopodia. However, no induction of invadopodia was observed 
following over-expression of either PAK1 or PAK2 (figure 5.10b). PAK1 has been 
implicated in promoting cell spreading in MDCK cells (Royal et al., 2000), thus cell 
shape analysis was performed to evaluate whether PAK1/2 contribute to this effect in 
MCF-7 cells. However, WT-PAK1/2 over-expression alone does not affect cell 






























Figure 5.10 PAK1 and PAK2 over-expression does not increase invadopodia formation 
in MDA-MB231 and MCF-7 cells. (a) MDA-MB-231 and MCF-7 cells were seeded at 
1X10
5 
cells/ml and allowed to adhere for 24 hours. Cells were transfected with GFP-control 
and WT-GFP-PAK1/2 for 24 hours. Cells were seeded on gelatin-coated coverslips for 3 
hours, followed by fixation with 4% PFA. (b) The mean percentage of cells with 
invadopodia formation was calculated. Scale bar=10µm. The results shown are mean ±SEM 
of 30 cells from each experimental condition over three separate experiments.(c and d) The 
mean relative spread area and elongation ratio of MCF-7 cells over-expressing PAK1/PAK2 
was calculated using ImageJ software. Statistical significance compared with GFP-control 




One of the aims of this study was to identify key proteins that are involved in the 
invadopodia response downstream of HGF and hypoxia. Invadopodia formation 
requires remodelling of the actin cytoskeleton; a process known to be regulated by 
the Rho family small GTP-binding proteins, consisting of the Rho, Rac and Cdc42 
subfamilies. p21-activated kinases 1 and 2 (PAK1, PAK2) are major effectors of the 
Rho GTPases Rac and Cdc42 (Bokoch, 2003). There is some evidence to suggest 
that PAK1 at least is involved in regulating invadopodia formation (Ayala et al., 
2008), but the specific role of PAK1 and PAK2 during the formation of invadopodia 
in MDA-MB-231 breast carcinoma had not previously been investigated. Moreover, 
the expression of a kinase-dead PAK1 mutant has implicated PAK1 activity in 
podosome (actin-rich structures that remodel ECM in normal cells) formation of 
vascular smooth muscle cells (Furmaniak-Kazmierczak et al., 2007). Podosome 
formation does not require PAK1 kinase activity; however, catalytic activity 
regulates the dynamics of podosomes (Webb et al., 2005). In contrast, the 
involvement of PAK2 on invadopodia formation and matrix degradation has not 
been studied. 
PAK1 and members of the PAK-interacting exchange factor (PIX) family are recent 
additions to the group of podosome-type adhesion regulatory proteins. In smooth 
muscle cells, over-expression of PAK1 kinase mutants induces podosome formation, 
and interaction with β-PIX is necessary to localise PAK1 to the podosomal ring 
structure (Webb et al., 2005). Similarly, PAK4 localises to macrophage podosomes, 
and PAK4 kinase activity regulates podosome size and number (Gringel et al., 
2006), which is partly dependent on α-PIX. It is likely that a complex consisting of 
PAK and its regulators binds to the ring structure of podosomes. PAK and PIX could 
thus form an interface between adhesion-associated proteins of the ring and the 
regulation of actin dynamics in the core. PAK might regulate F-actin levels by 
influencing cofilin activity (Gringel et al., 2006) or by phosphorylation of cortactin 
(Webb et al., 2006).  
Both EGF and HGF can induce invadopodia formation (chapter 3)  (DesMarais et 
al., 2009; Hwang et al., 2011; Rajadurai et al., 2012; Tague et al., 2004) and PAK1 is 
known to be activated by these growth factors (Adam et al., 1998; He et al., 2001; 
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Royal et al., 2000) in a number of cell types including MDA-MB-231 cells (Yang et 
al., 2011). HGF also activates PAK1 and PAK4 in prostate cancer cells (Bright et al., 
2009; Wells et al., 2010) and PAK1 in ovarian cancer cells (Siu et al., 2009). Indeed, 
it is demonstrated here that PAK1 and PAK2 are activated by HGF at 
Thr423/Thr402 in MDA-MB-231 and MCF-7 cells (figure 5.3) plated on a gelatin 
matrix. Thus it might be speculated that PAK1 at least acts downstream of HGF to 
regulate invadopodia formation and RNAi experiments confirmed that PAK1 and 
PAK2 are required for invadopodia formation in MDA-MB-231 cells (figure 5.5 
and 5.6). Moreover, the specificity of the RNAi treatment was verified by rescue 
experiments. This is the first report identifying specific requirements for PAK1 and 
PAK2 expression during invadopodia formation, and the first time that PAK2 has 
been linked to invadopodia.  
Interestingly, expression of WT-mouse-PAK1 in PAK1 knockdown cells and WT-
PAK2
r 
in PAK2 knockdown cells
 
restored the ability to form invadopodia and 
degrade gelatin matrix (figure 5.5 and 5.6); complimentary expression did not 
rescue the reduction in invadopodia formation (figure 5.5 and 5.6). This strongly 
suggests that both proteins function during invadopodia formation but their roles are 
non-overlapping.  
Although PAK1 and PAK2 are closely related family members, there are examples 
of non-overlapping functions in some cells. PAK1 and PAK2 play non-redundant 
roles in cell–cell junctions/interactions, lamellipodium extension and cell scattering 
(Bright et al., 2009). PAK1 and PAK2 differentially modulate focal adhesions, by 
playing opposite roles in regulating the phosphorylation of the myosin light chain 
(MLC), and RhoA signalling (Coniglio et al., 2008). 
The PAK1/2 signalling mechanisms involved in promoting invadopodia are still 
unclear. However, PAK1 is thought to function along with other proteins such as 
cortactin to initiate invadopodia formation (Ayala et al., 2008). This interaction may 
lead to assembly of invadopodia structures and proteases that facilitate ECM 
degradation such as MTI-MMPs. The PAK1 gene maps to the 11q13 amplicon, the 
same region that encodes cortactin (Bekri et al., 1997). The main PAK 
phosphorylation site on cortactin has been shown to be the Ser113 in the first actin-
binding repeat (Webb et al., 2006). As a consequence, cortactin binding to F-actin 
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was reduced suggesting a role for PAK-dependent phosphorylation of cortactin in 
the regulation of branched actin filament dynamics (Vidal et al., 2002; Webb et al., 
2006). There are no previous reports linking PAK2 activity to invadopodia 
formation; however both PAK1 and PAK2 have been shown to bind to cortactin in 
resting platelets. After thrombin stimulation, PAK and cortactin dissociate (Vidal et 
al., 2002), therefore possibly allowing phosphorylated cortactin to trigger 
remodelling of the actin cytoskeleton. In addition to differences in the cellular 
behaviour, PAK1 and PAK2 also exhibit differences in the regulation of their kinase 
activity.  
 
Regulation of PAK1 activity is a complex process involving protein-protein 
interactions, phosphorylation/dephosphorylation and sphingolipid binding (Bokoch 
et al., 1998; Chong et al., 2001). PAK1/2 are major effectors of the small GTPases 
Rac and Cdc42 (Arias-Romero and Chernoff, 2008) and HGF-induced PAK1/2 
activation can be attributed to Rac1 and Cdc42 (Bright et al., 2009). The binding of 
Rac/Cdc42 to the PAK1 regulatory domain induces the phosphorylation of important 
sites throughout the protein, both by PAK1 itself (Chong et al., 2001) and/or by 
exogenous kinases such as JAK2, PDK1 and PKA (Howe and Juliano, 2000; King et 
al., 2000; Rider et al., 2007). PAK2 is unique among the PAK isoforms because it 
can also be activated through proteolytic cleavage by caspases or caspase-like 
proteases. Activation of full length PAK2 stimulates cell survival, whereas 
proteolytic activation of PAK2p34 is involved in apoptosis. PAK2p34 exerts its pro-
apoptotic effects via the activation of JNK (Chan et al., 2007; Huang et al., 2009). 
 
Both PAK1 and PAK2 were localised to invadopodia (figure 5.9). PAK proteins 
have been shown to localize to focal adhesions via a PIX/GIT/PKL/paxillin complex 
(Brown et al., 2002; Manabe et al., 2002; Zhao et al., 2000), but the precise role of 
PAKs in focal adhesion generation and maturation are still unclear. More recently, 
focal adhesions have been shown to be able to degrade matrix substrates (Wang and 
McNiven, 2012). PAK1-induced actin columns in vascular smooth muscle cells 
containing actin-binding proteins known to be present in podosomes, such as 
cortactin, the Arp2/3 complex, α-actinin and caldesmon (Kaverina et al., 2003; 
Tanaka et al., 1993). Therefore, PAK1 and may be PAK2 could be interacting with 
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these actin-binding proteins to promote invadopodia assembly and facilitate 
digestion of ECM.  
A tight relationship between trafficking and invadopodia formation has been 
suggested (Baldassarre et al., 2006; Buccione et al., 2009). Staining of PAK1 with a 
specific antibody in fibroblasts revealed subcellular localization of endogenous 
PAK1 in sub membranous vesicles (Dharmawardhane et al., 1997). Vesicles are 
known for their function in trafficking of membrane proteins such as MT1-MMP, 
which is involved in ECM degradation. Therefore this could in part suggest that 
PAK1 mediates vesicular trafficking associated with invadopodia formation. In A7r5 
cells, the ability of PAK to induce podosomes depends on its interaction with the 
guanine nucleotide exchange factor PIX (Webb et al., 2005). Similarly, a kinase-
dead mutant of PAK1, in which the PIX binding site was eliminated exhibited a 
severely reduced ability to induce the formation of ECM-degrading invadopodia in 
VSMCs (Furmaniak-Kazmierczak et al., 2007).  
PAK1/2 over-expression alone did not increase invadopodia forming potential of 
MDA-MB-231 cells (figure 5.10) and could not induce MCF-7 cells to form 
invadopodia or degrade ECM (figure 5.10). This is in agreement with similar 
findings found in other cell types where over-expression of wild-type PAK1 had no 
significant effect on the overall morphology of the actin cytoskeleton (Frost et al., 
1998; Kiosses et al., 1999; Manser et al., 1997; Sells et al., 1997; Webb et al., 2005; 
Zhao et al., 1998). The lack of effect of wild-type PAK1 on the actin cytoskeleton 
suggests that PAK activity maybe tightly controlled by regulatory factors such as 
GTPases, and the cells are able to adjust and maintain optimal PAK activity in spite 
of over-expression of the wild-type protein. Apart from these studies, other reports 
have suggested that over-expression of WT-PAK4 alone was unable to elicit any 
morphological response in MDCK cells (Wells et al., 2002). Indeed, most of the 
reported morphological effects of PAK1 have been identified through expression of 
constitutively activated protein (Daniels et al., 1999; Manser et al., 1997), probably 
because wild-type proteins are rapidly turned off after stimulation. In contrast, over-
expression of constitutively active PAK1 caused the formation of podosomes (Webb 
et al., 2005), a cellular structure related to invadopodia. Moreover, constitutively 
active PAK2 has been noted to produce podosomes that later dispersed throughout 
the cytoplasm of endothelial cells (Zeng et al., 2000). Thus, whilst over-expression 
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of normal WT-PAK1/2 is insufficient to enhance invadopodia formation, 
constitutively active PAK1 might be able to induce MCF-7 cells to form 
invadopodia. However, neither HGF nor DMOG could induce invadopodia 
formation in these cells (chapter 3 and 4). Indeed, others have recently reported that 
invasive ability of MCF-7 cells could be increased by TGF-β signalling (Rosman et 
al., 2008; Walsh and Damjanovski, 2011). This suggests that the invasiveness of 
these could still be detected but not necessarily via the induction of invadopodia 
formation.  
 
Both HGF and DMOG can enhance invadopodia formation in MDA-MB-231 cells. 
However, whilst PAK1 and PAK2 are required for the HGF induced response, 
DMOG was still able to induce invadopodia activity in knockdown cells.  These 
suggest that HGF-mediated invadopodia activity is specifically regulated through 
PAK1 and PAK2 signalling modes and others have already reported a specific role 
for HGF in invadopodia formation (Rajadurai et al., 2012). In contrast, the increased 
levels of HIF-1α in DMOG treated cells were able to initiate invadopodia formation 
in the absence of PAK1/PAK2 expression, thus suggesting the involvement of a 
broader cytoskeletal signalling cascade or parallel signalling pathways. This is 
possibly mediated through the ability of HIF-1α to rapidly up-regulate expression of 
large number of different genes.  
 
This chapter has identified PAK1 and PAK2 as two proteins required for 
invadopodia formation in MDA-MB-231 cells. Interestingly, it is also shown here 
that PAK1 and PAK2 have non-overlapping functions during invadopodia 
formation. PAK1 and PAK2 are both localised at invadopodia F-actin structures and 
sites of gelatin degradation. Moreover, loss of PAK1 or PAK2 expression inhibits 
HGF-induced invadopodia formation. In addition, PAK1 or PAK2 expression is not 













Chapter 6 – β-PIX expression is up-regulated in 













Chapter 6 – β-PIX expression is up-regulated in response to 
over-expression of HIF-1α 
6.1 Introduction 
Previous chapters have demonstrated that invadopodia formation in MDA-MB-231 
cells can be modulated by growth factor stimulation, exposure to hypoxia and 
changes in the level of PAK1 and PAK2 expression. Whilst PAK1 and PAK2 were 
identified as key components of HGF-mediated invadopodia induction, the 
mechanism of HIF-1α-induced induction is less clear. This chapter focussed on 
exploring further how increased levels of HIF-1α might directly contribute to 
invadopodia formation. HIF-1α is a transcription factor and thus it is likely that HIF-
1α induced invadopodia formation might at least in part be mediated through 
changes in gene expression. Many proteins have been implicated in regulating the 
formation of invadopodia, including members of the Rho family GTPases Rac and 
Cdc42 (Nakahara et al., 2003), p-21-activated kinases (Ayala et al., 2008) and 
proteins also associated with other forms of cell: substratum adhesion such as 
paxillin and N-WASP (Badowski et al., 2008; Yamaguchi et al., 2005). Expression 
analysis has revealed that a number of genes which regulate cancer invasion such as 
CXCR4, pyruvate dehydrogenase kinase 1 (PDK1), matrix metalloproteinase 2, 
urokinase plasminogen activator receptor (uPAR), and fibronectin 1 are regulated by 
HIF-1α (Krishnamachary et al., 2003; Victor et al., 2006). Indeed, it has recently 
been shown that HIF-1α can modulate cell migration via induction of JMY (Coutts et 
al., 2011) and RhoE expression (Zhou et al., 2011). However, the regulation of 









6.2.1 PAK1/2 expression and activity are not regulated by HIF-1α   
PAK1 and PAK2 are required for invadopodia formation and loss of expression 
attenuates the effect of HGF and DMOG treatment (figure 5.7). Therefore, the level 
of endogenous PAK1/2 protein expression was assessed in both DMOG treated and 
HIF-1α over-expressing cells. There was no detectable change in PAK1/2 expression 
level observed with either DMOG or HIF-1α over-expression (figure 6.1a and b). In 
parallel, the effects on PAK1/2 activity downstream of both DMOG and HIF-1α 
over-expression was also monitored, however no reproducible changes in PAK1/2 
activity was observed (data not shown). This suggests that neither PAK1/2 
expression levels nor activity are directly regulated during HIF-1α-driven 
invadopodia formation and cannot account for the changes in invadopodia activity 
detected. 
6.2.2 Expression of cytoskeletal genes are regulated by HIF-1α 
Given that no changes in PAK1/2 expression or activity were detected, an alternative 
approach was adopted.  One of the most reliable and reproducible tools for analysing 
the changes in expression levels of a focused panel of genes is by PCR array. The 
particular array that was employed in this study was the pathway-focused, 96-well 
plate PCR Array which includes polymerases and primers tailored for cytoskeletal-
related genes (Qiagen). MDA-MB-231 cells treated with DMOG and control (non-
treated) were used for this study. Data analysis from the real-time-qPCR was 
performed by normalizing the raw data to the housekeeping genes provided by the 
manufacturer (SABiosciences). The internal positive controls of the PCR-array are 
the genes well characterised to be regulated by HIF-1α such as VEGFA, c-Met and 
EGFR. Unsurprisingly, these genes were significantly up-regulated by DMOG.  The 
top 10 up-regulated genes are listed in Table 6.1. Of these genes, Arf6, uPAR, 
Cdc42, and Arp2 are already known to be involved in the formation of invadopodia 
(Furmaniak-Kazmierczak et al., 2007; Tague et al., 2004; Yamaguchi et al., 2005). 
Although, this is the first report of a direct link between HIF-1α stabilisation and 
protein expression levels for these hits. In addition, expression of β-PIX, a 
cytoskeletal protein not yet known to be involved in the formation of invadopodia, 
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was also elevated in the PCR array. β-PIX is associated with regulation of adhesion 
turnover (Kuo et al., 2011; Rosenberger and Kutsche, 2006; Stofega et al., 2004) and 
































Figure 6.1 PAK1 and PAK2 expression levels do not change in response to DMOG or 
HIF-1α over-expression. a) MDA-MB-231 cells were seeded at 3X104 cells/ml and allowed 
to adhere for 24 hours. Cells were treated with dimethyloxaloylglycine (DMOG) for 6, 8 and 
6 hours plus maintaining DMOG for an extra 2 hours. b) Cells were seeded at 1X10
5 
cells/ml 
in a 6-well plate and transfected with GFP-HIF-1α. Cells were lysed at 24 hours following 
transfections. Equal amounts of protein lysates were electrophoresed on 7.5% SDS 
polyacrylamide gels. Western blot of the lysates was probed for levels of PAK1 and PAK2 
(Cell Signaling Technology) antibodies. ERK and Gapdh were used as loading controls. 







Table 6.1 Top 10 hits of up-regulated cytoskeletal genes in response to 6 hours DMOG 
treatment. MDA-MB-231 cells were seeded at 1X10
5 
cells/ml. and allowed to adhere for 24 
hours. Cells were treated with dimethyloxaloylglycine (DMOG) at a concentration of 
0.5mM for 6 hours. RNA was extracted from the treated and non-treated (control) cells. 





Array specific for Human Cell Motility gene profiling. The top 10 hits have been listed in 
this table. Full results can be referred to in the appendix. These results are representative of 
two independent experiments. Statistical significance compared with control (non-treated) 









6.2.3 β-PIX and VEGF mRNA are up-regulated in response to increased HIF-
1α expression 
 
Initially, to confirm the data from PCR-Array studies, reverse transcriptase PCR 
(RT-PCR) was used to monitor changes in β-PIX and VEGF mRNA expression 
levels. Level of β-PIX and VEGF mRNA expression significantly increased in 
response to DMOG treatment (figure 6.2 a and c). These results confirmed the 
results observed in the PCR-array. In parallel with DMOG treatment, RT-PCR was 
also performed on cells over-expressing GFP-HIF-1α. The level of β-PIX and VEGF 
mRNA expression was also significantly up-regulated by the HIF-1α over-
expression system (figure 6.2 b and d). This indicates that the over-expression 
strategy is functional and more importantly specific over-expression of HIF-1α 
significantly up-regulated transcription of the same genes as had been observed in 
response to DMOG treatment. 
6.2.4 β-PIX protein expression level increases in response to DMOG and HIF-
1α over-expression 
 
The effect of DMOG treatment in enhancing invadopodia forming potential of 
MDA-MB-231 cells was observed at 6 hours post-treatment (figure 4.2). The level 
of β-PIX mRNA expression significantly increased at 6 hours DMOG treatment 
(Figure 6.2 a and c) and β-PIX protein levels were also significantly increased, in 
cells treated with DMOG for 6 hours (figure 6.3 a). Alongside DMOG-treatment, β-
PIX protein expression was also monitored in cells over-expressing GFP-HIF-1α and 
in cells incubated for 6 hours in a hypoxia incubator. In both conditions, β-PIX 





Figure 6.2 β-PIX and VEGF genes are up-regulated in response to DMOG or over-
expression of HIF-1α. (a) MDA-MB-231 cells were seeded at 3X104 cells/ml and allowed 
to adhere for 24 hours. Cells were either treated with dimethyloxaloylglycine (DMOG) for 6 
hours or non-treated (control). (b) Cells were seeded at 1X10
5 
cells/ml in a 6-well plate and 
transfected with GFP-alone (control) and GFP-HIF-1α using Lipofectamine 2000 
transfection reagent (see materials and methods). Total RNA was extracted from the cells in 
all conditions. RNA was then converted into cDNA and used in PCR using primers specially 
designed for β-PIX, VEGF and actin as PCR loading control (see materials and methods). 
Following PCR, reaction samples were equally loaded on an agarose gel and run for the 
required amount of time. The bands were viewed using a UV Transilluminator machine. (c 
and d) Densitometric analysis of relative β-PIX, VEGF and actin expression. The results 
shown are RT-PCR from each experimental condition over three separate experiments. 
Statistical significance compared with control (non-treated) or/and GFP-alone was 






Figure 6.3 MDA-MB-231 cells increase β-PIX protein expression in response to hypoxic 
conditions. (a) Cells were seeded at 3X10
4 
cells/ml and allowed to adhere for 24 hours. 
Cells were stimulated with dimethyloxaloylglycine (DMOG) for 6, 8 and 6 hours plus 
maintaining DMOG for an extra 2 hours. (b) Cells were seeded at 1X10
5 
cells/ml in a 6-well 
plate and transfected with GFP-HIF-1α using Lipofectamine 2000 transfection reagent. (c) 
Cells were seeded at 2X10
4 
cells/ml on plastic dishes and allowed to adhere for 24 hours. 
Cells were exposed to normoxia (20% oxygen) and hypoxia (1% oxygen) for 16 hours. Cells 
were lysed at 6 or 8 hours DMOG treatment, 24 hours following transfections, and 16 hours 
hypoxia/normoxia, and equal amounts of protein lysates were electrophoresed on 7.5% SDS 
polyacrylamide gels. Western blot of the lysates was probed for levels of HIF-1α (Cell 
Signaling Technology), and β-PIX (Cell Signaling Technology) antibodies. Gapdh, a house-
keeping protein was used as a loading control. These results are representative of three 
independent experiments. (a, b and c bar graphs) Relative expression of β-PIX was 
measured using densitometric analysis. The results shown are mean ±SEM from each 
experimental condition over three separate experiments. Statistical significance compared 
with control (non-treated) or GFP-control or normoxia was calculated using Student‟s t-test; 




6.2.5 The β-PIX gene contains two putative HREs 
One pre-requisite of gene transcription is the binding of the HIF-1 complex to 
hypoxia response elements (HREs) in the promoter region of its target genes. In 
order to confirm whether β-PIX could potentially be one of the target genes of HIF-
1, HREs were located in the promoter sequence of β-PIX. Computer-assisted 
analysis for the inspection of the upstream promoter region of β-PIX identified two 
regions containing the core sequence of a consensus (HREs) 5‟-RCGTG-3‟(R, 
purine [A or G]) located between -651 and +299 sequence in the β-PIX promoter. In 
these regions, two putative HREs underlined in red (CGTG) were found (figure 6.4).   
6.2.6 β-PIX is required for invadopodia formation  
β-PIX has been reported to be an important protein involved in cell motility and 
invasion, and more importantly shown for the first time here, is up-regulated by 
increased HIF-1α expression, thus the effects of β-PIX on invadopodia formation 
were investigated. β-PIX expression was successfully depleted by 80% after 24 
hours RNAi transfection using siRNA SMARTpool technology targeting four 
mRNA regions at once (figure 6.5 a and b). β-PIX-depleted MDA-MB-231 cells 
were then seeded on gelatin-coated coverslips to assay for matrix degradation. The 
percentage of cells forming invadopodia dramatically dropped to 10% when β-PIX 
expression was reduced (figure 6.5 c). Moreover, β-PIX depletion attenuated the 
DMOG response in which percentage of cells forming invadopodia was significantly 
reduced compared to control cells with DMOG alone (figure 6.5 b and c). 
Furthermore, when β-PIX knockdown cells were transfected with GFP-HIF-1α, the 
level of invadopodia formation did not reach siRNA control levels (figure 6.6). 
However, both DMOG and HIF-1α over-expression still induced some invadopodia 
formation in the β-PIX knockdown background (figure 6.5 and 6.6). This suggests 







Figure 6.4 Two putative hypoxia-response elements are located in the promoter 
sequence of β-PIX. The HREs for β-PIX were identified using a gene promoter search 
website http://rulai.cshl.edu/cgi-bin/TRED/tred.cgi?process=searchPromForm. 
Following the identification of the sequence of the promoter, word search for CGTG was 












Figure 6.5 Loss of β-PIX expression influences invadopodia formation and attenuates 
the DMOG response in MDA-MB-231 cells. (a) Cells were seeded at 3X10
4 
cells/ml and 
allowed to adhere for 24 hours. Cells were transfected with mock, control and β-PIX  
siRNAs for 24 hours, with and without stimulation with DMOG for 6 hours. Cells were 
lysed for 10 minutes in lysis buffer. Equal amounts of protein lysates were electrophoresed 
on 7.5% SDS polyacrylamide gels. Western blot of the lysates was probed for levels of β-
PIX  (Cell Signaling Technology). Gapdh, a house-keeping protein was used as a loading 
control. (b) Relative expression of β-PIX was measured using densitometric analysis. (c) β-
PIX siRNA-treated cells, with and without DMOG were seeded on gelatin-coated coverslips. 
Cells were scored for the presence of actin puncta that colocalize with area of degradation on 
the gelatin and the mean percentage of cells with invadopodia formation calculated. (d) The 
results shown are mean ±SEM of 30 cells from each experimental condition over three 
separate experiments. Statistical significance compared with control siRNA or β-PIX  
















Figure 6.6 Loss of β-PIX expression influences HIF-1α-dependent invadopodia 
formation in MDA-MB-231 cells. (a) Cells were seeded at 1X10
5 
cells/ml and allowed to 
adhere for 24 hours. Cells were transfected with GFP-control and GFP-HIF-1α plasmids for 
24 hours, followed by transfection with β-PIX smartpool siRNA oligo for another 24 hours. 
These cells were then re-seeded on gelatin-coated coverslips. Cells were scored for the 
presence of dark holes on the gelatin only within the cell margin and the mean percentage of 
cells with invadopodia formation calculated. Scale bar=10µm. (b) The results shown are 
mean ±SEM of 30 cells from each experimental condition over three separate experiments. 
Statistical significance compared with either GFP-control or GFP-HIF-1α was calculated 







Chapter 5 demonstrated that PAK1/2 are not only required for invadopodia 
formation but are also required during DMOG-induced invadopodia formation. 
These results suggested that PAK1/2 could potentially be a novel transcriptional 
target of HIF-1α. Thus the level of expression and activity of PAK1/2 in response to 
DMOG and HIF-1α over-expression was monitored. However, HIF-1α did not 
regulate the expression or activity of PAK1/2 (figure 6.1). Given that HIF-1α does 
not appear to directly modulate PAK1/2 invadopodia it may up-regulate other 
cytoskeletal proteins to promote invadopodia formation and matrix degradation. As a 
transcription factor HIF-1α is known to be associated with a large number of targets, 
many of which are associated with angiogenesis.  
This study found that VEGFA and c-Met expression levels were significantly 
increased (Table 6.1) in breast cancer cells when HIF-1α protein levels were 
increased. Other cytoskeletal genes such as Cdc42, Wave2, Arp2 and β-PIX were 
also identified as being HIF-1α responsive (Table 6.1). This is the first time that 
these proteins have been identified as potentially HIF-1α regulated. It will be 
interesting, in the future, to explore in more detail the relationship between HIF-1α 
stabilization during hypoxia and the regulation of the expression of proteins 
associated with migration and invasion. Among the invasion-related genes known to 
be transcriptionally up-regulated by HIF-1 is urokinase-type plasminogen activator 
receptor (uPAR) which promotes invasion of breast (Yoon et al., 2006), pancreatic 
and liver cancers (Buchler et al., 2009). Previous reports suggested that over-
expression of HIF-1α has been observed in the invasive front of human brain and 
colon cancer biopsies (Zagzag et al., 2000; Zhong et al., 1999), where uPAR 
expression is localised. Putative HIF-1 binding sites are located upstream of the 
uPAR promoter (Graham et al., 1998), and uPAR expression and in vitro 
invasiveness of human colon carcinoma cells are increased by HIF-1α over-
expression, and decreased by knockdown of HIF-1α (Krishnamachary et al., 2003). 
Similarly, human renal cell carcinoma cells lacking VHL (increase HIF-1α level) 
show constitutively elevated uPAR levels, while mouse embryonic stem cells 
deficient for HIF-1α expression fail to upregulate uPAR expression under hypoxic 
conditions (Krishnamachary et al., 2003).  
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Other studies have demonstrated that HIF-1 also regulates adhesion and migration of 
melanoma cells through the regulation of alphavbeta3 (αvβ3) integrin surface 
expression at the plasma membrane (Cowden Dahl et al., 2005). In addition, a study 
highlighted the ability of HIF-1 to enhance the transcription of the Met receptor and 
promote hepatocyte growth factor-dependent invasion in hypoxic areas of tumours 
(Pennacchietti et al., 2003). These effects are mediated by HIF-1 binding sites 
located in the 5‟ untranslated region of the Met promoter (Pennacchietti et al., 2003). 
Another study suggested the requirement of HIF-1α expression for the synergistic 
activities of hypoxia and HGF on cellular invasion (Hara et al., 2006).  
 
Increased -PIX protein expression, following stabilisation of HIF-1α was validated 
and the increased levels correlated in time with increased levels of invadopodia 
formation in the cell population. If -PIX is a HIF-1 target gene, hypoxia-
responsive-elements within the β-PIX proximal promoter are required and two 
putative HREs in the β-PIX promoter sequence were identified. Other ways to 
further establish the functional significance of HIF-1α in regulating β-PIX 
transcription is by employing a gel mobility shift assay (EMSA), a luciferase 
reporter assay to measure luciferase activity and chromatin immunoprecipitation 
(ChIP) to explore the recruitment of HIF-1α to the β-PIX promoter. 
One of the key cytoskeletal proteins, the Arp2/3 complex is important for a variety 
of specialized cell functions that involve the actin cytoskeleton and is already known 
for its requirement during invadopodia formation in breast cancer cells (Yamaguchi 
et al., 2005). Indeed many proteins have been implicated in regulating the formation 
of invadopodia, including the members of the Rho family GTPases Rac and Cdc42 
(Nakahara et al., 2003), p21-activated kinases (PAKs) (Ayala et al., 2008)and 
proteins also associated with other forms of cell:substratum adhesion such as paxillin 
and N-WASP (Badowski et al., 2008; Yamaguchi et al., 2005). However, β-PIX, a 
guanine nucleotide exchange factor (GEF) for Rac and Cdc42, has been implicated 
in the regulation of cell adhesion (Kuo et al., 2011; ten Klooster et al., 2006) but has 




The N-terminus of PAK1 contains multiple proline-rich sites that bind to src 
homology 3 (SH3) domain-containing proteins, including β-PIX (Manser et al., 
1998). β-PIX specifically binds to PAK1/2 (Bagrodia et al., 1998; Manser et al., 
1998). PAK1 has been associated with focal complexes which represent sites of 
attachment with the substratum (Manser et al., 1997). β-PIX has been implicated in 
the localization of PAK1 to focal adhesions, because disruption of PIX-binding 
proline-rich regions abrogated the ability of ectopically expressed PAK1 to localize 
to focal adhesions (Manser et al., 1998). β-PIX was found in a complex with PAK1 
(Stofega et al., 2004; Webb et al., 2005), a protein thought to regulate invadopodia 
formation (Ayala et al., 2008) and is shown in Chapter 5 to be required for 
invadopodia formation in MDA-MB-231 cells. Thus invadopodia formation induced 
by HIF-1α might be mediated at least in part through the activity of β-PIX. 
In support of this hypothesis, reduced β-PIX expression levels led to a dramatic 
reduction in invadopodia formation. This would suggest a fundamental requirement 
for β-PIX expression during invadopodia formation and matrix degradation. 
Furthermore, in a background of β-PIX knockdown, neither DMOG treatment nor 
GFP-HIF-1α over-expression were able to induce invadopodia formation to the same 
extent as control cells. However, the modest induction in invadopodia formation in 
the β-PIX knockdown background might be due to the partial restoration of β-PIX 
expression following DMOG addition (see lane 4 Figure 6.5a). Again, this 
demonstrates that -PIX expression levels are highly sensitive to levels of HIF-1α in 
cells. Alternatively, DMOG/ HIF-1α over-expression induced increase in 
invadopodia activity in a -PIX knockdown background might indicate that HIF-1α 
is acting through multiple cytoskeletal pathways to induce invadopodia formation, a 
hypothesis that is supported by the PCR Array studies. Nonetheless, this study points 
to an essential requirement for β-PIX.  
A role for β-PIX in invadopodia formation has not been previously reported but PIX 
family members have been implicated in the regulation of podosome formation 
(Gringel et al., 2006; Webb et al., 2005). Podosomes are highly dynamic, actin-based 
structures that function at sites of cell adhesion and active ECM remodelling (Linder 
and Aepfelbacher, 2003). β-PIX has been reported to promote podosome formation 
where it colocalized with actin columns and enhanced the formation of these 
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structures in vascular smooth muscle cells (Webb et al., 2005). Interaction between 
PAK1 and β-PIX was required for podosome formation. Podosome biogenesis 
requires two highly coordinated events involving the remodelling of both focal 
complexes and actin stress fibers. It has been suggested that PAK-PIX interaction 
plays a crucial role in this regulatory mechanism (Webb et al., 2005). 
β-PIX has been implicated in influencing the migration and invasive activity of Src 
transformed cells (Feng et al., 2010). A number of reports suggested that β-PIX 
localizes to focal complexes (Nayal et al., 2006; Zhao et al., 2000). It would be 
interesting to determine whether β-PIX localises to invadopodia or can be recruited 
to invadopodia in response to hypoxia. Furthermore, the development of β-PIX 
antibodies suitable for immunohistochemistry would facilitate a better understanding 
of how β-PIX levels are regulated in hypoxic tumours.  
Taken together, this study demonstrates an important and novel link between β-PIX 
and HIF-1α, where β-PIX is identified as a novel HIF-1α target gene that mediates 
invadopodia formation in breast carcinoma cells. The ability of HIF-1α to elevate β-
PIX expression provides a mechanism that could maintain β-PIX at sufficient 
concentrations in hypoxic cells to facilitate cell invasion. Moreover, this study 
identified a cohort of cytoskeletal genes whose expression is regulated by HIF-1α. 
Given the enhanced cell motility and invasion that occurs under hypoxia (Sullivan 
and Graham, 2007), it makes sense that cytoskeletal proteins involved in focal 
adhesion turnover, cell motility and invadopodia formation, like β-PIX, should be 

























Chapter 7 – Concluding remarks 
This study has demonstrated that extracellular cues by HGF stimulation (Chapter 3) 
and hypoxia (resulting in an increase in the level of hypoxia-inducible transcription 
factor HIF-1α) affect invadopodia forming potential of MDA-MB-231 breast 
carcinoma cells (chapter 4). Moreover, this is the first report to suggest a link 
between HIF-1α and invadopodia formation in MDA-MB-231 breast carcinoma 
cells. At the molecular level PAK1 and PAK2 were specifically localised at 
invadopodia and loss of PAK1 or PAK2 expression inhibited HGF-induced 
invadopodia formation (Chapter 5). Moreover, it was established that PAK1 and 
PAK2 have non-overlapping functions during invadopodia formation. Furthermore, 
β-PIX was identified as a novel HIF-1α target gene that mediates invadopodia 
formation (Chapter 6).  
 
Role of PAK1 and PAK2 in invadopodia formation 
This study and others (Rajadurai et al., 2012; Tague et al., 2004) have reported that 
HGF can induce the formation of invadopodia in cancer cells and HGF is known to 
stimulate the activity of PAK kinases (Royal et al., 2000). Indeed, HGF stimulation 
increases PAK1 and PAK2 phosphorylation at Thr423/Thr402 on cells adhered on 
gelatin substrate (Chapter 5) and PAK1 and PAK2 are required for HGF-induced 
invadopodia formation. HGF stimulates PAK1/2 autophosphorylation (Chapter 5), 
PAK phosphorylation of cortactin is thought to promote invadopodia activity (Webb 
et al., 2006) and the PAK1-AID inhibits invadopodia formation (Ayala et al., 2008). 
Over-expression of kinase-active or kinase-dead PAK1 drives podosome formation 
suggesting that PAK1 exhibits kinase-dependent and kinase- independent functions. 
Therefore in the future, it might be interesting to more closely examine the role of 
PAK kinase activity during invadopodia formation in MDA-MB-231 cells. 
Expression of kinase dead rescue constructs would better elucidate the role of kinase 
activity, whilst other domain mutants could explore the role of proline rich binding 
interactions and/or Rho family GTPase activation.  
Since PAK1 and PAK2 appear to play important roles in invadopodia formation, it is 
intriguing to speculate which downstream effectors or signalling cascades the PAKs 
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may be influencing. From the current literature it is known that PAK1 can 
phosphorylate LIMK1 (Edwards et al., 1999) and that activated LIMK1 in turn 
induces phosphorylation of cofilin, an actin filament-depolymerization protein that is 
inactivated by LIMK1 phosphorylation (Arber et al., 1998). Furthermore, LIM 
kinase has been implicated in invadopodia formation (Scott et al., 2010). Similarly, 
cofilin has been linked to invadopodia formation and has been shown to localize at 
invadopodia (Yamaguchi et al., 2005). Expression of constitutively active cofilin up-
regulates the expression of the matrix-degrading enzymes matrix metalloproteinase 2 
(MMP2) and 14 in melanoma cells (Dang et al., 2006). Moreover, expression of both 
the serine protease urokinase type plasminogen (uPA) and its receptor uPAR are 
higher in the breast cancer cell line MDA-MB-435 upon LIMK1 over-expression 
(Bagheri-Yarmand et al., 2006). uPA is also a matrix-degrading protease and an 
activator of multiple other matrix proteases, including MMPs and transcriptional up-
regulation of uPAR in MDA-MB-231 cells was found under hypoxic conditions 
(Chapter 6). It is therefore likely that PAK1 and maybe PAK2 could affect 
invadopodia by phosphorylating LIMK which in turn phosphorylates cofilin, to 
regulate recruitment of MMPs facilitating ECM degradation.  
PAK1/2 might regulate F-actin levels by influencing cofilin activity as outlined 
above or by phosphorylation of cortactin (Webb et al., 2006). The enrichment of 
Tyr-phosphorylated cortactin in invadopodia is a hallmark of functional invadopodia 
(Bowden et al., 2006). In resting platelets, PAK1/2 and cortactin form a complex. 
Upon thrombin stimulation, this complex dissociates and releases cortactin to the 
periphery of the cell with a concomitant activation of PAK (Vidal et al., 2002). 
PAK1 has been implicated in cortactin phosphorylation and this subsequent 
phosphorylation is important during invadopodia maturation whereby recruitment of 
MT1-MMP takes place to facilitate ECM degradation. PAK1 has also been shown to 
induce podosome formation in vascular smooth muscle cells and it is partially co-
localised with cortactin in podosomes. PAK1 phosphorylation of cortactin may play 
a role in the regulation of the dynamics of branched actin structures during 
invadopodia formation; consistent with a finding that PAK-kinase activity increased 




The non-redundancy in the roles of PAK1 and PAK2 in invadopodia formation is 
very interesting, although other studies have shown examples of non-overlapping 
roles between these closely related proteins (Bright et al., 2009; Coniglio et al., 
2008). The functions of PAKs have been elucidated through the identification of 
protein binding partners and kinase substrates. To reveal the full scope of PAK1 and 
PAK2 in invadopodia formation, it will be important to identify the downstream 
effectors of PAK1/2 that are responsible for specific phenotypic alterations that lead 
to invasive state of cancer cells. Although PAK1 and PAK2 are thought to share 
essentially indistinguishable substrate specificity, interaction with cortactin (Vidal et 
al., 2002) and p41-Arc (Vadlamudi et al., 2004) is unique to PAK1 and has not been 
related to PAK2. Recently, PAK1 phosphorylation was shown to increase the 
interaction of cortactin with N-WASP to mediate endocytosis (Grassart et al., 2010). 
It could be speculated that PAK1 may regulate invadopodia formation via a similar 
mechanism.  
Almost all PAK2 binding partners have also been shown to bind PAK1; however, 
the exact effectors and mechanism of activation of PAK2-induced cytoskeletal 
activities have not been clearly elucidated. Furthermore, little is known about the 
regulatory mechanism of the PAK2 pathway. Studies have established that myosin II 
RLC is a substrate for PAK2 (Chew et al., 1998; Ramos et al., 1997) and PAK2 
phosphorylation of myosin II is thought to play a role in endothelial cell retraction 
(Zeng et al., 2000). In addition, a recent study has identified MYO18A, a member of 
the myosin superfamily as a novel interacting partner of the PAK2/β-PIX/GIT1 
complex and suggested its potentially important role in modulating focal adhesion 
turnover (Hsu et al., 2010). Furthermore, it has also been proposed that force and 
membrane tension generated by intracellular motors (such as myosin) and regulated 
by substrate viscoelasticity might affect actin polymerization, and in turn the 
formation of invadopodia (Albiges-Rizo et al., 2009). It is reasonable to speculate 
that involvement of PAK2 in invadopodia formation may be via this mechanism. 
Based on this speculation, it can be hypothesised that PAK1 may act as a scaffolding 
protein that couples to downstream effectors mediating assembly of molecules to 
promote invadopodia formation. Furthermore, PAK1 could be phosphorylating 
downstream substrates involved in invadopodia formation whereas PAK2 might be 
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involved in the local modulation of contractile forces that are all likely to play a 
central role in the promotion of invadopodia. 
 
β-PIX interplay with PAK1/2 during invadopodia formation 
In addition to identifying PAK1 and PAK2 as key components of invadopodia 
formation in MDA-MB-231 cells, the depletion of β-PIX by siRNA significantly 
impaired invadopodia formation, and significantly reduced the induction of 
invadopodia downstream of HIF-1α stabilisation (Chapter 6).  These data revealed 
for the first time the importance of β-PIX activity during invadopodia formation. β-
PIX is the guanine nucleotide exchange factor (GEF) for Cdc42 and Rac that can 
form larger complexes with various proteins including PAK1, PAK2 (Manser et al., 
1998; Shin et al., 2002; ten Klooster et al., 2006), Rac/Cdc42 (Shin et al., 2004), GIT 
(Zhao et al., 2000) and Shank (Park et al., 2003). Indeed PAK2 phosphorylates β-
PIX in response to bFGF during bFGF-induced neurite extension (Shin et al., 2002).  
β-PIX activity has already been associated with HGF stimulation where a β-
PIX/GIT1/ WAVE2 complex was localised at the leading edge of the cells, which 
promoted lamellipodia formation (Morimura et al., 2009). In a separate study HGF 
induced lamellipodia formation required Rac1 and PAK1 for the transport of 
WAVE2 along the microtubules to the leading edge (Takahashi and Suzuki, 2008). 
Here, PAK1 plays a critical role in the induction of WAVE2 transport along 
microtubules and lamellipodia formation by mediating phosphorylation of tubulin- 
bound stathmin/Op18 at Ser38 and subsequent recruitment of the protein to a PAK1–
WAVE2–kinesin complex (Takahashi and Suzuki, 2009). Collectively, these 
findings suggest the possible involvement of both β-PIX and PAK in the regulation 
of WAVE2 transport, which consequently leads to lamellipodia formation in MDA-
MB-231 cells. WAVE2 was also transcriptionally upregulated by HIF-1α (Chapter 
6). Therefore, β-PIX may act via WAVE2 to promote invadopodia formation 
downstream of increased HIF-1α expression. However, an association between 
invadopodia and WAVE2 has not been reported, indeed in MTLn3 cells WAVE2 is 




β-PIX has not been associated with invadopodia formation but it has been reported to 
mediate focal adhesion dynamics and podosome (structurally related to invadopodia) 
activity via its interaction with PAK and GIT1. GIT1 is an ADP-ribosylation factor 
GTPase-activating protein (ARFGAP), which specifically regulates ARF6 (Vitale et 
al., 2000; Zhao et al., 2000). Interestingly, ARF6 has been implicated in the 
formation of invadopodia downstream of HGF (Tague et al., 2004) and from the 
PCR array analysis, ARF6 has been shown to be transcriptionally up-regulated by 
HIF-1α (Chapter 6). Moreover, ARF6 has a critical role in regulating the shedding 
of microvesicles containing functional proteases to facilitate ECM degradation 
(Muralidharan-Chari et al., 2009). An important function of GIT1 is that it serves as 
a signalling anchor between β-PIX, PAK and the focal adhesion complex in 
migrating cells (Brown et al., 2002). The over-expression of a β-PIX mutant that 
either cannot bind PAK1 or lacks GEF function blocks PAK1 activation (Ku et al., 
2001) suggesting that β-PIX is required for Rho family GTPase activation upstream 
of PAK1. Abolition of the PIX-binding ability of PAK prevents both the 
translocation of PIX and GIT to focal adhesions and the formation of podosomes 
(Webb et al., 2005). The essential role for β-PIX in podosome formation is 
highlighted by the fact that over-expression of β-PIX by itself can induce the 
formation of podosomes. Given this close relationship between β-PIX and PAK in 
adhesion structures, and that in MB-MDA-231 cells, invadopodia formation requires 
PAK1, PAK2 and β-PIX expression it is reasonable to speculate that the requirement 
for PAK1 and PAK2 during HGF-induced invadopodia formation could involve 
interactions with β-PIX (Figure 7.1).  It will be interesting in the future to look at the 
recruitment/subcellular localisation of PAK1/PAK2 in β-PIX depleted cells.  
Moreover, can over-expressing WT PAK1/PAK2 or kinase active/dead mutants 
rescue the β-PIX phenotype? 
Another possible mechanism of β-PIX action during invadopodia formation could be 
through the molecule Scrib. Scrib is a scaffold protein conserved during evolution. 
The β-PIX/PAK protein complex interacts with Scrib and is required for the 
retention of the protein complex at the leading edge of migratory cells. PAK1 and 
PAK2 isoforms are part of this complex in proportion that is relative to their 
abundance in the cells (Nola et al., 2008). Additionally, the chemotactic activity of 




Figure 7.1 Proposed model for signalling pathways that promote invadopodia formation. (a) 
Upon HGF binding to c-Met, Rac is activated and this in turn could lead to PAK activation. 
(b) PAK can phosphorylate cortactin which could promote invadopodia formation via 
recruitment of MT1-MMPs. (c) Additionally, PAK could phosphorylate LIMK and that 
activated LIMK in turn induces phosphorylation of cofilin that has been linked to 
invadopodia formation. (d) HIF-1α is an important transcription factor that up-regulates 
known components of invadopodia such as Arf6. (e) Another transcriptional target of HIF-
1α is β-PIX which is recognised as a GEF for Rac, an activator of PAK. β-PIX expression is 
required for invadopodia formation and loss of β-PIX expression attenuated HIF-1α-induced 
invadopodia formation in MDA-MB-231 breast carcinoma cells. (f) β-PIX may promote 
invadopodia formation by forming a complex with GIT1 and/or ARF6  since ARF6 has a 
critical role in regulating the shedding of microvesicles containing functional proteases. 
PAK1/PAK2 may be directly activated by interaction with β-PIX to facilitate invadopodia 
formation.The functional complex formed by β-PIX-PAK-GIT1-Arf6 could subsequently act 
to recruit and activate cofilin and/or cortactin to promote invadopodia formation. (g) HIF-1α 
is established as a transcriptional modulator of c-Met. Taken together, β-PIX could have the 
dual role of activating as a GEF and then functioning as an active scaffolding protein; 
bringing together components, each domain being necessary for the formation of 














the interaction between Scrib and β-PIX-PAK. Cells lacking Scrib or β-PIX poorly 
activate PAK (low T423 phosphorylation) (Nola et al., 2008) suggesting that β-PIX 
is required for PAK activation. Thus Scrib may also be involved in invadopodia 
formation; however, further studies will be needed to address this hypothesis. 
 
Future studies on invadopodia formation  
Detailed analysis of invadopodia has resulted in a much clearer definition of these 
cellular organelles. They represent a powerful paradigm to study the tight 
interactions between the cytoskeleton, signalling and trafficking machineries. 
Beyond completion of the molecular and cellular description of invadopodia, a 
challenging issue will be to monitor matrix remodelling and invadopodia dynamics 
in invasive cells in the tumour microenvironment. High spatial- and temporal-
resolution imaging techniques are available that allow visualization of invadopodia 
components in action in living cells in 3D reconstituted matrices and recent 
developments in intravital imaging methods make it possible to visualize invasive 
cells in situ. Improvement of the spatial and temporal resolution of intravital 
microscopy will be necessary to visualize the dynamics of cellular components and 
invasive structures of tumour cells in their native environment in vivo. Questions that 
remain unanswered are what is the role of polarised intracellular trafficking in the 
formation, extension, and functionality of invasive adhesions/protrusions in matrix 
remodelling? Second, what do invadopodia look like in vivo in a three-dimensional 
environment, and is it possible to identify them by morphological criteria? Is the 
current definition of invadopodia in 2D applicable to the 3D situation, and if not, 
how would it have to be modified?  
Implications for anti-angiogenic therapies 
This study has provided evidence that specifically increasing levels of HIF-1α either 
by chemical, over-expression or environmental strategies increases the invasive 
potential of cancer cells. Such data demonstrating a direct correlation between 
hypoxic environment and invasive potential has serious consequences for the 
treatment of solid tumours with anti-angiogenic agents. Anti-angiogenic therapy by 
way of targeting VEGF pathway has been thought to hold significant potential for  
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the treatment of cancer (Folkman et al., 1971). However, clinical trials among breast 
cancer patients reveal only limited effectiveness of anti-angiogenic agents in 
prolonging patient survival (Folkman, 2007). Recent research using preclinical 
models further suggests that the administration of anti-angiogenic agents generate 
intratumoral hypoxia which actually increases invasive and metastatic properties of 
breast cancer cells, mediated by the HIF-1α pathway (Conley et al., 2012). In 
contrast, a recent study has indicated that simultaneous inhibition of c-Met and 
VEGF signalling not only slows tumour growth but also reduces invasion and 
metastasis (Sennino et al., 2012). This suggests a role for HGF/c-Met pathway in 
development of resistance to anti-angiogenic therapy and represents a potential 
strategy to bypass resistance to VEGFR inhibition. 
 
How might tumours become more invasive during anti-angiogenic therapy? One 
possibility is that tumours may elevate the activity of a pre-
existing invasion program that was not previously the driving force of 
expansive tumour growth, given the capability for angiogenesis. Alternatively, 
some tumours may switch on an invasive growth program distinct from that arising 
spontaneously during unperturbed tumour development and progression. These 
observations suggest that the invasive growth program induced in response to 
therapy may be qualitatively different than the pathway used in 
normal tumour progression. The realization that potent angiogenesis inhibition can 
alter the natural history of tumours by increasing invasion and metastasis warrants 
clinical investigation, as the prospect has important implications for the development 
of enduring antiangiogenic therapies. In human tumours, the expression of MET 
correlates with HIF-1α expression (which is usually higher in the inner mass where 
oxygen diffusion is hampered) (Pennacchietti et al., 2003; Scarpino et al., 2004). 
HIF-1α can promote cell motility and invasion by inducing c-Met transcription (Hara 
et al., 2006; Pennacchietti et al., 2003) and sensitizing cells to HGF stimulation 
(Pennacchietti et al., 2003). A positive feedback loop may contribute to sustain and 
amplify MET over expression in hypoxic regions of solid tumours since the c-Met 
pathway induces both the Met gene itself (Boccaccio et al., 1994) and HIF-1 activity 
(Tacchini et al., 2001; Tacchini et al., 2003). In the future it will be important to 
better understand how hypoxia changes the behaviour of the cancer cell when 
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